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Abstract 





Adviser: Professor David Mootoo 
             C-Glycosides are carbohydrate analogues in which the glycosidic oxygen is replaced 
with a methylene substituent. Because of their stability under acidic hydrolysis or enzymatic 
cleavage, they are widely used as mimetics of their parent O-glycosides in medicinal chemistry. 
This thesis describes the development of new synthetic methods for C-glycosides, which center 
on the use of readily available, simple C-allyl glycosides as precursors. C- glycosides of three 
structurally distinct and pharmacologically interesting carbohydrates, the immunostimulatory 
glycolipid C-KRN700, the insulin mimetic glycoinositol β-galactosamine-(14)-3-O-methyl-D-
chiro-inositiol (INS-2), and α-mannose-(16)-D-myo-inositiol, a subunit of the cell wall in 
Mycobacterium tuberculosis, will be used as test cases for these methodologies.  
 
Chapter I and II 
            α-Galactosylceramide (α-GalCer) also called KRN7000 is a potent stimulant of invariant 
natural killer T (iNKT) cells. The C-glycoside of KRN7000 shows higher activity than its parent 
O-glycoside against malaria and melanoma in mice models. The high activity of C-KRN7000 
could be due to its hydrolytic stability or the way in which it interacts with receptors in the 
immunological pathway. New analogues of C-KRN7000 are needed to elucidate this picture.  
Two robust synthetic methodologies that can provide structurally diverse structures in the polar 
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head region were developed.  
              Chapter 1 describes the first approach, which entails: (i) the convergent union of 
relatively simple and readily accessible carbohydrate and lipid precursors to give a homoallylic 
alcohol, (ii) introduction of the amino group in the target via an iodocyclization reaction on 
derived homoallylic trichloroacetimidates and carboimidothioates. The cyclization reactions 
were evaluated for both E and Z alkene substrates. The E and Z trichloroacetimidates showed 
opposite facial selectivities, with the Z isomer providing the desired result for C-KRN7000. This 
stereochemical result is as expected for related electrophilic cyclizations. In contrast both E and 
Z carboimidothioates showed the same facial selectivity, in favor of the desired product. The 
iodo-carbamate products that were obtained from the reactions of the E and Z carboimidothioates 
were both processed to C-KRN7000 via established and straightforward deiodination and alcohol 
protecting group procedures. However, the elaboration of the iodo-oxazine products from the 
tricholoroacetimidate reactions was problematic.  
                Chapter II describes the second method, which centers on the Lewis acid mediated 
crotylation reaction of a C-glycoside crotylstannane on a simple α-alkoxy aldehyde to give 
diastereomeric homoallylic products. These products can be transformed to different 
diastereomers of C-KRN7000, and homologated and reverse amide analogues thereof. The 
diasteroselectivity of the crotylation reaction was examined and found to vary with the Lewis 
acid or the protecting group on the aldehyde. The key step in the processing of the crotylation 
products to C-glycosides of C-KRN700 was a Curtius rearrangement on the acyl azide derived 
from the terminal alkene in the crotylation product.  This chemistry was applied to C-KRN7000, 
its amide epimer, and an analogue of C-KRN7000 with a fluorine atom at the pseudoanomeric 
position.  
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Chapter III 
               As an extension to the crotylation chemistry in Chapter II, we developed a new 
approach to the synthesis of C-glycoinositols, which pivots on late stage construction of the 
inositol ring. The strategy uses easily accessed 3,4-dialkoxy-4-enals as aldehyde partners for C-
linked crotyltins. A ring closing metathesis (RCM) on the crotylation product gives a C-linked 
dioxygenated cyclohexene that can be converted to a fully oxygenated C-glycoinositol by a 
dihydroxylation reaction. Different alkene functionalization reactions on the RCM product leads 
to inositol with different functional groups. Using different combinations of crotylstannane and 
aldehydes can further increase analogue diversity. For a given crotylstannane the 
diastereoselectivity of crotylation reaction was found to vary with choice of Lewis acid and the 
stereochemistry of the aldehyde partner. This methodology was applied to the C-glycosides of 
INS-2 and α-mannose-(16)-D-myo-inositiol.  
         The results in Chapters II and II illustrate the attributes of the C-glycoside crotyltin 
methodology: (i) easy availability of the crotyltin and aldehyde precursors; (ii) the compatibility 
of the key segment coupling reaction with a variety of different functional groups; (iii) the 
synthetic versatility of the reaction products, which allows for a high throughput of complex and 
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C-Glycosides of α-GalCer 
1.1 Introduction 
              The immune response involves both innate and adaptive components. Innate immunity 
includes an immediate line of defense; the innate immune cells utilize evolved non-specific 
receptors to recognize a broad spectrum of pathogens or any foreign fragments that enter the 
body. Innate immune cells secret protein modulators “Cytokines” that act on neighboring cells, 
each receptor recognizes fragments of molecules that belong to a set of pathogens. This 
recognition event triggers a series of internal defenses, beginning with phagocytes; white blood 
cells recognize and engulf invading pathogens. Unlike the innate response, adaptive immunity is 
very specific and recognizes the returning pathogens that have infected the body previously. B-
cells and T-cells, types of white blood cells known as lymphocytes, are the major players in 
adaptive immunity, they recognize antigens, a fragments of pathogens presented on the cell 
surface. Upon recognition, lymphocytes undergo cell division and produce a set of new cells 
with memory; they can fight any future infections of the host by same pathogen. Some T cells 
help in activating other lymphocyte. Other T cells detect and kill infected host cells. Specific B 
cells secrete soluble receptor proteins that attack foreign molecules and cells circulating in body 
fluids.1 In the classical pathway of T-cell activation, a T cell is activated by a peptide antigen, 
which is presented on the surface of an antigen-presenting cell (APC) to the T cell by a multiple 
histocompatibility complex (MHC) class I or II molecule. The activated T cell then stimulates an 
immune response. Another antigen-presentation pathway involves cluster differentiation 1 
(CD1d) molecules. CD1d molecules are non-classical MHC class I molecules. They 
characteristically bind to lipids or glycolipid antigens and present them to natural killer T (NKT) 
cells.2 
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                       Figure 1.1 NKT cells activation by glycolipid-CD1d complex2 
 The accepted mechanism for stimulating NKT cells requires two distinct molecules on two 
different cell types. First the antigen is bound to the CD1d molecule on APCs (Figure 1.1). The 
antigen/CD1d complex is then recognized by the T cell receptor (TCR) on NKT cells. While 
TCRs on T cells involved in the MHC pathway are variable and specific to different peptide 
antigens, the TCR on NKT cells is invariant and recognizes complexes of CD1d and different 
glycolipid antigen. Upon recognition of the antigen/CD1d by the TCR, NKT cells secrete 
cytokines such as interferon-γ (IFN- γ) and interleukin-4 (IL-4), while the CD1d- bearing APCs 
secrete interleukin-12 (IL-12). This response regulates the differentiation of T helper cells into 
Th1/Th2 cells, thus affecting an inflammatory or immunomodulatory type response. Disruption 
of the natural Th1/Th2 balance is associated with different diseases. Thus, glycolipids that are 
biased to Th1 response are potential therapeutics against foreign pathogens, asthma and cancer, 
whereas Th2 biased glycolipids may be effective to autoimmune diseases caused by a hypo-
responsive to Th2 cells.4 α-Galactosylceramide (α-GalCer) also called KRN7000 (Figure 1.2) is 
one of the most potent glycolipid antigens for NKT cells.3 Structure activity relationship (SAR) 
for α-GalCer is an active area of research. Studies have focused on four major groups of 
analogues, categorized by modification of the sugar moiety, the configuration and the nature of 
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the anomeric bond, the polar head of the ceramide, and the lipid chains (Figure 1.2).4,5,6,7,8 
 
Figure 1.2 Major types of α-GalCer modifications. 







Modification of the sugar unit
Modification of polar head of ceramide







1.1 A, B, C, D = OH, (a-GalCer KRN7000)
1.2 A = COOH, B, C, D = OH
1.3 A = NHCOAr, B, C, D = OH
1.4 A, B, C = OH, D = F
1.5 A, B, D = OH, C = F
1.6 A, C, D = OH, B = F
1.7 R = C21H43 R' = C5H11 (OCH) 
1.8 R = (CH2)3Ph R' = C14H29
1.9 R = (CH2)5Ph R' = C14H29
1.10 R = (CH2)2Ph(p-F)
1.11 R1 = OH, R2 = F2,  R3,R4,R5, R6 = H
1.12 R1 = F, R2 = H, R3, R4,R5,R6 = H
1.13 R1 = F2, R2 = H, R3,R4,R5,R6 = H
1.14 R1 = OH, R2 = OH, R3, R4, R6 = H R5  = F2, 






Modification of anomeric center
1.16 X = CH2  a-C-GalCer
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                 Concerning the sugar moiety, D-galactose is found to be superior to D-glucose and D-
mannose.9 Introducing electron-withdrawing groups such as -COOH or -NHCOAr at C6 (1.2, 
1.3) of D-galactose increases the Th1 response.10,11 changing the OH group at position 2 in D-
galactose ring into F (1.4, Figure 1.2) gave completely inactive compound. While, Fluorinated 
derivatives of D-galactose (1.5, 1.6 Figure 1.2) still stimulate some NKT cell hydridomas based 
on Levels of IL-2 production.12,13 Regarding the lipid part modification, truncation of the 
sphingosine lipid chain (1.7, Figure 1.2) favors a Th2 response.14 In contrast, introducing 
aromatic residues on the fatty acid chain (e.g. 1.8-1.10) enhances the Th1 response.15,16 
Modification of the polar head of both lipid parts showed a significant Th1/Th2 polarization 
effect. Recently, new fluorinated analogues like 1.11, 4’, 4’-difluoro-KRN700017 have been 
examined; this analogue showed a Th1 bias response. In contrast, 1.14, 2’’, 2’’-difluoro-
KRN7000 exhibits a weak Th2 response. It was suggested that the hydrogen bonding between 
the amide and the TCR did not contribute to ternary complex stability. Pipelier18 and coworkers 
evaluated 3’-fluoro- 1.12 and the 3’, 3 ’-difluoro-3’, 4’-dideoxy-KRN7000 1.13, respectively. 
Analogue 1.12 with one fluorine atom at C3’ induced a very weak Th1 response compared to 
KRN7000. However, 1.13 the difluoro derivative restored Th1 activity similar to KRN7000, 
albeit still lower. Another interesting modification was made by Mori et al by introducing 
additional hydroxyl group on the sphingosine lipid e.g., compound 1.15, which showed Th2 
response with 35% less IL-4 compared to KRN7000.19  
                   One of the most active analogous used in mice is the C-glycoside α-C-GalCer 1.16, 
which shows a Th1 response and higher activity than its parent O-glycoside in a malaria model. 
α -C-GalCer was also 100-fold more active than α-GalCer in a melanoma model.20 However, the 
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stimulation of cytokine release in human iNKT cells by α-C-GalCer is very weak. Other C-
analogues E-alkene 1.19 and the truncated analogue 1.18 have shown more promise against 
human cells.21,22,23 The E- alkene shows high Th1 bias, with reduced overall potency than α -
GalCer (KRN7000) and 1.18 shows even higher Th1 bias but with lower potency. The α –S-
GalCer 1.17 was reported as totally inactive in mice.24 Just recently, has been evaluated to 
stimulate Th1 response in human cells.25 Llebaria et al reported another example for 
modification of the anomeric region; carbasugar derivatives with amine moiety at the anomeric 
center 1.20 and 1.21 were evaluated for Th1 response. Compound 1.20 is able to induce 
equivalent quantity of IFN-γ to that in KRN7000, 1.21 was slightly weaker with bias to Th2 
response.26   
                                      
Figure 1.3 Overlay of the sugar residues for α-GalCer (red/gray) in the mTCR ternary 
complex (3HE6) and α-CF2-GalCer (brown) in a conformation similar to that found for the 
α-C-GalCer in the ternary complex. Contancts for α-GalCer (green). Contacts for α--CF2-
GalCer (red). Contacts for the sugar segment (black) 
 
              Accordingly, it appears that the region of the phytosphingosine close to C1 of the sugar 
is a “hot- spot” for cytokine tuning. Thus, we are interested in synthesizing new analogues of α-


















Figure 3. Overlay of the sugar residues for !-GalCer 
(red/gray) in the mTCR ternary complex (3HE6) and  !-
CF2-GalCer (brown) in a conformation similar to that 
found for !-C-GalCer in the ternary complex. Contacts for  
!-GalCer (green); Contacts for!-CF2-GalCer (red). 
Contacts for the sugar segment  (black)
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Because of the relatively small size and low H-bonding capacity of the fluorine atom, and the 
large C-F bond dipole, these analogues are expected to form new stabilizing electrostatic 
interactions without introducing severely destabilizing steric interactions and disrupting existing 
H-bonds. A hypothetical Chem 3D binding model for the proposed CF2 analogue 1.24 compared 
to the bound complex for α-GalCer27 illustrates how these new fluorinated probes may interact 
in the ternary complex (Figure 1.3). 
 
1.2. Retrosynthetic Analysis of α-C-GalCer  
                 The synthesis of the C-glycoside of α-GalCer is challenging because both the sugar 
and aglycone segments are highly functionalized. Our synthetic strategy for 1.16, 1.23 and 1.24 
centers on intramolucular delivery of the C2’ nitrogen on a homoallyl alcohol template 1.25. An 
attractive feature of this plan is the versatility of 1.25, which means that 1.25 can serve as a key 
relying compound for 1.16, 1.23, and 1.24, and through other alkene reactions to other groups of 
analogues. These materials are possible via alkene metathesis protocols. Z alkenes can also be 
prepared via stabilized Wittig reactions. Thus our synthetic plan divides α-C-GalCer into readily 
accessible fragments 1.26 and 1.27 that could be prepared from simple and commercially 
available starting materials.  
 


























1.23 Y = CHF
1.24 Y = CF2
H
N
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         We envisaged an intramolecular nitrogen delivery step that was based on the electrophilic 
cyclization on a homoallylic imidate. Because the stereoselectivity of the product may vary with 
alkene geometry (vide infra) evaluation of this plan for both E and Z alkenes was necessary.  
 
 
Scheme 1.2 Stereochemical model for imidate cyclization         
                
             Based on the results by Kang and co-workers on simple non-sugar Z– and terminal 
alkenes, 28 for electrophile promoted alkene-heteroatom cyclization in substrates, which contain 
an allylic electronegative substituent, terminal alkenes are predicted to favor the product in 




















































a. Terminal  olefinic homoallylic trichloroacetamidate
b. Z-Olefinic homoallylic trichloroacetamidate
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syn (Scheme 1.2). This bias is attributed to the preference for a reactive conformation in which 
the allylic C-OPG bond is orthogonal to the plane of pi overlap and in an “inside” position 
relative to the alkene. For Z-disubstituted alkenes steric hindrance between the vinylic 
substituent and the heteroatom allylic substituent (A1,3 strain), overrides the electronic factors 
due to the allylic substituent (transition state 1.31).29 However, cyclization of homoallylic 
imidate of E-alkenes is not well explored. Thus, the stereochemistry outcome is not guaranteed, 
we decided to evaluate the cyclization on both E and Z alkenes substrates. 
Our synthetic strategy is to be distinguished from the epoxy-trichloroacetamidate 
cyclization procedure that has been used by Bittman and coworkers because it is more 
convergent, involves simpler chemistry and potentially more general in scope as far as 
substituent on the ethylene linker that connect the pseudo anomeric center to the attached 
aminated carbon in the acetamide  (Scheme 1.3). 30 
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1.3. Results and discussion 
1.3.1 Preliminary evaluation of E-homoallylic trichloroacetamidate 
 
Scheme 1.4: Iodocyclization on E-homoallylic alkene  
 
           The E homoallylic alkene 1.38 was obtained as the major isomer in the CM on readily 
accessible C-glycoside 1.36 and known alkene 1.37 (Scheme 1.4).31,38 An inseparable E/Z (4/1) 
mixture was obtained in 75% yield. Alcohol 1.38 was converted to trichloroacetamidate 1.39 by 
treatment with trichloroactonitrile and DBU at -20 oC. Electrophilic cyclization on 1.39 using IBr 
furnished oxazine 1.40 as the major diastereomer in 65% yield. The stereochemistry of 1.40 was 
















































Reagents and Conditions: a) alkene 27, 10% Grubbs II, DCM/reflux 16 h, 75 %. b) Cl3CCN, DBU, 
CH3CN  -20 oC, 20 min. c) IBr, K2CO3, CH3CN, -20 oC, 2h.
Scheme 4 Iodocyclization on E-homoallylic alkene
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analysis were helpful. This result indicates that the configuration at C2’ is epimeric to that 
required for KRN7000. This result suggests that the iodocyclization the E-homoallylic 
trichloroacetamidate as for analysis of terminal alkene substrates is controlled by the 
configuration at the allylic position. 
                                               









	   12	  
 
1.3.2 Preliminary evaluation of Z-homoallylic trichloroacetamidate  
        Z-alkene 1.48 was prepared via Wittig reaction of phosphonium salt 1.45 and aldehyde 1.47 
(Scheme 1.5). For 1.45, hydroxy alkene 1.41 was converted to silyl ether 1.42.   Ozonolysis of 
1.42 and reduction of the resulting aldehyde using NaBH4 gave the primary alcohol 1.43. The 
alcohol was then converted to phosphonium salt 1.45, via sequential treatment with I2-PPh3 and 
imidazole followed by excess PPh3 (85% over two steps). Protection of hydroxy alkene 1.37 with 
PMBCl and ozonolysis gave aldehyde 1.47 in 74% overall yield. The Wittig reaction on 1.45 and 
1.47 using NaHMDS as base produced Z olefin 1.48 in 53 % yield (based on 1.45). The TBS 
group in 1.48 was removed with TBAF. Acetylation of the resulting alcohol and subsequent 
removal of the PMB group afforded the desired homoallylic alcohol 1.51 (92 % yield). The silyl 
ether group was changed to acetate to prevent possible iodoetherification from C2-O of the sugar 
during the subsequent iodocyclization of the imidate. Alcohol 1.51 was converted to 
trichloroacetamidate 1.52. Treatment of 1.52 with IBr furnished oxazine 1.53 as the major 
product (65% yield). J = 5, 10 Hz of CHN in 1.53 supported the desired (S) configuration at C2’. 
H2’/H4’ nOe confirmed this assignment. Another important nOe was observed for the 
benzylidene proton and H3’ and H5’. Thus, this stereochemical result is consistent with that 
observed for simple Z-disubstituted alkene, i.e. stereoselectivity is controlled by geometry of 
alkene in the trichloroactamidate-electrophilic cyclization model.  
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1.41 R = H








1.43 R = OH





























1.48 R1 = TBS, R2 = PMB




































Reagents and conditions: a) TBSCl, imidazole, DMF, rt, 16h. b) 1.O3, DCM, -78 oC, PPh3, 3h,rt. 2. MeOH, 
NaBH4, 20 min 0 oC. c) PPh3, imidazole, I2, toluene, 60 oC. d) PPh3, fuse at 80 oC, 3h. e) NaH, DMF, PMBCl, 
2h, 0 oC-rt. f) O3, DCM, -78 oC, PPh 3, 3h,rt. g) NaHMDS, THF/DCM 2:1 -78 oC, then aldehyde 37, 16 h. 
h)1.THF, TBAF, 3h, 0 oC-rt. 2. EtOAc, Ac2O, DMAP. 3.DCM/H2O 10:1 DDQ, 30 min, rt. i)Cl3CCN, DBU, 
CH3CN, 20 min at -20 oC. j) IBr, K2CO3, CH3CN, -20 oC.
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1.3.3 Tethered Ring Closing Metathesis Approach to make the Z-alkene 
                     The foregoing results suggest that a Z-homoallylic precursor will be needed for the 
stereochemistry in the natural series of C-KRN7000 analogues. Thus, we suggest a more general 
synthesis of the Z-alkene precursors. In this content, Wittig protocol is laborious and might not 
be suitable for substrates with an electronegative moiety on the pseudoanomeric carbon because 
of competing elimination reactions of the ylides. Olefin metathesis strategy seemed a viable 
option. Grubbs and others developed Z-selective ruthenium and molybdenum catalyst for CM. 32, 
33 However, these catalysts are not practical for complex synthesis as they require in situ 
preparation and very anhydrous conditions. Therefore, we explored a (TRCM) protocol, which 
can be promoted by the more conventional, robust and commercially available Grubbs second-
generation catalyst (Grubbs II). 
 








































Reagents and conditions: a) Phthalic anhydride, DMAP, DCM, rt, 16 h. b) 2,4,6-trichlorobenzoyl chloride, Et3N, 
THF, 0 oC then alcohol 1.54 in toluene, DMAP. c) 5% Grubbs II catalyst, DCM, refluc 2h.
Scheme 6 Ring closing metathesis protocol to construct Z- alkene 57
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             A phthalate tethered RCM 34 was selected because it can be easily introduced and 
removed, and also gives rigidity to the forming ring, which could increase Z stereoselectivity. 
We tested our hypothesis on the bis alkene 1.56. Thus, half ester 1.55 was first prepared from 
alcohol 1.41 and phthalic anhydride in presence of DMAP (Scheme 1.6). Yamaguchi 
esterification on half ester 1.55 and known alcohol 1.54 (6 steps from D-mannitol),35 gave 1.56 
in 83% yield. Treatment of 1.56 with 5% Grubbs II catalyst at reflux in DCM afforded Z-alkene 
1.57 in 89% yield as the only RCM product. The Stereochemistry of 1.57 was assigned on the 
bases of Jvic = 9.0 Hz. 
 
1.3.4 α-C-GalCer via Homoallylic trichloroacetamidates  
               Z-alkene 1.57 could be easily elaborated to C-KRN7000 through standard 
transformation for introduction the lipid chain, followed by the nitrogen delivery protocol.  
However, we opted for a more convergent synthesis in which TRCM is performed on a precursor 
bis-alkene that already contained the required lipid segment. Thus, alkene 1.61 was selected to 
partner 1.41 in the TRCM protocol. The precursor for 1.61 is  (3S, 4R)-octadec-1-ene-3, 4-diol 
1.60, which can be prepared via Shapless asymmetric epoxidation methodology on divinyl 
carbinol but, for this study, it was obtained from D-ribose (Scheme 1.7). 36,37 Thus, CM on 
known compound 1.58 and 1-tetradecene using 10% Grubbs II catalyst followed by 
hydrogenation with Pd/C and Hydrogen gas gave alcohol 1.59, which was subjected to a 
sequence involving TEMPO oxidation, Wittig olefination and isopropylidene hydrolysis, to 
finish 1.60. Methoxybenzylidination on 1.60 and reductive acetal cleavage with DIBAL-H 
afforded 1.61.  
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Scheme 1.7 Synthesis of lipid precursors 
 
        Half phthalic acid 1.55 and alkene 1.61 were then converted to the mixed-phthalate 1.64, as 
described later, in 85% yield (Scheme 1.8). RCM on 1.64 using 5% Grubbs II catalyst led to Z 
alkene 1.65 in 93% yield, with no evidence of the E isomer. Oxidative cleavage of the PMB 
ether in 1.65 produced 1.66.  
        Intial attempt to make the E-homoallylic subatrate was by performing CM on 1.67 and 1.62. 
Unfortunately, this reaction was sluggish and low yielding. E-alkene 1.68 was collected in 20% 
yield after heating at reflux for four days. Interestingly, when the TRCM was repeated on bis-
alkene 1.69; we collected 1.70 as a major product in 75% yield. The phathalate group in 1.70 





















1.61 R = H 1.63
Reagents and conditions: a) ref 31. b) 1. Tetradecene, ethylene gas, 10% GII, 40 oC, 16 h. 2. EtOAc, 10% Pd/C, 
 H 2 gas, 16h, rt. c) 1.TEMPO, K 2CO3, NCS, DCM, 12h. 2. Ph 3PCH3Br, t-BuOK, THF, 0 oC. 3. MeOH,
 acetyl chloride (catalytic), rt, 16 h. d)1. p-anisaldehyde dimethyl acetal, CSA, DCM, 2 h, rt. 2. DIBAL-H, DCM, 
-78 oC to rt, 3h. e) DMF, NaH, BnBr, rt. 2 h. b) DDQ, DCM, NaHCO3,25 min. rt.
Sche e 7 Synthesis of lipid precursors
1.62 R = OBn
f
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1.71 by treatment with 1.5 eq of Ac2O and DMAP at -40 oC. The Stereochemistry of 1.71 was 
assigned on the bases of Jvic = 16.0 Hz. 
 



































1.41 R = H




Reagents and condition: a) 2,4,6-trichlorobenzoyl chloride, Et 3N, THF, 0 oC then compound 1.61 in toluene,
 DMAP, 85%.  b) 5% GII catalyst, DCM, ethylene gas, reflux 40 oC, 2 h, 93%. c) DDQ, DCM, NaHCO 3,
25 min. rt, 80% d) benzoyl chloride, pyridine, rt,16 h, 91% e) alkene 1.62, 20% GII catalyst, DCM, ethylene 
gas, reflux, 40 oC, 4 d, 20%. f) 2,4,6-trichlorobenzoyl chloride, Et3N, THF, 0 oC then compound 1.63 in toluene 83%. 
g) 1. DIBAL-H, DCM, -78 oC, 3 h, 89% 2) DCM, Ac2O (1.5 eq), DMAP, -40 oC to rt. 16 h, 60%.
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         The iodocyclization was first tested on the E-substrate 1.72 and the cyclic phthalate 
derivative of the Z-alkene 1.74. In both cases an ester group at the C-2 position of the sugar was 
chosen to avoid the possibility of iodo-etherification from the C-2 oxygen.38 Installation of the 
trichloroacetamidate on homoallylic alchohols 1.66 and 1.71 was performed as described earlier, 
and preceded in approximately 95% yield on both cases. Treatment of imidate 1.72 with IBr at -
78 oC gave oxazine 1.73 as a single isomer in 79% yield. Based on our previous results for E-
substrate 1.39, the stereochemistry was tentatively assigned as shown.  When the IBr conditions 
were applied to phthalate 1.74, only starting material was recovered.   
         However, with iodonium dicollidine perchlorate (IDCP) at rt oxazine 1.75 was collected as 
a major product, albeit in 40% yield. The apparent lower reactivity of 1.74 compare to 1.72 may 
be a result of steric and electronic effects. Therefore, It was decided to perform the cyclization on 
an acyclic Z-substrate. Thus a protecting group sequence involving DIBAL-H reduction, 
benzylation, and DDQ cleavage of the PMB group on 1.65 gave alcohol 1.76 in 75% overall 
yield. Installation of the imidate on 1.76 produced the required Z-substrate 1.77. Exposure of 
1.77 to IBr and anhydrous K2CO3 at -78 oC gave a 1:1 mixture of two compounds oxazine 1.78 
and oxazepine 1.79 in a total yield of 65% (Scheme 1.9); the given structures of 1.78 and 1.79 
were assigned from NMR data, but the stereochemistry at the newly formed centers were not 
determined. The stereochemistry in the oxazine 1.78 was tentatively assigned on the basis of the 
results for Z-alkene 1.39. Thus, oxazine 1.78 should be the right candidate for the C-KRN7000. 
Having oxazine 1.78 in hand, we turned our attention to elaborate 1.78 to C-KRN7000.   
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Scheme 1.9 Nitrogen delivery system using trichloroacetamidate 
 
               The key steps in this transformation are the reductive deiodonation step and conversion 
of the oxazine moiety to an amino-alcohol. Standard deiodenation on 1.78 using excess Bu3SnH-



















































































Reagents and conditions: a)  Cl3CCN, DBU, CH3CN, -25 oC, 95%. b) IBr, K2CO3, CH3CN, -78 oC. 75%
c) 1. DCM, DDQ, NaHCO 3, 25 min, 83%. 2) Cl3CCN, DBU, CH 3CN, -25 oC, 95%. d) IDCP, 4h, rt.
e) 1. DIBAL-H, DCM, -78 oC, 3h. 2. DMF, NaH, BnBr, 0 oC to rt, 3 h. 3. DCM, NaHCO 3, 
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Apparently, the trichlorinated carbon is more susceptible to reduction than the iodinated carbon. 
In addition, benzyl ether oxidation to benzoate was also observed. Using stochiometric Bu3SnH 
and degassing the reaction mixture prior the addition of AIBN and Bu3SnH gave the partially 
dechlorinated compound 1.81 as major compound in 40% yield. The same behaviour was 
observed when 1.78 was treated with Et3B/THF and Bu3SnH at 0 oC.41 Raney Ni in EtOH at 40 
oC42 also gave 1.81 (Scheme 1.10).  
 
Scheme 1.10 Trials for deiodination of 1.78 
          When LiEt3BH was used, only one of the chlorine atoms get reduced and iodide survived. 
In view of the complications from the trichloromethyl group during the deiodenation step, it was 
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liability of the iodide to base, oxazine hydrolysis was attempted under acidic conditions. For 
example, when compound 1.78 was treated with 1 M HCl in MeOH at, after stirring at rt for 6 h, 
only starting material was recovered and < 10% of amide- alcohol 1.83 was observed. When 1.78 
was dissolved in n-BuOH/MeOH mixture and treated with 6M HClat rt for 48 h (Scheme 1.11), 
the tetrahydrofuran 1.84 was obtained in 50% yield. This material was characterized by NMR 
and HRMS analysis as the amide 1.84. The stereochemistry for the newly formed C-O bond in 
1.85 is undefined. The formation of 1.85 may be explained by SN2 like reaction or may be 
double SN2 reaction due to neighboring group participation (Scheme 1.11). 
 
























































2. Pd/C/ MeOH/ rt/ 24 h.
Scheme 11 Acidic hydrolysis of the oxazine 1.78
Recovered
Starting Material+
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         Base promoted dehydro-deiodination of on 1.53 was also attempted. Treatment of 1.53 
with DBU43 at rt afforded 1.87 (Scheme 1.12). A similar behavior was also observed when 
oxazine 1.78 was treated with thiourea in effort to cleave the trichloromethyl group.  This 
regioselectivity of the elimination might be favored because of formation of the conjugated 
products.  
 
 Scheme 1.12 Attempted dehydroiodination using thiourea and DBU 
 
1.3.5 Intramolecular nitrogen delivery via carboimidothioate  
                In view of the problems in processing products from the iodocyclization of the 
homoallylic trichloroacetamidate, we turned our attention to the Knapp halocyclization44 of 
homoallylic carboimidothioates to cyclic iodo-carbamates. This type of cyclization has been 
reported for cyclopentane and cyclohexane frameworks, but to the best of our knowledge 



















































Scheme 12: Attempted dehydroiodination using thiourea and DBU
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examined. Following the results for the trichloroacetamidate cyclyzations, the Z-alkene was 
expected to favor the desired 1,3 syn selectivity45 for the newly created amino alcohol moiety, 
and the E-alkene to favor the 1,3 anti pattern.46  
 
Scheme 1.13 Carboimidothioate as a nitrogen delivery system  
 
           The homoallylic Z-carboimidithioate 1.88 was prepared by sequential treatment of the 
previously prepared alcohol 1.76, with sodium hydride, benzylisothiocyanate and iodomethane. 
For the E-substrate, the homoallylic alcohol 1.91 was first prepared from the tetra-O-benzyl 
alkene 1.90 via the CM procedure used on 1.67. Thus, CM on 1.90 (2 eq) and 1.63 (1 eq) using 





































1.41 R = H

































Reagents and conditions: a) 1. THF, NaH, BnNCS, rt, 3h, then MeI, rt, 1 h, 95%. b) DCM, IDCP, rt, 4h, 80%. 
c) 1.63, DCM, 10% GII,40 oC, 16 h, 55%. d) DCM, IDCP, rt, 16 h, 54%.
Scheme 13 Carboimidothioate as nitrogen delivery system
1.91 1.92 1.93
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was then prepared as for 1.88 (Scheme 1.13). Treatment of the Z-substrate 1.88 with IDCP at rt 
in DCM afforded the iodocarbamate 1.89 cleanly in 80% yield. The stereochemistry at the newly 
created 1,3 amino alcohol was assigned as syn by conversion of 1.90 to the eventual target (vide 
infra). The relative stereochemistry at the iodinated carbon was deduced from the established 
anti addition in these reactions. Iodocyclization of the E substrate 1.92 also gave a single 
stereoisomer, albeit the reaction was very sluggish compare to the Z substrate and gave an 
apparently lower yield (54%) after 16 h at rt. Interestingly, the newly formed C-N in 89 was 
shown to have the same stereochemistry as in 1.89, by subsequent deiodoination of both 1.89 and 
1.93 to the identical product 1.94 (Scheme 1.14). Thus, the reactions of these homoallylic 
carboimidothioates show identical facial selectivity in the iodocyclization on both E and Z 
alkenes, regardless of alkene geometry; i.e. in both cases E and Z alkenes favor the related 
carbamate of the syn 1,3 amino alcohol. This result is in contrast to the iodocyclization of E- and 
Z-trichloroacetamidate, in which the Z-alkenes give the syn 1,3 motif, but the E-substrates give 
the anti-1,3 pattern.46 
 





































Reagents and conditions a) Bu 3SnH, AIBN, PhH, 80 oC, 1h b) 2M KOH in EtOH:THF:H 2O, sealed tube,
 120 oC, 6h, 90% c) 1. 10% Pd/C, cyclohexene-MeOH, 1N HCl, 65 oC, reflux, 4 h. 2. p-nitrophenyl hexacosanoate, 
DMAP, THF, 48 h, rt, 55% (over 3 (steps).
Scheme 4 End games for C-KRN7000
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The different stereochemical result seen for the E alkenes in the carboimidothioate vs 
trichloroacetamidate substrate may be due to steric effects brought about the benzyl substituent 
that is present on the nucleophilic nitrogen in the carboimidothioate but not on the nitrogen of the 
trichloroacetamidate. Thus, following a reactant-like transition state (TS) generally invoked for 
such cyclization competing TSs A and A’, in which the alkene is eclipsed with the allylic C-H or 
C-O bond are envisaged (Figure 1.5).47  
 
Figure 1.5 Transition states for iodocyclization of E-carboimidothioates 
           TS A’ is disfavored in the carboimidothioate cyclization even though it is electronically 
stabilized (alkene eclipsing the allylic OBn), because steric interactions involving the forming 
pseudoaxial sustituent and the pseudoaxial hydrogen and the benzyl group on the nitrogen are 
more crucial. Therefore TS A’, which matches the syn 1,3 product 1.93 is favored. In the case of 



















TS A for 1.92
electronically disfavored
sterically favored




















1.93 (syn-1,3-amino alcohol) 1.93' (anti-1,3-amino alcohol)
Figure 5. Transition states for iodocyclization of E-carboimidothioates
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because the absence of the benzyl group that is responsible for the destabilizing steric 
interactions in the carboimidothioate substrate. 
              Bu3SnH deiodination of 1.89 and 1.93 provided in 70% and 45% yields, respectively, 
the identical product 1.94, as judged by HRMS as well as 1H and 13C NMR (Scheme 1.14). The 
synthetic ramification of these results is that either E or Z alkene precursors can be used for the 
C-KRN7000, albeit the Z precursor would be more productive. Following procedures for the 
processing of related derivatives, 1.94 was transformed to C-KRN7000 1.96 in 55% yield over a 
three-step sequence including carbamate hydrolysis, cleavage of benzyl protecting groups, and 
amidation with p-nitrophenyl hexacosanoate. The 1H and 13C NMR of the final product were 
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Table 1.1: Comparison of 1H and 13C NMR data 
 Dr. Franck20 Dr. Bittman30 Our Data 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   







8.47 (d, J = 8.8 Hz, 1H), 
6.78-6.00 (br, 6H, OH), 
5.14 (m, 1H),  
4.74 (dd, J = 5.5, 8.8 Hz), 
4.52 (m, 3H),  
4.37 (dd, J = 4.3, 11.0), 
4.25 (m, 4H),  
2.72 (m, 1H),  
2.59 (m, 1H),  
2.48 (m, 3H),  
2.33 (m, 2H), 
 2.22 (m, 1H), 
 1.94 (m, 2H),  
1.86 (m, 3H), 
 1.71 (m, 1H), 
 1.37 (s, 64H), 
 0.88 (t, J = 6.4 Hz, 6H). 
8.55 (d, J = 9.0 Hz, 1H) 
  
5.21-5.14 (m, 1H)  
4.76 (dd, J = 5.5, 8.9 Hz, 1H) 
4.57-4.50 (m, 3H) 
 4.38 (dd, J = 4.6, 11.2 Hz, 
1H) 4.29-4.19 (m, 4H)  
2.80-2.71 (m, 1H) 
 2.67-2.57 (m, 1H) 
 2.52-2.43 (m, 2H) 
 2.40-2.28 (m, 2H) 
 2.27-2.17 (m, 1H) 
 2.01-1.90 (m, 2H)  
1.91-1.82 (m, 2H)  
1.76-1.66 (m, 1H)  
1.50-1.16 (m, 66H)  
0.87 (t, J = 6.4 Hz, 6H) 
8.47 (d, J = 7.1 Hz, 1H),  
5.7 (br, 6H),  
5.14 (m, 1H), 
 4.74 (dd, J = 9.0, 5.5 Hz), 
4.52 (m, 3H),  
4.37 (dd, J = 11.2, 4.6), 
4.25 (m, 4H),  
2.73 (m, 1H), 
 2.60 (m, 1H), 
 2.46 (m, 2H),  
2.32 (m, 2H), 
 2.20 (m, 1H), 
 1.94 (m, 2H), 
 1.87 (m, 3H),  
1.70 (m, 1H),  
1.25 (m, 64H), 
 0.88 (t, J = 7.0 Hz, 6H). 







173.4, 78.4, 76.9, 73.6, 
72.5, 72.1, 70.5, 70.3, 
62.6, 52.6, 36.9, 34.3, 
32.0, 30.3, 30.1, 29.9, 
29.7, 29.5, 26.4, 22.8, 
14.1 
173.8, 79.0, 77.6, 74.2, 73.0, 
72.7, 71.1, 70.8, 63.2, 53.1, 
37.4, 34.9, 32.6, 30.7, 30.5, 
30.3, 30.1, 30.1, 26.9, 23.4, 
14.8 
173.9, 79.0, 77.6, 74.2, 
73.1, 72.7, 71.1, 70.8, 
63.2, 53.1, 37.4, 32.6, 
30.9, 30.7, 30.4, 30.3, 
30.1, 27.0, 27.0, 23.4, 14.7 
HRMS   878.7430 
 
 
1.4 Synthesis of fatty acid analogues of C-KRN7000.    
              O-GalCer derivatives with aromatic moieties at the end of the acyl chain have been 
shown to elicit a Th1 bias in iNKT cells. The p-fluoro derivative 1.98 was exhibited a higher 
level of IFN-γ than the non-fluorinated analogue 1.97 (Scheme 1.15).48,49 To evaluate whether 
that trend extends to the C-glycoside series, 1.99 and 1.100 were prepared. Known acids50 1.105 
and 1.106 were made in the same way from commercially available undec-10-enoic acid 1.99 
and Wittig salts 1.101 and 1.102.  Catalytic hydrogenation of alkenes 1.103 or 1.104 followed by 
basic hydrolysis gave the corresponding acids 1.105 and 1.106, respectively. The acids were 
converted to the corresponding p-NO2 phenyl esters 1.107 and 1.108 for the amidation step. 
Accordingly, hydrogenolysis of the previously obtained derivative 1.95, followed by amidation 
of the product with 1.107 and 1.108 produced 1.109 and 1.110 respectively. These materials 
were purified and characterized as the peracetylated derivatives 1.111 and 1.112.  
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Scheme 1.15 Synthesis of C-KRN7000 analogues with aromatic groups on the end of the 









































1.101 R = H
1.02   R =F
1.103 R = H
1.104 R =F
1.109 R = H
1.110 R =F



















1.97 X = H
1.98 X = F
Reagents and conditions a), 1. MeOH, TMSCl (catalytic), rt, 12 h. 2. DCM, O 3 steam, 5 min, then PPh 3, rt, 2 h.
 b) THF, t-BuOK, 1.101 or 1.102, then aldehyde 1.100. c)1. MeOH, Pd/C, H2 gas, rt, 16 h. 2. 2M NaOH, MeOH, rt, 3 h.
d) p-NO2 phenol, DMAP, THF, DCC, rt, 12 h. e) 1. 10% Pd/C, cyclohexene-MeOH, 1N HCl, 65 oC, reflux, 4 h.
 2. 1.107 or 1.108, DMAP, THF, 48 h, rt. f) EtOAc, Ac2O, DMAP, rt, 30 min
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1.5 C-KRN7000 analogues with fluorine at the pseudoanomeric position 
          Fluorination of bioactive compounds is a popular strategy for improving the drug efficacy. 
This may be a result of the high electronegativity but low steric demand of the fluorine. The Van 
der Waals radius for fluorine rν  (1.47 A°) lies between that for oxygen (1.57 A°) and hydrogen 
(1.2 A°). Thus, the electronegativity of the fluorine atom may lead to new polar contacts with 
receptors without sever ateric demands. The low polarizability of fluorine may also contribute to 
decrease lipophilicity of some fluorinated hydrocarbons compared to its parent and that may 
enhance membrane permeability and their oral bioavailability.51 Introducing fluorine can also 
induce conformation changes where the fluorine atom is vicinal to another electronegative atom, 
a gauche relation between the fluorine atom and the vicinal electronegative atom is expected 
rather than anti conformation. This orientation is expected because of optimum stabilizing 
hyperconjugation effect (σ-σ∗), where the fluorine atom prefers anti relation with C-H bond. If 
this gauche conformation is favors the active conformation of a drug, activity may be 
enhanced.52 Another important feature of fluorinated compounds is the great resistance of C-F vs 
C-H bonds to oxidative metabolism, which may lead to improved bioavailability of fluorinated 
compounds. 
          Compared to their hydrocarbon analogues, the importance of fluorinated compounds 
demands new synthetic methodologies to introduce fluorine atoms selectively and practically. In 
carbohydrate synthesis, three major classes of reactions are used generally to introduce a fluorine 
atom: free radical fluorination, neucleophilic fluorination, and electrophilic fluorination.53 For 
application of our iodocyclization strategy to C-glycosides with fluorine at the pseudo anomeric 
position, we required fluorinated C-glycoside like 1.119. Our lab had previously developed a 
	   31	  
procedure for making such derivatives (Scheme 1.16),54 via the electrophilic fluorination of a C-
glycoside allylsilanes. Following this strategy, CM between the readily accessible C-glycoside 
alkene 1.113 and allyl trimethylsilane gave 1.114, which was subjected to electrophilic 
fluorination using Select Fluor® to give 1.115 in 60% yield as 1:1 fluorinated mixture of epimers. 
For a more stereoselective fluorination procedure, we next evaluated the Jorgensen 
organocatalytic fluorination of aldehydes (Scheme 1.16).55 Thus, treatment of known aldehyde 
1.117 with Jorgensen catalyst® followed by NFSI afforded the α-fluorinated aldehyde 1.118. 
However, due to the instability of 1.118, the crude product was converted to alkene 1.119 using 
Wittig olefination. Fluorination-Wittig protocol gave 1.119 as a major product in 55% overall 
yield from 1.117. The β-analogue of 1.119 was also obtained in 20% yield. This product might 
be formed via retro-Michael type reaction prior to or after the fluorination step. 56 The 
stereochemistry in fluoro aldehyde 1.118 was confirmed by making the lactone 1.122. Reduction 
of 1.118 followed by oxidative cleavage of the PMB group with DDQ gave diol 1.121, which 
was treated with TEMPO and N- chlorosuccinimide (NCS) to afford lactone 1.122. 2D COSY 
and NOESY between the CHF proton and the H2 in the sugar ring confirmed the stereochemistry 
in 1.122. The (S) configuration at the fluorinated carbon is consistent with the model proposed 
by Jorgensen. 
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Scheme 1.16 Synthesis of fluorinated galactose derivatives  
 
With allylic fluoride 1.120 in hand, we next performed the TRCM protocol with previously 
obtained allylic alcohol 1.61. Surprisingly the RCM reaction on bis-alkene 1.124 gave 1.125 as 
the major product, the E-alkene 1.125 and not the Z product as seen in the RCM of the non-
fluorinated structures (Scheme 1.17). The geometry of alkene 1.125 was confirmed by 1HNMR, 































1.41 R = H











































Reagents and conditions: a) MeOH, 10% GII, 65 oC, 16 h. b) DCM, AllylTMS, 10% GII, 40 oC, 16 h. 
c) CH 3CN, select fluor, rt, 16 h. d) DMF, NaH, PMBCl. e) DCM, 10% MeOH, O 3 stream, -78 oC, 5 min,
 then PPh 3, rt, 2h. MTBE, (S)-Jorgensen cata;yst, rt, 15 min, then NFSI, rt, 4h. g) Ph 3PCH3Br, NaHMDS, 
THF, -78 oC to rt, then aldehyde 1.118. rt, 16 h. h) DCM, NaHCO3, DDQ rt, 25 min i) 1. MeOH, NaBH4, 0 oC, 
20 min. 2. DCM, NaHCO3, DDQ rt, 25 min. j) TEMPO, TBACl, K2CO3, NCS, DCM, rt, 2h.
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was converted to the carboimidothioate 1.127. Unfortunately, no reaction was observed when 
1.127 was treated with IDCP under the standard conditions. Use of the more reactive promoter 
bromonium dicollidine perchlorate (BDCP) gave an unrelated and unidentified product. This 
resut suggests that the electrophilic cyclization strategy on E-homoallylic substrates may be 
problematic on allylic fluorides such as 1.127.   It is possible that the reaction may proceed more 
smoothly on the Z- analogue of 1.127. Alternatively, for the fluorinated C-KRN7000 analogues, 
the simple fluorinated C-glycosides 1.119 and 1.120 can be used in other methodologies as will 
be illustrated in chapter II.  
  





















































Reagents and condition:  a) pyridine, phthalic anhydride, DMAP, rt, 1 h. b) 2,4,6-trichlorobenzoyl chloride, Et3N, 
THF, 0 oC then compound 51 in toluene, DMAP. c)  5% GII catalyst, DCM, ethylene gas, reflux 40 oC, 16 h.
d) 1. DCM, DIBAL-H, -78 oC, 3h. 2. DMF, NaH, BnBr, rt, 2 h. 3. )DDQ, DCM, NaHCO 3,25 min. rt.








	   34	  
1.6 Conclusion: 
           In summary, we have developed a convergent and highly stereoselective procedure for the 
synthesis of C-glycoside of KRN7000. Our methodology centers on the convergent union of 
relatively simple and readily accessible carbohydrate and lipid precursors. Two 
diastereoselective procedures were developed for E and Z alkenes respectively. Electrophilic 
cyclization on derived E and Z homoallylic carboimidothioates were found to be superior to their 
trichloroacetamidate derivatives, both have been illustrated in the synthesis of the glycolipid C-
KRN7000. We found that carbonimidothioate is superior to trichloroacetamidate derivatives in 
terms of stereoselectivity and processing of the reaction precursors to the desired C-glycoside. 
However or initial studies suggests that the key elecrtophilic cyclization used for nitrogen 
delivery may be problematic for homoallylic alcohol derivatives that contain a highly 
electronegative substituent at the pseudoanomeric position. A practical protocol for introducing 
fluorine into complex carbohydrate derivatives based on the Jorgensen organocatlytic 
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1.7 Experimental Part: 
1.7.1 General   
Unless otherwise stated, all reactions were carried out under a nitrogen atmosphere in oven-dried 
glassware using standard syringe and septa technique. 1H and 13C NMR spectra were obtained on 
a Bruker (500 MHz) spectrometer. Chemical shifts are relative to the deuterated solvent peak or 
the tetramethylsilane (TMS) peak at (δ 0.00) and are in parts per million (ppm). Assignments for 
selected nuclei were determined from 1H COSY experiments. Thin layer chromatography (TLC) 
was done on 0.25 mm thick pre-coated silica gel HF254 aluminum sheets. Chromatograms were 
observed under UV (short and long wavelength) light, and/or were visualized by heating plates 
that were dipped in a solution of ammonium (VI) molybdate tetrahydrate (12.5 g) and cerium 
(IV) sulfate tetrahydrate (5.0 g) in 10% aqueous sulphuric acid (500 mL). Flash column 
chromatography (FCC) was performed using silica gel 60 (230-400 mesh) and employed a 
stepwise solvent polarity gradient, correlated with TLC mobility. Petroleum ether used for FCC 
had a boiling point in the 40-60 oC range.  
  
E/Z alkene mixture 1.38 
 
          Ethylene gas was bubbled through a mixture of alkene 1.36 (370 mg, 1 mmol) and alkene 1.37 
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then added. The reaction mixture was heated at reflux for 16 h. The solvent was concentrated in vacuo 
and the crude mixture was subjected to FCC to give mixture 1.38 (75%): Rf = 0.15 (40% EtOAc/PE); 
1HNMR (500Mz, CDCl3) δ 7.45 (m, 5H), 5.85 (m, 1H), 5.69 (dd, J = 15.5, 7 Hz, 1H), 5.54 (s, 1H), 5.42 
(t, J = 3.7 Hz, 1H), 5.23 (dd, J = 7.4, 3.3 Hz, 1H), 5.18 (dd, J = 7.3, 3.9 Hz, 1H) 4.61 (dd, J = 11.7, 8.1 
Hz, 1H), 4.38 (m, 1H) 4.31 (m, 1 H) 4.14 (m, 1H) 4.02 (t, J = 7.8 Hz, 1H), 3.97 (dd, J = 11.9, 4.8 Hz, 
1H), 3.65 (m, 2H), 2.51 (m, 1H), 2.28 (m, 1H), 2.15 (s, 3H), 2.13 (s, 3H), 2.10 (s, 3H), 2.07 (s, 3H). 
13CNMR (125 MHz, CDCl3) δ 171.6, 170.4, 170.1, 169.8, 137.8, 130.4, 130.0, 129.2, 128.5, 128.5, 
126.4, 101.2, 83.3, 71.0, 69.8, 68.8, 68.0, 67.8, 66.9, 65.5, 60.6, 31.4, 21.1, 21.0, 20.9, 20.8. 
 
E/Z Homoallylic trichloroacetamidate 1.39 
 
           To a solution of alcohol 1.38 (550 mg, 1 mmol) in dry CH3CN (20 mL) at -25 oC was 
added DBU (164 µL, 1.1mmol) and CCl3CN (250 µL, 2.5 mmol). The reaction was stirred at this 
temperature for 20 min, and then diluted with water. The reaction mixture was extracted with 
EtOAc (3 X 5 mL). The organic phase was washed with brine and dried (Na2SO4), filtered, and 
concentrated in vacuo. The crude residue was purified by FCC to give 1.39 (85%): Rf = 0.58 
(40% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 8.43 (s, 1H), 7.30 (m, 5H), 5.77 (m, 1H), 5.64 (m, 
1H), 5.52 (s, 1H), 5.32 (m, 1H), 5.16 (m, 2H), 4.92 (td, J = 12.1, 5.2 Hz, 1H), 4.52 (dd, J = 10.7, 













	   37	  
Hz, 1H), 3.98 (m, 2H), 3.68 (t, J = 10.4 Hz, 1H), 2.41 (m, 1H), 2.16 (m, 1H), 2.04 (s, 3H), 1.98 
(s, 3H), 1.95 (s, 3H), 1.87 (s, 3H). 13CNMR (125 MHz, CDCl3) δ 170.8, 170.3, 170.15, 170.0, 
161.6, 137.4, 130.0, 129.4, 129.0, 128.6, 128.5, 126.5, 101.7, 79.8, 71.7, 70.6, 68.5, 68.3, 68.0, 




              To a solution of imidate 1.39 (530 mg, 0.76mmol) in dry CH3CN (15 ml) at -25 oC was 
added anhydrous K2CO3 (207 mg, 1.5 mmol) and IBr (315 mg, 1.5 mmol). The reaction was 
stirred at this temperature for 2 h and then diluted with water. The reaction mixture was extracted 
with EtOAc (3 X 5 mL). The organic phase was washed with brine and dried (Na2SO4), filtered, 
and concentrated in vacuo. The crude material was purified by FCC. 1HNMR (500Mz, CDCl3) δ 
7.12 (d, 2H), 7.10 (t, 2H), 7.09 (t, 1H), (m, 5H), 5.57 (m, 1H), 5.48 (m, 1H), 5.39 (m, 1H), 5.09 
(s, 1H), 4.77 (m, 2H), 4.55 (m, 1H), 4.29 (m, 1H) 3.97 (dd, J = 6.5, 4.8 Hz, 1 H) 3.92 (m, 2H), 
3.84 (m, 1H), 3.36 (dd, J = 8.9, 7.7 Hz, 1H), 3.18 (t, J = 10.2 Hz, 1H), 2.18 (m, 2H), 1.77 (s, 3H), 
1.68 (s, 3H), 1.59 (s, 3H), 1.47 (s, 3H). 13CNMR (125 MHz, CDCl3) δ 170.3, 170.0, 169.5, 
153.3, 137.5, 130.0, 129.4, 129.0, 126.9, 103.1, 76.7, 72.1, 69.5, 68.7, 68.3, 68.1, 67.3, 62.3, 
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Alkene 1.46 
 
          To a solution of alcohol 1.37 (1 g, 4.85 mmol) in dry DMF (20 mL) at 0 oC was added 
NaH (213 mg, 5.3 mmol). The reaction was stirred at this temperature for 15 min. Then, PMBCl 
(1.0 mL, 7.2 mmol) was added slowly. The reaction mixture was stirred at r.t for an additional 2 
h, then diluted with water and extracted with EtOAc (3X25 mL). The organic phase was washed 
with brine, dried (Na2SO4), filtered, and concentrated in vacuo, the crude material was purified 
by FCC to give 1.46. 1HNMR (500Mz, CDCl3) δ 7.48 (d, J = 1.8 Hz, 2H), 7.32 (m, 3H), 7.23 (d, 
J = 9.2 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H) 6.03 (ddd, J = 17.3, 10.8, 5.8 Hz, 1H), 5.35 (dd, J = 
95.8, 16.8, Hz 2H), 4.45 (m, 2H), 4.25 (dd, J = 10.9, 5.1 Hz, 1H), 4.12 (dd, J = 9.2, 5.9 Hz, 1H), 
3.79 (s, 3H), 3.62 (t, J = 10.4, 1H) 3.42 (dt, J = 9.5, 5.1 Hz, 1 H), 13CNMR (125 MHz, CDCl3) δ 




              A stream of O3 gas was passed through a solution of alkene 1.46 (1.00 g, 3.06 mmol) in 
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reaction mixture. The reaction mixture was warmed to rt and stirred for 2 h. The organic solvent 
was concentrated in vacuo. The crude material was purified by FCC.  
 
α-C-allyl galactose 1.42 
 
             TBSCl (175 mg, 1.16 mmol) and imidazole (143 mg, 2.1 mmol) were added to a solution 
of alcohol 1.41 (500 mg 1.05 mmol) in dry DMF (10 mL). The reaction mixture was stirred at rt 
for 12 h. The reaction was diluted with water and extracted with EtOAc (3X25 mL). The organic 
phase was washed with brine, dried (Na2SO4), filtered, and concentrated in vacuo The crude 
residue was purified by FCC. 1HNMR (500Mz, CDCl3) δ 7.32-7.30 (m, 15H), 5.78 (m, 1H), 5.00 
(m, 2H), 4.68-4.41 (m, 6H), 3.97 (m, 1H), 3.90 (m, 2H), 3.86 (ddd, J = 9.8, 9.0, 4.1 Hz, 1H), 
3.77 (t, J = 10.5 Hz, 1H), 3.62 (dd, J = 10.6, 4.7 Hz, 1H), 3.50 (dd, J = 7.0, 2.7 Hz, 1H), 2.27 (m, 
2H), 0.83 (s, 9H), 0.00 (s, 3H), -0.06 (s, 3H). 13CNMR (125 MHz, CDCl3) δ 138.8, 138.7, 135.7, 
128.5, 128.5, 128.1, 127.9, 127.8, 127.7, 127.6, 116.7, 78.5, 74.2, 73.4, 73.2, 73.2, 72.7, 70.3, 
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α-C-allyl galactose 1.43 
 
              A stream of O3 gas was passed through a solution of 1.42 (1.0 g, 1.7 mmol) in CH2Cl2 
(150 mL) at -78 oC for 10 min, then PPh3 (500 mg, 1.9 mmol) was added and the reaction 
mixture stirred at rt for 2 h. The organic solvent was concentrated in vacuo. 1HNMR (500Mz, 
CDCl3) δ 9.75 (s, 1H), 7.32-7.30 (m, 15H), 4.73-4.5 (m, 7H), 4.03 (m, 1H), 4.00 (m, 1H), 3.96 
(m, 1H), 3.86 (t, J = 10.3 Hz, 1H), 3.68 (dd, J = 10.6, 4.5 Hz, 1H), 3.54 (dd, J = 6.7, 2.5 Hz, 1H), 
2.62 (m, 2H), 0.83 (s, 9H), 0.00 (s, 3H), -0.05 (s, 3H). 13CNMR (125 MHz, CDCl3) δ 201.3, 
138.5, 128.6, 128.5, 128.0, 127.9, 127.8, 127.7, 78.2, 73.7, 73.4, 73.3, 70.1, 68.2, 67.3, 42.9, 
26.0, 18.2, -4.5, -4.7.  
             The crude material was used without purification. To a solution of the resulting aldehyde 
in methanol (20 mL) at 0 oC was added slowly NaBH4 (125 mg, 3.5 mmol). Reaction mixture 
was stirred for 30 min and then mixed with saturated solution of NH4Cl (5 mL). The organic 
solvent was concentrated in vacuo. The crude mixture was dissolved in EtOAc (100 mL) and the 
organic layer was washed with NaHCO3 (25 mL), brine (25 mL) and dried (Na2SO4). The residue 
obtained upon concentration in vacuo was subjected to FCC to give 1.43 ascolorless oil (830 mg, 
81.4 %): Rf = 0.25 (20%EtOAc/Hexane); 1HNMR (500Mz, CDCl3) δ 7.32-7.30 (m, 15H), 4.71-
4.50 (m, 6H), 4.09 (m, 2H), 3.98 (t, J = 10.05 Hz, 1H), 3.89 (m, 2H), 3.75 (m,2H), 3.55 (dd, J = 
6.6, 2.8 Hz, 1H), 3.51 (dd, J = 10.7, 3.5 Hz, 1H), 1.90 (m, 1H), 1.61 (m, 1H), 0.83 (s, 9H), 0.00 
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128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 78.4, 74.0, 73.4, 73.0, 72.4, 70.8, 67.8, 61.7, 30.0, 26.2, 
26.0, 25.9, 25.8, 18.2, -4.6, -4.7.  
 
Triphenyl phosphonium salt 1.45 
 
          To a stirred solution of alcohol 1.43 (630 mg, 1.06 mmol), in anhydrous toluene at 40 oC 
were added pph3 (837 mg, 3.48 mmol) and imidazole (289 mg, 4.24 mmol); the reaction mixture 
was stirred at this temperature for 15 min. Then, the reaction mixture was then cooled down to rt, 
I2 (673 mg, 2.65) was added and stirring continued for 30 min. The reaction mixture was 
quenched with saturated aqueous sodium thiosulphate solution and the mixture extracted with 
EtOAc (3X50 mL). The organic phase was washed with brine, dried (Na2SO4) and concentrated 
in vacuo. The residue was subjected to FCC to give iodo derivative as colorless oil (691 mg, 
93%): Rf = 0.6 (10 % EOAc/Hexanes); 1HNMR (500 MHz, CDCl3) δ 7.30-7.23 (m, 15H), 4.70-
4.45 (m, 6H), 3.99 (ddd, J = 10.6, 6.9, 3.5 Hz, 1H), 3.93-3.89 (m, 2H), 3.67 (dd, J = 10.4, 4.1 Hz, 
1H), 3.49 (dd, J = 6.9, 2.6 Hz, 1H), 3.27 (m, 1H), 3.18 (m, 1H), 2.05 (m, 1H), 1.92 (m, 1H), 0.82 
(s, 9H), 0.00 (s, 3H), -0.06 (s, 3H). 13CNMR (125 MHz, CDCl3) δ 138.7, 138.6, 128.7, 128.6, 
128.5, 128.4, 128.1, 128.0, 127.9, 127.8, 127.7, 78.8, 74.1, 73.6, 73.2, 72.9, 70.4, 68.1, 31.8, 
26.2, 26.0, 25.9, 25.8, 18.2, 3.6, -4.6, -4.7.  
       Compound from previous step (691 mg, 0.984 mmol) was fused with PPh3   (2.24 g, 8.5 
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and 1:1 DCM/acetone to give compound 1.45 (845 mg, 88 %); 1HNMR (500Mz, CDCl3) δ 7.75 
(m, 15 H), 7.65 (m, 15H), 4.61-4.47 (m, 6H), 4.13 (m, 2H), 4.04 (m, 1H), 3.86 (m, 1H), 3.75 (m, 
1H), 3.69 (1H), 3.65 (d, J = 7.6 Hz, 1H), 3.62 (dd, J = 5.7, 2.8 Hz, 1H), 3.43 (m, 1H), 2.07-1.83 
(m, 2H), 0.60 (s, 9H), -0.20 (s, 3H), -0.28 (s, 3H). 13CNMR (125 MHz, CDCl3) δ 139.0, 138.5, 
135.2, 134.0, 133.9, 130.8, 130.7, 128.6, 128.5, 128.1, 128.0, 127.9, 127.7, 127.6, 118.7, 118.0, 
73.9, 73.6, 73.5, 73.0, 72.4, 70.3, 68.1, 25.9, 23.2, 19.7, 19.3, 18.0, -4.6, -4.9. 
 
Z-Alkene 1.48  
 
         NaHMDS (0.57 mL of 2 M in THF, 1.14mmol) was added at -78 oCto a solution of 
phosphonium salt 1.45 (1.1 g, 1.14 mmol) in anhydrous 2:1 THF/DCM (24 mL), the resulting 
bright orange solution was stirred for 1 h at this temperature. The aldehyde 1.47 (450 mg, 1.37 
mmol) in a THF (10 mL) was then added and the resulting mixture was warmed up slowly to rt 
over 5 h. The reaction mixture was then poured into saturated solution of NH4Cl and extracted 
with EtOAc (4X50mL). The organic phase was washed with brine, dried (Na2SO4), filtered, and 
evaporated under reduced pressure. FCC of the crude product 1.48 (385 mg, 46%): Rf = 0.23 
(10%EtOAc/Hexanes); 1HNMR (500Mz, CDCl3) δ 7.38-7.20 (m, 22H), 6.8 (m, 2H), 5.8 (m, 
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(m, 3H), 3.89 (m, 1H), 3.32 (m, 1H), 3.79 (s, 3H), 3.64 (m, 1H), 3.57 (m, 1H), 3.47 (m, 1H), 
3.42 (m, 1H), 2.6-2.4 (m, 2H), 0.86 (s, 9H), -0.02 (s, 3H), -0.08 (s, 3H). 13CNMR (125 MHz, 
CDCl3) δ 159.6, 139.0, 138.5, 135.2, 134.0, 133.9, 130.8, 130.7, 128.6, 128.5, 128.1, 128.0, 
127.9, 127.7, 127.6, 114.0, 101.1, 78.9, 77.5, 74.3, 73.5, 73.2, 72.5, 72.3, 68.1, 55.5, 26.1, 18.3, -
4.5, -4.6. 
 
Z-Homoallyl alcohol 1.51 
  
         To a solution of 1.48 (240 mg, 0.27 mmol) in dry THF (3 mL) at 0 oC was added dropwise 
1M solution of Bu4NF (2.7 mL, 2.7 mmol) in THF. The reaction mixture was stirred for 10 min 
at 0 oC and then at rt for 2 h, then diluted with water and extracted with EtOAc (3X20 mL). The 
organic phase was washed with brine, dried (Na2SO4), and concentrated in vacuo. The crude 
material was dissolved in EtOAc (2 mL) and treated with Ac2O (0.2 mL) and DMAP (5 mg). 
After stirring for 10 min at rt. The organic solvent was concentrated in vacuo, and the crude 
material was purified by FCC to give the corresponding alcohol (91%). To a solution of the 
material from the previous step (200 mg, 0.24) in CH2Cl2/H2O 10:1 (5 mL) was added DDQ 
(66.8 mg, 0.29 mmol). The resulting mixture was stirred at rt for 30 min. The organic solvent 
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steps): Rf = 0.19 (30%EtOAc/Hexanes); 1HNMR (500Mz, CDCl3) δ 7.38-7.20 (m, 20H), 5.57 
(dt, J = 11, 4.7 Hz, 1H), 5.47 (m, 2H), 5.00 (m, 1H), 4.66-4.40 (m, 7H), 4.25 (m, 2H), 4.17 (m, 
1H), 4.02 (d, J = 10.5 Hz, 1H), 3.95 (t, J = 11 Hz, 1H), 3.84 (dd, J = 17.9, 5.25 Hz, 1H), 3.70 
(dd, J = 5.1, 3.0 Hz, 1H), 3.56 (m, 3H), 3.38 (dt, J = 9.5, 5.4 Hz, 1H), 2.50 (m, 1H), 1.98 (m, 
4H). 13CNMR (125 MHz, CDCl3) δ 170.5, 138.3, 138.2, 138.9, 137.9, 131.4, 129.7, 129.2, 





            To a solution of alcohol 1.51 (60 mg, 0.09 mmol) in dry CH3CN (2 mL) at -25 oC was 
added DBU (29 µl, 0.18 mmol), and CCl3CN (17 µl, 0.18 mmol). The reaction mixture was 
stirred at this temperature for 20 min, and then diluted with water and extracted with EtOAc 
(3X5mL). The organic phase was washed with brine, dried (Na2SO4), filtered, and concentrated 
in vacuo. The crude material was purified by FCC to give 1.52 (60 mg, 80%): Rf = 0.75 
(60%EtOEt/PE). To a solution of acetimidate 1.52 (50 mg, 0.06 mmol) in dry CH3CN (2 ml) at -
25 oC was added anhydrous K2CO3 (16 mg, 0.12 mmol) and IBr (24 mg, 0.12 mmol). The 
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extracted with (EtOAc 3 X 5mL). The organic phase was washed with brine, dried (Na2SO4), 
filtered, concentrated in vacuo. The crude material was purified by FCC to give 1.53 (50%): Rf  
= 0.6 (30% EtOAc/PE); 1HNMR (500Mz, C6D6) δ 7.40-7.18 (m, 20H), 5.40 (m, 1H), 5.20 (s, 
1H), 5.00 (m, 1H), 4.62-4.25 (m, 10H), 3.96 (m, 1H), 3.92 (m, 1H) 3.85 (m, 2 H), 3.80 (m, 1H), 
3.77 (m, 1H), 3.69 (dt, J = 9.8, 5.05 Hz, 1H), 3.32 (m, 1H), 3.27 (t, J = 10.3 Hz, 1H) 3.18 (dd, J = 
5, 10 Hz, 1H). 2.60 (m, 2H), 1.68 (s, 3H), 13CNMR (125 MHz, C6D6) δ 169.8, 153.0, 139.6, 
139.1, 139.0, 137.7, 130.0, 129.6, 129.0, 128.9, 127.9, 127.1, 126.9, 102.4, 77.7, 74.7, 74.2, 74.0, 
73.2, 72.7, 72.0, 70.1, 68.3, 61.6, 37.6, 20.8.  
 
Phthalate half ester 1.55 
 
        To a solution of alcohol 1.4157 (400 mg, 0.84 mmol) in dry pyridine (10 mL) was added 
phthalic anhydride (262 mg, 1.68 mmol) and DMAP (108 mg, 0.89 mmol). The reaction mixture 
was stirred at rt for 16 h. The volatiles were then removed in vacuo and the residue taken up in 
EtOAc.  The resulting mixture was washed with 1 M HCl and brine, and the organic phase dried 
(Na2SO4), filtered and concentrated under reduced pressure. FCC of the residue provided 1.55 
(500 mg, 96%): Rf = 0.13 (40% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.68 (d, J = 7.1 Hz, 1H), 
7.45 (m, 2H), 7.38 (m, 1H), 7.20 (m, 15H), 5.62 (m, 1H), 5.10 (m, 1H), 4.93 (m, 2H), 4.65-4.40 
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2.6 Hz, 1H), 2.49-2.15 (m, 2H); 13CNMR (125 MHz, CDCl3) δ 170.5, 167.2, 138.8, 138.5,134.2, 
132.4, 132,1, 131.4, 130.3, 129.9, 129.1, 128.0, 127.8, 127.7, 117.7, 74.6, 74.0, 73.5, 73.3, 73.2, 
72.2, 67.2, 66.0, 34.4; HRMS (ESI, MNa+) m/z calc for C38H38O8Na+ 645.2464, found 
645.2462. 
 
Mixed phthalate 1.56 
 
          A mixture of acid 1.55 (250 mg, 0.40 mmol), 2,4,6-trichlorobenzoyl chloride (0.075 mL, 
0.48 mmol) and triethylamine (0.11 mL, 0.8 mmol) in dry THF (20 mL) was stirred for 4 h at 0 
oC. Alcohol 1.54 (76 mg, 0.48 mmol) and DMAP (63 mg, 0.5 mmol) in toluene were added, and 
stirring continued for 1h. The mixture was then diluted with ether (30 mL), washed with 
saturated aqueous NaHCO3 and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The 
residue was purified by FCC to give ester 1.56 as a colorless oil (86%): Rf = 0.50  (20% 
EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 2.2 Hz, 1H), 7.48 (m, 3H), 7.24 (m, 
15H), 5.82 (m, 1H), 5.66 (m, 1H), 5.44 (t, J = 5.7 Hz, 1H) 5.31 (m, 3H), 5.22 (m, 1H), 4.98 (m, 
2H), 4.70-4.46 (m, 6H), 4.20 (m, 2H), 4.05 (m, 4H), 3.88 (m, 1H), 3.70 (dd, J = 11.2, 2.6 Hz, 
1H), 2.33-2.13 (m, 2H), 1.32 (s, 3H), 1.27 (s, 3H). 13CNMR (125 MHz, CDCl3) δ 167.2, 165.8, 
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119.3, 117.7, 117.2, 110.2, 78.2, 76.7, 75.5, 74.7, 73.8, 73.6, 73.4, 73.2, 72.0, 71.9, 67.1, 66.1, 
66.0, 64.9, 34.4, 26.6, 25.3.  
Cyclic Z-alkene 1.57 
 
      Ethylene gas was bubbled through a solution of mixed phthalate 1.56(300 mg, 0.41 mmol) in 
dry dichloromethane (200 mL) for 1 h. Grubbs II catalyst (17.32 mg, 0.0204 mmol) was added, 
then reaction mixture was heated at 40 oC for 2 h. The excess organic solvent was concentrated 
in vacuo. The crude material was purified by FCC to give compound 1.57 (85 %): Rf = (20% 
EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 3.9 Hz, 1H), 7.50 (m, 2H), 7.37 (m, 1H), 
7.25 (m, 13H), 7.08 (m, 2H), 5.89 (t, J = 5.5 Hz, 1H), 5.59 (dt, J = 6.9, 2.15 Hz, 1H), 5.41 (t, J = 
10.3 Hz, 1H), 4.72 (m, 2H), 4.60-4.29 (m, 5H), 4.22 (m, 2H), 4.10 (t, J = 9.4 Hz, 1H), 3.94 (m, 
2H), 3.87 (t, J = 3.3 Hz, 1H), 3.65 (m, 2H), 3.56 (dd, J = 6.2, 3.0 Hz, 1H), 2.46-2.13 (m, 2H), 
1.25 (s, 6H). 13CNMR (125 MHz, CDCl3) δ 168.4, 166.9, 138.8, 138.7, 138.0, 134.4, 132.8, 
131.9, 131.3, 131.2, 128.9, 128.8, 128.5, 128.0, 127.7, 127.6, 125.5, 110.23, 76.7, 74.7, 73.9, 
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(3S, 4S)-octadec-1-ene-3,4-diol 1.60 
 
          Ethylene gas was bubbled through a solution of alcohol 1.5858 (1.0 g, 6.33 mmol) and 
tetradecene (12 mL, 49 mmol) in DCM (65 mL) for 1 h. Grubbs II catalyst (53.6 mg, 0.0633 
mmol) was added and the reaction was heated at 40 0C for 6 h under an atmosphere of ethylene. 
The volatiles were then removed in vacuo and the residue purified by FCC to give the 
corresponding CM alkene (1.5 g, 85%): Rf = 0.46 (10% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 
5.76 (dd, J = 15.4, 8.3 Hz, 1H), 5.41 (dd, J =15.4, 8.4 Hz, 1H) 4.55 (t, J = 7.4 Hz, 1H), 4.14 (q, J 
=  6.1, 5.7 Hz, 1H), 3.51 (d, J = 5.8 Hz, 2H,), 2.00 (m, 2H) 1.77 (bs, 1H), 1.44 (s, 3H) 1.32 (m, 
5H), 1.18 (m, 18H) 0.82 (t, J = 6.8 Hz, 3H); 13CNMR: (125 MHz, CDCl3) δ 137.4, 124.4, 108.7, 
78.4, 62.3, 32.6, 32.0, 29.9, 29.8, 29.7, 29.6, 29.4, 29.2, 28.1, 25.4, 22.9, 14.5; HRMS (ESI, 
MNa+) m/z calc for C20H38O3Na+ 349.2719, found 349.2714. 
 
To a solution of the compound from the previous step (1.5 g) in EtOAc (150 mL) was added at rt 
Pd/C (150 mg, 10% w/w). The reaction mixture was stirred 12 h under hydrogen (balloon), and 
then filtered over a Celite pad.  The filtrate was evaporated in vacuo, to give an oily residue 1.59 
(1.45 g, 94%). A portion of 1.59 (50 mg, 0.10 mmol), TEMPO (1.5 mg, 0.01 mmol), nBu4NCl 
(2.8 mg, 0.01 mmol) in CH2Cl2 (1 mL) and an mixture of 0.5 M aqueous NaHCO3 (0.5 mL) and 
0.05 M aqueous K2CO3 (0.5 mL) were vigorously stirred at rt. NCS (17.4 mg, 0.13 mmol) was 
next added and stirring continued for 12 h. The organic layer was then separated and the aqueous 
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(Na2SO4), filtered and concentrated in vacuo. Purification of the residue by FCC afforded the 
corresponding aldehyde (61 % over two steps): Rf = 0.55 (20% EtOAc/PE); 1HNMR (500Mz, 
CDCl3) δ 9.56 (d, J = 3.5 Hz, 1H), 4.26 (m, 1H), 4.18 (m, 1H), 1.52 (s, 3H), 1.44 (m, 4H), 1.35 
(m, 3H), 1.18 (m, 22 H), 0.81 (t, J = 7.3 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 202.5, 110.6, 
82.3, 78.9, 32.2, 29.9, 29.8, 29.7, 29.6, 29.5, 27.9, 26.6, 25.5, 22.9, 14.3; HRMS (ESI, MNa+) 
m/z calc for C20H40O3Na+ 351.2875, found 351.2872. 
 
          To a solution of methyl triphenylphosphonium bromide (71 mg, 0.2 mmol) in anhydrous 
THF (2mL) was added potassium tert-butoxide (28 mg, 0.25 mmol) at 0 oC. The reaction 
mixture was warmed to rt, stirred for 1 h at this temperature, and re-cooled to 0 °C.  A solution 
of the aldehyde form the previous step (50 mg, 0.1 mmol) in THF (0.5 mL) was then added to 
the mixture, and stirring maintained at rt for 2 h. At this time, saturated aqueous NH4Cl (3 mL) 
was added and the mixture extracted with ether (3 x 5 mL), The organic layer was washed with 
brine, dried (Na2SO4), filtered and concentrated in vacuo. FCC on the residue provided the 
corresponding alkene (35 mg, 70%): Rf = 0.71 (10% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 
5.79 (m, 1H), 5.21 (m, 2H), 4.44 (t, J = 7.8 Hz, 1H), 4.11 (dd, J = 12.9, 8.65 Hz, 1H), 1.46 (s, 
3H), 1.34 (s, 3H), 1.23 (m, 26 H), 0.86 (t, J = 6.4 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 135.0, 
118.4,108.4, 80.3, 78.5, 32.2, 30.6, 29.9, 28.5, 26.5, 25.8, 23.0,14.4; HRMS (ESI, (M-
C3H6)Na+) m/z calc for  C18H36O2Na+ 307.26.2613 found 307.2612. The 1H and 13C NMR of 
this material was essentially identical to the literature data.59 
         To a solution of the alkene from the previous step (1.2 g, 3.7 mmol) in methanol (10 mL) 
was added acetyl chloride (0.25 ml, 3.5 mmol). The reaction mixture was stirred for 30 min, and 
the volatiles removed in vacuo to give 1.60 (954 mg, 90 %): Rf = 0.17 (20% EtOAc/PE); 
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1HNMR (500Mz, CDCl3) δ 5.90 (m, 1H), 5.28 (m, 2H), 4.06 (dd, J = 4.9, 3.5 Hz, 1H), 3.65 (dd, 
J = 8.25, 4.1 Hz, 1H), 2.43(b, 1H), 2.26 (b, 1H), 1.22 (m, 26 H), 0.85 (t, J = 6.8 Hz, 3H); 
13CNMR (125 MHz, CDCl3): δ 136.2, 117.8, 76.2, 74.3, 32.2, 32.1, 29.9, 29.8, 29.6, 26.1, 
22.9,14.3; HRMS (ESI, MNa+) m/z calc for C18H36O2Na+ 307.2613 found 307.2609.  
The 1H and 13C NMR of this material was essentially identical to the literature data.59 
 
(3S, 4S)-4-(4-methoxybenzyloxy)octadec-1-ene-3-ol 1.61 
 
       To a solution of 1.60 (1.0 g, 3.46 mmol) in dry CH2Cl2 (10 mL) were added p-TsOH (60 mg, 
0.35 mmol) and p-anisaldehyde dimethyl acetal (1.9 ml, 10.38 mmol). The reaction mixture was 
stirred at rt for 2 h, then diluted with saturated aqueous NaHCO3 and extracted with CH2Cl2 (3 x 
10 mL).  The organic phase was washed with brine, dried (Na2SO4) filtered, and evaporated in 
vacuo. FCC of the residue afforded the corresponding benzylidene derivative as mixture (1:3): 
(1.0 g, 79%): Rf = 0.75 (20% EtOAc/PE); 1HNMR for major empimer (500Mz, CDCl3) δ 7.41 
(d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.87 (m, 1H), 5.76 (s, 1H), 5.28 (m, 2H), 4.53 (t, J 
= 7.55 Hz, 1H), 4.15 (m, 1H), 3.79 (s, 3H), 1.53 (m, 2H), 1.23 (m, 26H), 0.84 (t, J = 6.8 Hz, 3H); 
13CNMR (125 MHz, CDCl3) δ 160.7, 134.8, 128.5, 118.8, 114.0, 103.5, 80.5, 80.2, 55.5, 32.2, 
30.0, 29.6, 26.4, 22.9, 14.3; HRMS (ESI, MH+) m/z calc for C26H42O3H+ 403.3212 found 
403.3208. 
            The material from the previous step (1.2 g, 2.98 mmol) was dissolved in dry CH2Cl2 (500 
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min, the reaction mixture was gradually warmed to rt and stirred at rt for 3 h, then quenched with 
solution of Rochelle’s salt (500 mL). The resulting biphasic mixture was stirred vigorously at rt 
until saturated aqueous organic phase turned clear. The organic phase was separated, dried 
(MgSO4), filtered, and concentrated in vacuo. FCC of the residue provided 1.61 (960 mg, 82%): 
Rf = 0.42 (10% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.25 (d, J = 10.4 Hz, 2H), 6.86 (d,J = 
8.5 Hz, 2H), 5.86 (ddd, J = 10.4, 8.0, 2.4 Hz, 1H), 5.24 (m, 2H), 4.52 (q, J = 15.2, 11.3 Hz, 1H), 
4.25 (m, 1H), 3.79 (s, 3H), 3.40 (m, 1H), 2.12 (d, J = 3.4 Hz, 1H), 1.53 (m, 2H), 1.23 (m, 26H), 
0.86 (t, J = 6.8 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 159.5, 136.9, 130.8, 129.7, 116.6, 114.0, 
82.0, 77.4, 73.7, 72.0, 55.5, 32.1, 29.9, 29.8, 29.6, 29.5, 26.0, 22.9, 14.3; HRMS (ESI, MNa+) 
m/z calc for C26H44O3Na+ 427.3188, found 427.3182. 
 
(3S, 4S)-3-(benzyloxy)octadec-1-ene-4-ol 1.63 
 
            A solution of 1.61 (248 mg, 0.613 mmol) in dry DMF (6 mL) was treated with oil-free 
NaH (37 mg, 60% suspension in mineral oil, 0.92 mmol) at 0 oC. After stirring for 15 min at 0 
oC, BnBr (0.11 mL, 0.92 mmol) was added and the reaction mixture was warmed to rt and 
maintained at this temperature for an additional 3 h. At that time the mixture was diluted with 
saturated aqueous NH4Cl, and extracted with EtOAc. The organic phase was washed with brine, 
dried (Na2SO4) filtered, and concentrated in vacuo. FCC of the residue afforded the derived 
benzyl ether (213 mg, 93 %): Rf = 0.57 (10% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.25 (m, 
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4.36 (dd, J = 40.05 Hz, 11.15 Hz, 1H), 3.73 (m, 4H), 3.42 (dd, J = 3.8 Hz, 7.9 Hz, 1H), 1.47 (m, 
3H), 1.23 (m, 26H), 0.82 (t, J = 6.8 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 159.3, 139.0, 136.1, 
131.3, 130.0, 129.5, 128.5, 128.4, 127.8, 127.6, 119.0, 113.9, 83.1, 81.1, 72.6, 70.6, 55.5, 32.1, 
31.4, 29.9, 29.8, 29.6, 25.9, 22.9, 14.3.   
           To a solution of the material from the previous step (300 mg, 0.6 mmol) in CH2Cl2 (10 
mL) was added saturated aqueous NaHCO3 (0.5 mL) and DDQ (272.4 mg, 1.2 mmol). The 
reaction mixture was stirred at rt for 25 min. The organic solvent was removed in vacuo, and the 
residue diluted with ether. The organic layer was separated, washed with brine, dried (Na2SO4) 
filtered, and evaporated in vacuo. FCC of the residue afforded 1.62 (184 mg, 80%): Rf = 0.30 
(10% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.28 (m, 5H), 5.83 (ddd, J = 10.4, 8.0, 2.4 Hz, 
1H), 5.33 (m, 2H), 4.61 (d, J = 11.9 Hz, 1H), 4.36 (d, J = 11.9 Hz, 1H), 3.70 (m, 2H), 2.08 (b, 
1H), 1.40 (m, 3H), 1.23 (m, 26H), 0.86 (t, J = 6.8 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 138.5, 
134.7, 128.6, 128.0, 127.8, 120.4, 83.8, 73.5, 70.4, 32.4, 32.1, 29.9, 29.8, 29.6, 25.9, 22.9, 14.3; 
HRMS (ESI, MNa+) m/z calc for C25H42O2Na+ 397.3083 found 397.3083. 
 
Mixed phthalate 1.64 
 
           A mixture of 1.55 (250 mg, 0.40 mmol), 2,4,6-trichlorobenzoyl chloride (0.075 mL, 0.48 
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Alcohol 1.61 (76 mg, 0.48 mmol) and DMAP (63 mg, 0.5 mmol) in toluene were added and 
stirring continued for 1 h at rt. The reaction mixture was then diluted with ether (30 mL), washed 
with saturated aqueous NaHCO3 and brine, dried (Na2SO4), filtered, and concentrated in vacuo. 
The residue was purified by FCC to give ester 63 (348 mg, 86%) as a colorless oil: Rf = 0.50 
(20% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 2.3 Hz, 1H), 7.52 (m, 3H), 7.26 
(m, 17H), 6.78 (d, J = Hz, 2H), 5.91 (m, 1H), 5.75 (m, 1H), 5.60 (m, 1H) 5.27 (m, 2H), 5.17 (m, 
1H), 5.08 (m, 2H), 4.73-4.40 (m, 8H), 4.23 (m, 1H), 4.18 (t, J = 3.9 Hz, 1H), 4.08 (m, 2H), 3.95 
(dd, J = 5.8, 3.1 Hz, 1H), 3.75 (m, 4H), 3.58 (m, 1H), 2.38-2.19 (m, 2H), 1.44 (m, 2H), 1.23 (m, 
24H), 0.85 (t, J = 2.5 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 167.7, 165.8, 159.4, 138.9, 138.6, 
134.3, 133.6, 132.7, 131.9, 130.9, 130.7, 129.8, 129.5, 128.7, 128.5, 128.0, 127.8, 127.7, 127.6, 
118.9, 117.6, 113.9, 80.1, 77.4, 77.3, 74.8, 73.7, 73.4, 73.2, 72.5, 72.0, 71.8, 67.0, 66.0, 55.4, 
34.5, 32.1, 31.1, 29.9, 29.8, 29.7, 29.6, 26.0, 22.9, 14.3; HRMS (ESI, MNa+) m/z calc for 
C64H80O10Na+ 1031.5649, found 1031.5652. 
 
Cyclic Z-alkene 1.65 
 
         Ethylene gas was bubbled through a solution of 1.64 (300 mg, 0.41 mmol) in dry CH2Cl2 
(200 mL) for 1 h. Then, Grubbs II catalyst (17 mg, 0.02 mmol) was added and the reaction 











	   54	  
gave 1.65 (374 mg, 93%): Rf = 0.63 (20% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J 
= 2.3 Hz, 1H), 7.54 (m, 2H), 7.36 (d, J = 8.6 Hz, 1H), 7.29 (m, 15 H), 7.05 (d, J = 8.5 Hz, 1H), 
6.66 (d, J = 8.55 Hz, 2H), 5.87 (m, 1H), 5.77 (m, 1H), 5.42 (t, J = 12.1 Hz, 1H), 4.85 (m, 1H), 
4.79 (d, J = 11.9 Hz, 1H), 4.66-4.45 (m, 5H), 4.37 (d, J = 12.1 Hz, 1H), 4.26 (m, 2H), 4.17 (t, J = 
11.6 Hz, 1H), 3.97 (dd, J = 11.6, 5.4 Hz, 1H), 3.87 (t, J = 4.0 Hz, 1H), 3.72 (m, 4H), 3.63 (dd, J 
= 6.2, 3.2 Hz, 1H), 3.55 (m, 1H), 2.46 (m, 1H), 2.28 (m, 1H), 1.39 (m, 2H), 1.22 (m, 26H), 0.86 
(t, J = 6.65 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 168.7, 166.3, 159.2, 138.9, 138.7, 138.0, 
133.6, 133.4, 132.1, 130.9, 130.6, 129.7, 128.6, 128.5, 128.1, 128.0, 127.9, 127.8, 127.7, 125.6, 
113.7, 78.6, 74.8, 74.0, 73.8, 73.0, 72.7, 72.0, 71.5, 71.0, 65.8, 65.2, 55.4, 32.2, 31.8, 30.3, 29.9, 
29.8, 29.7, 29.6, 26.0, 22.9, 14.4; HRMS (ESI, MNa+) m/z calc for C62H76O10Na+ 1003.5336, 
found 1003.5334. 
 
Cyclic homoallyl alcohol 1.66 
 
         To a solution of 1.65 (180 mg, 0.180 mmol) in CH2Cl2 (5.0 mL) was added saturated 
aqueous NaHCO3 (0.5 mL) and DDQ (83.0 mg, 0.36 mmol). The reaction mixture was stirred at 
rt for 25 min. The organic solvent was removed in vacuo, and the residue diluted with ether. The 
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vacuo. FCC of the residue afforded 1.66 (131 mg, 83%): Rf = 0.33 (20% EtOAc/PE); 1HNMR 
(500Mz, CDCl3) δ 7.82 (m, 1H), 7.51 (m, 2H), 7.32-7.10 (m, 16H), 5.77 (m, 1H), 5.67 (d, J = 6.8 
Hz, 1H), 5.39 (t, J = 10.8 Hz, 1H), 4.77 (d, J = 2.5 Hz, 1H), 4.73 (J = 12.0 Hz, 1H), 4.56 (m, 
2H), 4.42 (m, 2H), 4.31 (d, J = 12.1 Hz, 1H), 4.20 (t, J = 7.5 Hz, 1H), 4.11 (dd, J = 9.6, 11.6 Hz, 
1H), 3.94 (dd, J = 10.8, 5.3 Hz, 1H), 3.84 (t, J = 3.25 Hz, 1H), 3.78 (m, 1H), 3.66 (dd, J = 11.7, 
1.7 Hz, 1H), 3.57 (dd, J = 6.2, 3.1 Hz, 1H), 2.43 (q, J = 24.4, 12.9 Hz, 1H), 2.24 (d, J = 11.4 Hz, 
1H), 1.77 (d, J = 3.1 Hz, 1H), 1.40 (m,1H), 1.32 (m, 2H), 1.18 (m, 24H), 0.81 (t, J = 6.7 Hz, 3H); 
13CNMR (125 MHz, CDCl3) δ 168.6, 166.6, 138.8, 138.6, 137.9, 133.9, 133.2, 132.2, 131.1, 
130.6, 129.7, 128.7, 128.6, 128.5, 128.1, 127.9, 127.8, 125.0, 77.4, 74.7, 74.0, 73.7, 73.0, 72.7, 
72.6, 71.4, 71.2, 65.7, 65.1, 32.2, 32.1, 30.2, 29.9, 29.8, 29.7, 29.5, 25.9, 22.9, 14.3. 
 
Cyclic homoallylic trichloroacetamidate 1.74 
  
      To a solution of alcohol 1.66 (129 mg, 0.15 mmol) in dry propionitrile (5 mL) at 0 oC was 
added DBU (45 µL, 0.3 mmol) and CCl3CN (90 µL, 0.9 mmol). The reaction was stirred at this 
temperature for 20 min, and then diluted with water. The reaction mixture was extracted with 
EtOAc (3X5mL). The organic phase was washed with brine, dried (Na2SO4), filtered, and 
concentrated in vacuo. The crude residue was purified by FCC to give 1.74 (94.1%); Rf = 0.33 
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(m, 16H), 5.87 (m, 1H), 5.77 (m, 1H), 5.34 (m, 2H), 4.70 (m, 2H), 4.55 (m, 2H), 4.43 (m, 2H), 
4.31 (d, J = 12.0 Hz, 1H), 4.19 (t, J = 7.3 Hz, 1H), 4.11 (dd, J = 9.6, 11.6 Hz, 1H), 3.92 (dd, J = 
10.5, 5.1 Hz, 1H), 3.83 (t, J = 3.25 Hz, 1H), 3.65 (dd, J = 11.7, 1.9 Hz, 1H), 3.57 (dd, J = 6.2, 3.1 
Hz, 1H), 2.41 (q, J = 24.4, 13.0 Hz, 1H), 2.22 (d, J = 11.4 Hz, 1H), 1.53 (m, 2 H), 1.38 (m,1H), 
1.17 (m, 24H), 0.81 (t, J = 6.7 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 168.4, 166.3, 162.8, 
138.8, 138.0, 134.0, 133.2, 131.0, 130.5, 129.8, 128.7, 128.6, 128.5, 128.1, 127.9, 127.8, 125.0, 
78.4, 77.6, 74.7, 74.2, 73.8, 73.1, 72.8, 72.6, 71.5, 71.1, 70.8, 65.8, 65.2, 32.1, 30.1, 29.9, 29.8, 
29.7, 29.6, 29.5, 25.5, 22.9, 14.4. 
 
Cyclic oxazineiodide 1.75 
 
        To a solution of 1.74 (100 mg, 0.1 mmol) in dry CH2Cl2 (2.0 mL) was added IDCP (706 
mg, 1.5 mmol). The reaction mixture was stirred at rt for 12 h, then diluted with saturated 
aqueous Na2S2O3 (2.0 mL). The volatiles were removed under reduced pressure and the residue 
extracted with ether (4 x 3 mL). The organic layer was washed with brine, dried (Na2SO4), 
filtered, and concentrated in vacuo. FCC of the residue afforded 1.75 as a colorless oil (42%): Rf 
= 0.60 (20% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.75 (m, 1H), 7.64 (m, 1H), 7.56 (m, 
2H), 7.27-7.09 (m, 16H), 5.65 (m, 1H), 5.52 (t, J = 8.4 Hz, 1H), 4.79 (d, J = 11.5 Hz, 1H), 4.62 
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2.44 (m, 1H), 2.26 (m, 1H), 1.55 (m, 2H), 1.18 (m, 24H), 0.81 (t, J = 6.7 Hz, 3H); 13CNMR (125 
MHz, CDCl3) δ 167.4, 154.8, 138.4, 138.1, 138.0, 132.0, 131.9, 128.7, 128.7, 128.6, 128.5, 
128.3, 128.2,128.1, 128.0, 127.9, 127.8, 77.7, 76.6, 74.6, 74.1, 73.7, 72.6, 71.9, 71.8, 71.6, 68.1, 
34.0, 32.1, 30.6, 29.8, 29.7, 29.6, 29.5, 29.3, 24.4, 22.9, 14.3. 
Z-homoallylic alcohol 1.76 
 
To a solution of 1.65 (700 mg, 0.71 mmol) in anhydrous CH2Cl2 (10 mL) was added a 1 M 
solution of DIBAL-H in hexane (2.1 ml, 2.1 mmol) at -78 oC. The reaction mixture was warmed 
to rt over 3 h, then quenched with MeOH (2 mL). Water (2 mL), then 1 M NaOH (2 mL) were 
slowly introduced at 0 oC, and stirring continued at rt for 1h. The resulting mixture was dried 
(MgSO4), filtered over a Celite pad, and concentrated in vacuo. FCC of the residue gave the 
corresponding diol (596 mg, 98 %): Rf = 0.29  (40% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 
7.26 (m, 17 H), 6.85 (d, J = 8.55 Hz, 2H), 5.62 (t, J = 10.55 Hz, 1H), 5.54 (dt, J = 4.45, 10.9 Hz, 
1H), 4.69 (d, J = 11.9 Hz, 1H), 4.60-4.46 (m, 8H), 4.20 (m, 1H), 4.05 (t, J = 10.8 Hz, 1H), 3.99 
(d, J = 4.45 Hz, 1H), 3.87 (t, J = 7.7 Hz, 1H), 3.75 (m, 5H), 3.71 (dd, J = 3.0, 11.2 Hz, 1H), 3.52 
(bs, 1H), 3.43 (m, 1H), 2.65 (q, J = 10.45, 13.55 Hz, 1H), 2.55 (bs, 1H), 2.22, (m, 1H), 1.39 (m, 
2H), 1.26 (m, 26H), 0.86 (t, J = 6.65 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ  159.5, 138.8, 
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74.4, 73.7, 73.3, 73.2, 72.3, 72.1, 68.8, 68.2, 68.0, 66.4, 55.5, 32.1, 29.9, 29.8, 29.6, 28.5, 25.5, 
22.9, 14.3; HRMS (ESI, MNa+) m/z calc for C54H74O8Na+ 873.5281, found 873.5282.  
     NaH (61 mg, 60% suspension in mineral oil, 1.54 mmol) and BnBr (0.19 mL, 1.54 mmol) 
were sequentially added, at 0 oC, to a solution of the material from the previous step (596 mg, 
0.70 mmol) in anhydrous DMF (15 mL).  The reaction mixture was then warmed to rt, 
maintained at this temperature for 3 h, then re-cooled to 0 oC and diluted with saturated aqueous 
NH4Cl. The resulting mixture was extracted with EtOAc (3 x 15 mL), and the organic washed 
with brine, dried (Na2SO4) filtered, and evaporated in vacuo. FCC of the residue provided the 
pent-O-benzyl ether (710 mg, 98 %): Rf = 0.26 (10% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 
7.26 (m, 25 H), 6.79 (d, J = 8.5 Hz, 2H), 5.73 (m, 1H), 5.55 (t, J = 9.4 Hz, 1H), 4.68-4.29 (m, 
12H), 4.15 (dd, J = 3.45, 9.2 Hz, 1H), 3.95 (m, 3H), 3.78 (m, 2H), 3.74 (s, 3H), 3.65 (m, 2H), 
3.44 (m, 1H), 2.32 (m, 2H), 1.39 (m, 2H), 1.26 (m, 26H), 0.86 (t, J = 6.65 Hz, 3H); 13CNMR 
(125 MHz, CDCl3) δ 159.2, 139.1, 138.8, 138.7, 138.6, 138.4, 131.5, 131.0, 129.8, 129.4, 128.8, 
128.6, 128.5, 128.1, 128.0, 127.9, 127.8, 127.7, 127.5, 127.2, 113.8, 81.3, 76.8, 74.5, 73.5, 73.4, 
73.3, 72.6, 70.3, 67.6, 55.5, 32.2, 31.4, 30.0, 29.9, 29.6, 26.1, 22.9, 14.4; HRMS (ESI, MNa+) 
m/z calc for C68H86O8Na+ 1053.6220, found 1053.6222.   
           To a mixture of the material from the previous step (600 mg, 0.58 mmol) in CH2Cl2 (12 
mL) and water (1 mL) was added DDQ (264 mg, 1.163 mmol). The reaction mixture was stirred 
at 0 0C for 30 min, then concentrated in vacuo at rt. The residue was taken up in ether and the 
organic layer was separated and washed with saturated aqueous NaHCO3 and brine, dried 
(Na2SO4), filtered, and evaporated in vacuo. FCC of the residue provided 1.76 as a colorless oil 
(530 mg, 78% or 75% over 3 steps): Rf = 0.42 (20% EtOEt/PE); 1H NMR (500 MHz, CDCl3) δ 
7.22 (m, 25 H), 5.74 (dd, J = 11.3, 7.1 Hz, 1H), 5.41 (t, J = 10.8 Hz, 1H), 4.66-4.22 (m, 10H), 
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3.92 (m, 4 H), 3.73 (m, 2H), 3.63 (m, 1H), 3.53 (m, 2H), 2.39-2.19 (m, 3H), 1.42 (m, 2H), 1.19 
(m, 24H), 0.82 (t, J = 7.1 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 138.7, 138.6, 138.4, 132.8, 
128.7, 128.6, 128.5, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 77.8, 76.9, 74.4, 73.5, 73.4, 73.2, 
72.6, 71.7, 70.3, 68.0, 32.6, 32.1, 30.0, 29.9, 29.8, 29.6, 26.0, 22.9, 14.3; HRMS (ESI, MNa+) 




         Treatment of 1.76 (91 mg, 0.1 mmol) under the conditions used for the synthesis of 1.74 
provided 73 (99 mg, 94%): Rf = 0.62 (20% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 8.11 (s, 
1H), 7.24-7.16 (m, 25H), 5.64 (m, 1H), 5.42 (dd, J = 10.1, 9.0 Hz, 1H), 4.94 (m, 1H), 4.67-4.33 
(m, 10H), 3.97-3.90 (m, 3H), 3.72 (m, 2H), 3.65 (dd, J = 7.2, 2.7 Hz, 1H), 3.58 (dd, J = 10.4, 4.9 
Hz, 1H), 2.35 (m, 1H), 1.81 (M, 1H), 1.55 (M, 2H), 1.18 (m, 24), 0.81 (t, J = 6.8 Hz, 3H), 
13CNMR (125 MHz, CDCl3) δ 161.4, 137.6, 137.5, 137.3, 130.7, 127.8, 127.4, 127.3, 127.2, 
126.9, 126.8, 126.7, 126.6, 126.5, 126.4, 126.3, 80.3, 76.2, 75.6, 74.0, 73.4, 72.2, 72.0, 69.6, 
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Oxazineiodide 1.78 
 
           Treatment of 1.77 (775 mg, 0.77 mmol) under the conditions used for the synthesis of 
1.53 provided 1.78 (320 mg, 35 %): Rf = 0.38, (20% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 
7.27-7.12 (m, 25H), 4.69 (m, 1H), 4.63-4.41(m, 10H), 4.33 (d, J = 11.6 Hz, 1H), 4.27 (m, 1H), 
3.96 (m, 1H), 3.93 (m, 2H), 3.73 (m, 1H), 3.62 (m, 2H), 3.00 (dd, J = 8.3, 1.6 Hz, 1H), 2.40 (t, J 
= 14.1 Hz, 1H), 2.10 (m, 1H), 1.83 (m, 1H), 1.54 (m, 2H), 1.35 (m, 2H), 1.19 (m, 24H), 0.81 (t, J 
= 6.8 Hz, 3H). 13CNMR (125 MHz, CDCl3) δ 153.9, 138.8, 138.7, 138.6, 138.3, 137.4, 128.8, 
128.5, 128.3, 128.0, 127.9, 79.5, 78.0, 75.3, 74.4, 73.6, 73.2, 68.2, 64.5, 40.4, 32.1, 31.3, 29.9, 
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        Treatment of 1.77 (775 mg, 0.77 mmol) under the conditions used for the synthesis of 1.53 
provided 1.79 (280 mg, 30 %): Rf = 0.18, (20% EtOAc/PE); 1H NMR (500 MHz, C6D6) δ 7.47-
7.15 (m, 25H), 4.80 (d, J = 2.3 Hz, 1H), 4.74-4.35 (m, 14H), 4.16 (dd, J = 4.9, 2.5 Hz, 1H), 4.08 
(dd, J = 10.7, 3.1 Hz, 1H), 3.93 (d, J = 11.2 Hz, 1H), 3.84 (dd, J = 5.4, 2.7 Hz, 1H), 3.79 (m, 
1H), 3.53 (dd, J = 9.3, 3.3 Hz, 1H), 2.62 (dd, J = 12.6, 9.9 Hz, 1H), 2.45 (dd, J = 8.8, 3.1 Hz, 
1H), 2.41 (m, 1H), 2.13 (m, 1H), 1.78 (m, 2H), 1.44 (m, 2H), 1.40 (m, 24H), 0.99 (t, J = 7.1 Hz, 
1H). 13CNMR (125 MHz, C6D6) δ 155.0, 139.7, 139.6, 139.5, 139.3, 138.2, 129.0, 128.9, 128.3, 
128.0, 83.5, 81.4, 79.2, 75.3, 75.0, 74.2, 73.6, 73.5, 71.5, 68.3, 55.8, 43.9, 32.7, 32.5, 30.5, 30.4, 
30.3, 30.2, 25.8, 23.5, 14.7.  
 
Reduced oxazine 1.81 
 
         To a solution of 1.78 (20 mg, 0.017 mmol) in dry benzene (1 mL) and MeOH (0.2 mL) was 
added AIBN (few crystals). Nitrogen gas was bubbled through the mixture for 1 h, at which time 
Bu3SnH (20 uL, 0.074 mmol) was added. Then reaction mixture was heated at 80 oC under 
Nitrogen for 2 h. After cooling to rt, KF (10 mg) was added and the mixture filtered over a Celite 
pad. The volatiles were removed in vacuo and the residue purified by FCC to give 1.81 (mg, < 
50 %) as colorless oil: Rf = 0.1 (10% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.24-7.20 (m, 
25H), 5.90 (s, 1H), 4.64-4.34 (m, 10H), 3.90 (m, 4H), 3.78 (m, 1H), 4.64 (m, 2H), 3.57 (m, 1H), 
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3H); 13C NMR (125 MHz, CDCl3) δ 151.9, 137.7, 137.6, 137.5, 137.3, 136.5, 127.5, 127.4, 
127.3, 127.2, 127.0, 126.9, 126.7, 126.6, 126.5, 126.4, 77.8, 75.9, 75.8, 73.7, 73.5, 72.2, 72.1, 




           To a solution of oxazine 1.78 (60 mg, xx mmol) in MeOH/n-Butanol (1 mL) was added 
6M HACl (1mL). Reaction mixture was stirred at rt for 48 h, then was extracted with EtOAc (3 x 
2 mL), and the organic phase was washed with saturated aqueous NaHCO3 and brine, dried 
(Na2SO4), filtered, and evaporated in vacuo. FCC of the residue provided 1.84 as a colorless oil. 
To a solution of amine 1.84 (25 mg, 0.027 mmol) in EtOH (2mL) was added hexacosanoic acyl 
chloride (25 mg, 0.06 mmol), Et3N (2 drops). Reaction mixture was stirred at rt for 30 min. 
excess solvent was evaporated in vacuo, and the residue was purified by FCC to afford the 
corresponding amide (17 mg, 50%): Rf = (20%EtOAc/PE); 1H NMR (500 MHz, C6D6) δ 7.33-
7.04 (m, 25H), 5.93 (d, J = 8.1 Hz, 1H), 4.78 (d, J = 11.3 Hz, 1H), 4.69 (m, 1H), 4.65-4.16 (m, 
10H), 4.12 (m, 1H), 4.03 (m, 1H), 3.98 (m, 1H), 3.89 (t, J = 2.5 Hz, 1H), 3.78 (dd, J = 9.8, 5.5 
Hz, 1H), 3.64 (m, 2H), 2.52 (m, 1H), 2.30 (m, 1H), 1.92 (m, 2H), 1.57 (m, 6H), 1.29 (m, 79H), 
0.88 (t, J = 6.7 Hz, 3H). 13CNMR (125 MHz, C6D6) δ 172.8, 139.9, 139.7, 139.6, 139.0, 129.0, 
128.9, 128.8, 128.7, 128.5, 128.3, 128.2, 128.0, 83.3, 83.1, 80.5, 78.8, 77.8, 76.1, 74.6, 73.6, 
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26.8, 26.5, 23.5, 14.7. To a solution of the material in the previous step (17 mg) in MeOH (1.0 
mL) was added Pd/C (1.7 mg), then the reaction mixture was stirred under H2 gas at rt for 12 hr. 
Another 2 mg of Pd/C were added and the reaction left stirring at rt for 24 hr at rt. Reaction 
mixture then filtered over celite, and the excess solvent was evaporated in vacuo, to give 
compound 1.85 (5.0 mg, 45%): Rf = 0.21 (10%MeOH/CHCl3); 1H NMR (500 MHz, C5D5N) δ 
8.49 (d, J = 8.4 Hz, 1H), 4.95 (m, 7H), 4.76 (dd, J = 8.3, 5.2 Hz, 1H), 4.69 (t, J = 7.7 Hz, 1H), 
4.67 (m, 1H), 4.63 (m, 1H), 4.47 (m, 3H), 4.41 (dd, J = 8.4, 3.3 Hz, 1H), 4.23 (m, 1H), 2.74 (m, 
1H), 2.46 (m, 1H), 1.79 (m, 1H), 1.64 (m, 1H), 1.28 (m, 79H), 0.88 (m, 6H), 13CNMR (125 
MHz, C5D5N) δ 174.2, 86.4, 80.2, 75.3, 75.1, 72.7, 71.0, 70.5, 62.6, 57.7, 37.1, 35.4, 32.5, 30.2, 




            To a solution of alcohol 1.76 (354 mg, 0.388 mmol) in anhydrous THF (6 mL) was added 
sodium hydride (23 mg, 60% suspension in mineral oil, 0.585 mmol) at 0 oC. After 30 min at 0 
oC, a solution of benzyl isothiocyanate (78 uL, 0.585 mmol) in THF (2 mL) was introduced 
dropwise. The reaction mixture was stirred at 25 oC for 3 h. Then (50 uL, 0.78 mmol) of 
iodomethane was added and stirring continued for an additional 1 h. reaction mixture was 
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in ether.  The mixture was washed with brine and the organic phase dried (MgSO4), filtered and 
evaporated under reduced pressure. FCC of the residue afforded 1.88 (400 mg, 96 %): Rf = 0.53 
(15% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.24 (m, 30 H), 5.72 (dd, J = 11.2, 6.8 Hz, 1H), 
5.48 (t, J = 10.8 Hz, 1H), 5.26 (ddd, J = 7.5, 3.5 Hz, 1H), 4.68-4.36 (m, 13 H), 3.95 (m, 2 H), 
3.82 (m, 1H), 3.72 (m, 2H), 3.58 (dd, J = 4.8, 10.25 Hz, 1H), 3.50 (dd, J = 2.4, 7.4 Hz, 1H), 2.36 
(s, 5 H), 1.76 (m, 1H), 1.61 (m, 1H), 1.25 (m, 24H), 0.87 (t, J = 7.1 Hz, 3H). 13CNMR (125 
MHz, CDCl3) δ 157.0, 140.9, 139.0, 138.8, 138.7, 138.6, 138.5, 131.6, 128.7, 128.5, 128.3, 
128.1, 120.0, 127.9, 127.8, 127.7, 127.6, 127.5, 127.2, 126.4, 78.5, 77.5, 77.4, 77.2, 77.0, 75.7, 
74.6, 73.5, 73.4, 73.1, 70.5, 52.7, 32.1, 29.9, 29.8, 29.7, 29.6, 26.0, 22.9, 14.3; HRMS (ESI, 




             To a solution of 1.88 (331 mg, 0.31 mmol) in dry CH2Cl2 (31 mL) was added IDCP (291 
mg, 0.62 mmol). The reaction mixture was stirred at rt for 4 h, then diluted with saturated 
aqueous Na2S2O3 (25 mL). The volatiles were removed under reduced pressure and the residue 
extracted with ether (4 x 25 mL). The organic layer was washed with brine, dried (Na2SO4), 
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79.9%): Rf = 0.33 (15% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.20 (m, 30 H), 5.08 (d, J = 
15.4 Hz, 1H), 4.77-4.30 (m, 12 H), 3.99 (dt, J = 3.65, 8.5 Hz, 1 H), 3.88 (m, 3H), 3.76 (m, 2H), 
3.70 (dd, J = 8.6, 2.8, Hz, 1H), 3.62 (dd, J = 7.4, 2.4 Hz, 1H), 3.57 (t, J = 2.5 Hz, 1H), 3.48 (q, J 
= 7.65, 13.7 Hz, 1H), 1.87 (m, 2H), 1.69 (m, 2H), 1.23 (m, 24 H), 0.86 (t, J = 7.1 Hz, 3H); 
13CNMR (125 MHz, CDCl3) δ 156.8, 138.7, 138.5, 138.4, 137.5, 136.0, 128.9, 128.7, 128.5, 
128.4, 128.2, 128.1, 127.9, 127.8, 127.7, 79.7, 78.87, 76.36, 74.5, 73.9, 73.3, 73.2, 72.4, 65.2, 
50.0, 32.7, 32.1, 29.9, 29.7, 29.6, 25.1, 22.9, 14.4; HRMS (ESI, MNa+) m/z calc for 
C68H84INO8Na+ 1192.5139, found 1192.5141. 
 
E-homoallylic alcohol 1.91 
 
            Nitrogen gas was bubbled through a solution of 1.90 (106 mg, 0.188 mmol) and 1.63 (33 
mg, 0.088 mmol) in CH2Cl2 (65 mL) for 1 h. Grubbs II catalyst (7.5 mg, 0.009 mmol) was added 
and the reaction mixture was heated at 40 0C for 16 h. The volatiles were then removed in vacuo. 
FCC of the residue provided Crude material was purified by FCC to give 1.91 as colorless oil (48 
mg ca 60%): Rf = 0.42 (20%EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.26 (m, 25 H), 5.60 (dd, 
J = 15.5, 6.7 Hz, 1H), 5.50 (dd, J = 15.7, 8.4 Hz, 1H), 4.73-4.27 (m, 10H), 4.03 (m, 3 H), 3.83 
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(m, 26H), 0.86 (t, J = 7.2 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 138.7, 138.5, 138.4, 133.6, 
128.7, 128.6, 128.5, 128.1, 128.0, 127.8, 127.7, 83.0, 76.6, 74.5, 73.6, 73.4, 73.1, 72.2, 69.9, 
67.7, 32.6, 32.1, 29.9, 29.6, 26.0, 22.9, 14.3; HRMS (ESI, MH+) m/z calc for C60H78O7Na+ 




      Treatment of 1.91 (116 mg, 0.127 mmol) under the conditions used for the synthesis of 1.88 
provided 1.92 (85 mg, 63 %): Rf = 0.37 (10% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.25 
(m, 30 H), 5.57 (dd, J = 14.7, 6.7 Hz, 1H), 5.45 (dd, J = 15.4, 7.7 Hz, 1H), 5.24 (q, J = 3.8 Hz, 
1H), 4.74-4.32 (m, 12 H), 3.99 (m, 3 H), 3.91 (dd, J = 7.3, 4.7 Hz, 1H), 3.84 (m, 1H), 3.64 (m, 
3H), 2.37 (m, 2H), 2.32 (s, 3 H), 1.66 (m, 2H), 1.23 (m, 24H), 0.86 (t, J = 7.2 Hz, 3H); 13CNMR 
(125 MHz, CDCl3) δ 156.6, 141.0, 138.9, 138.8, 138.5, 138.4, 132.4, 129.6, 129.0, 128.6, 128.5, 
128.4, 128.3, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 127.4, 126.5, 125.2, 80.6, 78.2, 
77.0, 76.7, 74.6, 73.7, 73.5, 73.4, 73.1, 70.1, 67.7, 52.7, 32.1, 29.9, 29.8, 29.6, 26.6, 25.7, 23.7, 
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Iodocarbamate 1.93 
 
             To a solution of 1.92 (50 mg, 0.047 mmol) in dry CH2Cl2 (00 mL) was added IDCP (88 
mg, 0.186 mmol). The reaction mixture was stirred at rt for 16 h, then processed as described for 
the synthesis of 1.89, to give 1.93 (30 mg, 54 %): Rf = 0.33 (15% EtOAc/PE); 1H NMR (500 
MHz, CDCl3) δ 7.29 (m, 30 H), 4.85 (d, J = 15.2 Hz, 1H), 4.70-4.29 (m, 12 H), 3.98 (dt, J = 8.5, 
3.1 Hz, 1 H), 3.87 (m, 3H), 3.70 (m, 2H), 3.60 (dd, J = 7.4, 2.7, Hz, 1H), 3.49 (dd, J = 9.7, 3.5 
Hz, 1H), 3.22 (t, J = 4.2 Hz, 1H), 2.31 (m, 2H), 2.17 (m, 1H), 2.00 (m, 1H), 1.65 (m, 2H), 1.23 
(m, 24 H), 0.86 (t, J = 7.1 Hz, 3H). 13CNMR (125 MHz, CDCl3) δ 156.0, 138.5, 138.4, 138.1, 
138.0, 137.3, 136.8, 129.9, 128.9, 128.8, 128.6, 128.6, 128.4, 128.3, 128.2, 128.1, 127.9, 127.8, 
127.7, 80.2, 78.2, 76.4, 74.3, 73.9, 73.6, 73.4, 73.3, 73.1, 73.0, 71.8, 68.1, 62.7, 49.8, 35.3, 32.3, 
32.1, 29.9, 29.7, 29.6, 29.5, 29.3, 24.9, 23.6, 22.9, 14.4; HRMS (ESI, MH+) m/z calc for 
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Carbamate 1.94 
 
           To a solution of 1.89 (275 mg, 0.24 mmol) in dry benzene (24 mL) was added AIBN (39 
mg, 0.24 mmol). N2 gas was bubbled through the mixture for 1 h, at which time Bu3SnH (0.194 
mL, 0.72 mmol) was added. Then reaction mixture was heated at 80 oC under N2 for 1 h. After 
cooling to rt KF (300 mg) was added and the mixture filtered over a Celite pad. The volatiles 
were removed in vacuo and the residue purified by FCC to give 1.94 (175 mg, 70%) as colorless 
oil: Rf = 0.25 (20% EtOAc/PE); 1H NMR (500 MHz, CDCl3) δ 7.24 (m, 30 H), 5.13 (d, J = 15.15 
Hz, 1H), 4.72-4.24 (m, 10 H), 3.98 (dt J = 8.4, 3.6 Hz, 1H), 3.94 (m, 2H), 3.89 (d, J = 15.15, 
1H), 3.69 (m, 4H), 3.35 (dd, J = 1H), 3.18 (q, J = 13.7, 7.7, Hz, 1H), 1.85 (m, 1 H), 1.71 (m, 
1H), 1.56 (m, 3H), 1.24 (m, 24 H), 0.86 (t, J = 7.1 Hz, 3H); 13CNMR (125 MHz, CDCl3) δ 156.2, 
138.7, 138.5, 138.4, 137.3, 136.7, 128.8, 128.7, 128.6, 128.5, 128.3, 128.1, 127.9, 127.8, 79.6, 
78.2, 74.6, 73.5, 73.4, 72.8, 72.7, 68.1, 57.8, 49.4, 33.1, 32.1, 29.9, 29.7, 29.6, 26.7, 25.3, 22.9, 
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Aminoalcohol 1.95 
 
        Compound 1.94 (50 mg, 0.048 mmol) was dissolved in a mixture of EtOH (2 mL), THF (1 
mL) and H2O (1 mL). N2 gas was bubbled through the mixture for 20 min, at which time KOH 
(0.5 g) was added. After sealing the reaction tube, the mixture was heated at 150 oC for 6 h. The 
reaction mixture was cooled to rt then diluted with saturated aqueous NH4Cl and extracted with 
EtOAc (3 x 20 mL). The organic extract was dried (Na2SO4), filtered, and concentrated in vacuo.  
FCC of the residue afforded 1.95 (43 mg, 90%): Rf = 0.33 (15% EtOAc/PE); 1H NMR (500 
MHz, CDCl3) δ 7.25 (m, 30 H), 4.71-4.38 (m, 10 H), 3.88 (m, 3H), 3.78-3.73 (m, 5H), 3.63 (m, 
1H), 3.54 (dd, J = 4.15, 11.1 Hz, 1H), 3.05 (t, J = 7.65 1H), 2.87 (q, J = 12.5, 5.6 Hz, 1H), 1.89 
(m, 1H), 1.71 (m, 1H), 1.55 (m, 2H), 1.23 (m, 24H), 0.86 (t, J = 7.1 Hz, 3H); 13CNMR (125 
MHz, CDCl3) δ 139.7, 138.8, 138.7, 138.5, 128.7, 128.6, 128.2, 128.1, 128.0, 127.9, 127.8, 
127.7, 127.4, 82.9, 76.9, 75.0, 74.6, 73.9, 73.5, 73.4, 73.3, 72.4, 68.1, 61.2, 51.8, 34.5, 32.1, 30.1, 
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C-KRN7000 1.96 
 
           A mixture of 1.95 (39 mg, 0.052 mmol) in MeOH (1 mL), 10% Pd/C (40 mg), 1 N HCl 
(52 µL, 0.052 mmol) and cylcohexene (0.2 mL) was heated at reflux for 4 h. The mixture was 
then cooled to rt, filtered over a pad of Celite and basic resin, and concentrated in vacuo. The 
residue (23 mg) was taken up in THF (1 mL) and treated with p-nitrophenyl hexacosanoate (75 
mg, 0.144 mmol) and DMAP (0.5 mg). The resulting solution was stirred at rt for 48 h, then 
concentrated in vacuo.  FCC of the residue afforded 1.96 as a white solid (23 mg, 60% over 2 
steps): Rf = 0.125 (10% MeOH, 90% CHCl3); 1H NMR (500 MHz, C5D5N) δ 8.47 (d, J = 7.1 Hz, 
1H), 5.7 (br, 6H), 5.12 (m, 1H), 4.74 (dd, J = 9.0, 5.5 Hz 1H), 4.52 (m, 3H), 4.37 (dd, J = 11.2, 
4.6 Hz, 1H), 4.25 (m, 4H), 2.73 (m, 1H), 2.60 (m, 1H), 2.46 (m, 2H), 2.32 (m, 2H), 2.20 (m, 1H), 
1.94 (m, 2H), 1.87 (m, 3H), 1.70 (m, 1H), 1.25 (m, 64H), 0.88 (t, J = 7.0 Hz, 6H); 13C NMR (125 
MHz, C5D5N) δ 173.9, 79.0, 77.6, 74.2, 73.1, 72.7, 71.1, 70.8, 63.2, 53.1, 37.4, 32.6, 30.9, 30.7, 
30.4, 30.3, 30.1, 27.0, 27.0, 23.4, 14.7; HRMS (ESI, MH+) m/z calc for C51H101O8NNa+ 
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Peracetylated C-KRN 7000  
 
             To a solution of 1.96 (4 mg, 4.7 µmol) in 0.5 mL EtOAc, Ac2O (30 µL, 0.27 mmol) and 
DMAP (1 mg, 8.19 µmol) were added. The mixture was stirred at rt for 3 h. The residue was 
purified by column chromatography on silica gel eluting with 40% EtOAc:PE to afford 4 mg of 
the peracetylated derivative (80%). 1H NMR (500 MHz, C6D6):  δ 5.56 (m, 2H), 5.42 (dd, J = 
3.2, 9.2 Hz, 1H), 5.27 (m, 2H), 5.00 (d, J = 9.9 Hz, 1H), 4.46 (m, 2H), 4.33 (m, 1H), 4.10 (dd, J 
= 5.3,  11.4 Hz, 1H), 3.72 (m, 1H), 2.01 (m, 3H), 1.84 (s, 3H), 1.82 (s, 3H), 1.79 (s, 3H), 1.74 (s, 
3H), 1.70 (s, 3H), 1.62 (s, 3H), 1.45 (m, 1H), 1.35−1.31 (m, 74H), 0.91 (m, 6H). 13C NMR (125 
MHz, C6D6) δ 172.7, 171.1, 170.6, 170.4, 170.2, 169.9, 169.8, 75.7, 73.8, 72.8, 69.5, 69.0, 68.7, 
68.3, 61.7, 48.8, 37.9, 37.1, 32.7, 30.9, 30.6, 30.5, 30.4, 30.3, 30.2, 28.7, 27.9, 27.7, 26.6, 26.5, 
23.5, 21.1, 20.9, 20.7, 20.6, 20.4, 14.7. 
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                Treatment of 1.95 under the conditions used for the synthesis of 1.96 provided 1.109. 
1H NMR (500 MHz, C5D5N) δ 8.42 (d, J = 9.0 Hz, 1H), 7.38-7.23 (m, 5H), 6.80-5.40 (bm, 6H), 
5.11 (m, 1H), 4.73 (dd, J = 8.9, 5.5 Hz, 1H), 4.52 (m, 3H), 4.36 (dd, J = 11.2, 4.6 Hz, 1H), 4.22 
(m, 4H), 2.72 (m, 1H), 2.58 (m, 3H), 2.45 (m, 2H), 2.31 (m, 2H), 2.22 (m, 1H), 1.93 (m, 2H), 
1.85 (m, 2H), 1.70 (m, 1H), 1.58 (m, 2H), 1.26 (m, 40H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR (125 
MHz, C5D5N) δ 173.9, 143.7, 129.3, 129.2, 126.5, 79.0, 77.5, 74.2, 73.1, 72.7, 71.1, 70.9, 63.2, 
53.2, 37.4, 36.6, 34.9, 32.6, 32.3, 30.8, 30.6, 30.5, 30.4, 30.3, 30.2, 30.1, 30.0, 27.0, 26.9, 23.4, 
23.1, 14.7.  
 
Peracetylated-Phenylundecanoyl amide 1.111 
 
Treatment of 1.109 under the conditions used for the synthesis of the peracetylated KRN7000 
provided 1.111. 1H NMR (500 MHz, CDCl3) δ 7.26-7.13 (m, 5H), 5.71 (d, J = 9.7 Hz, 1H), 5.38 
(m, 1H), 5.15 (m, 2H), 4.90 (m, 2H), 4.30 (dd, J = 13.1, 3.9 Hz, 1H), 4.17 (m, 1H), 4.06 (m, 1H), 
4.02 (m, 2H), 2.57 (t, J = 7.7 Hz, 2H), 2.15 (t, J = 7.7 Hz, 2H), 2.09 (s, 3H), 2.08 (s, 3H), 2.04 (s, 
6H), 2.03 (s, 3H), 2.01 (s, 3H), 1.63 (m, 1H), 1.56 (m, 8H), 1.40 (m, 1H), 1.22 (m, 40H), 0.86 (t, 
J = 6.8 Hz, 3H). 13CNMR (125 MHz, CDCl3) δ 173.1, 171.3, 170.8, 170.2, 170.1, 170.0, 143.1, 
128.6, 128.4, 125.8, 75.8, 72.9, 72.0, 68.7, 68.0, 67.6, 61.3, 48.7, 37.1, 36.2, 32.2, 31.8, 29.9, 
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(4-fluorophenyl) undecanoyl amide 1.110 
 
       Treatment of 1.95 under the conditions used for the synthesis of 1.109 provided 1.110. 1H 
NMR (500 MHz, C5D5N) δ 8.46 (d, J = 9.0 Hz, 1H), 7.20-7.11 (m, 4H), 5.15 (m, 1H), 4.97 (bm, 
5H), 4.74 (dd, J = 8.9, 5.5 Hz, 1H), 4.52 (m, 3H), 4.37 (dd, J = 11.2, 4.6 Hz, 1H), 4.24 (m, 4H), 
2.73 (m, 1H), 2.60 (m, 1H), 2.51 (t, J = 7.9 Hz, 2H), 2.48 (m, 2H), 2.36 (m, 2H), 2.24 (m, 1H), 
1.95 (m, 2H), 1.86 (m, 2H), 1.70 (m, 1H), 1.54 (m, 2H), 1.41 (m, 5H), 1.25 (m, 32H), 0.88 (t, J = 
6.7 Hz, 3H). 13C NMR (125 MHz, C5D5N) δ 173.4, 161.6 (d, JC-F = 240.5 Hz), 139.1 (d, JC-F = 
2.8 Hz), 130.4 (d, JC-F = 7.4 Hz), 115.3 (d, JC-F = 20.8 Hz), 78.5, 77.1, 73.8, 73.1, 72.7, 72.2, 
70.6, 70.4, 62.8, 52.7, 37.0, 35.2, 34.5, 32.2, 30.9, 30.4, 30.2, 30.1, 30.0, 29.9, 29.7, 29.6, 29.5, 
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Peracetylated (4-fluorophenyl) undecanoyl amide 1.112 
 
Treatment of 1.110 under the conditions used for the synthesis of the peracetylated KRN7000 
provided 1.112. 1H NMR (500 MHz, CDCl3) δ 7.08 (m, 2H), 6.92 (m, 2H), 5.69 (d, J = 9.7 Hz, 
1H), 5.38 (m, 1H), 5.14 (m, 2H), 4.89 (m, 2H), 4.30 (dd, J = 13.1, 3.9 Hz, 1H), 4.17 (m, 1H), 
4.06 (m, 1H), 4.00 (m, 2H), 2.53 (t, J = 7.7 Hz, 2H), 2.15 (t, J = 7.7 Hz, 2H), 2.08 (s, 6H), 2.04 
(s, 6H), 2.03 (s, 6H), 2.00 (s, 3H), 1.74 (m, 1H), 1.56 (m, 8H), 1.40 (m, 1H), 1.22 (m, 40H), 0.85 
(t, J = 6.8 Hz, 3H). 13CNMR (125 MHz, CDCl3) δ 173.1, 171.3, 170.8, 170.2, 170.0, 161.6 (d, 
JC-F = 240.5 Hz), 139.1 (d, JC-F = 2.8 Hz), 129.9 (d, JC-F = 7.4 Hz), 115.1 (d, JC-F = 20.8 Hz), 
77.4, 75.7, 72.9, 72.0, 68.8, 68.7, 68.0, 67.5, 61.3, 48.7, 37.1, 35.3, 32.2, 31.8, 29.9, 29.8, 29.7, 
29.6, 29.4, 29.1, 27.0, 26.0, 25.7, 22.9, 22.7, 21.3, 21.1, 21.0, 20.9, 14.3.  
 
α-CHF Galactoside Compound 1.119 
 
          To a solution of aldehyde 1.118 (mg, mmol) in MTBE (mL) was added (S)-Jorgensen 
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added, and stirring continued at rt for 3h. After NMR indicated disappearance of the starting 
material. The reaction mixture was diluted with ethyl ether (xxmL), cooled down to -78 oC, and 
filtered over Celite. The Filterate was concentrated at rt under reduced pressure and the residue 
filtered very quickly over short column of silica gel. The filterate was evaporated in vacuo at rt, 
and the crude fluoro-aladehyde was used directly in the next step.  
 To a solution of Ph3PCH3Br salt (mg, mmol) in anhydrous THF (mL) was added 2M NaHMDS, 
2M in THF (mL, mmol). The resulting bright orange solution was stirred for 1 h at this 
temperature at which time a solution of the material formed in the previous step (mg, mmol) in a 
THF (10 mL) was added. The resulting reaction mixture was warmed up slowly to rt over 5 h, 
the poured into saturated solution of NH4Cl solution. The reaction mixture was extracted with 
EtOAc (4 X 50 mL) and the organic phase was washed with brine, dried (Na2SO4), filtered, and 
evaporated under reduced pressure. FCC of the residue gave the alkene derivative 1.119. 
1HNMR (500Mz, CDCl3) δ 7.26-7.11 (m, 15H), 7.08 (d, J = 8.6 Hz, 2H), 6.77 (d, J = 6.8 Hz, 
2H), 5.99 (m, 1H), 5.38 (m, 1H), 5.23 (m, 1H), 4.96 (ddd, d, J = 46.7, 7.0, 5.5 Hz, 1H), 4.51-4.31 
(m, 8H), 4.27 (t, J = 7.1 Hz, 2H), 4.02 (dd, J = 11.9, 8.9 Hz, 1H), 3.94 (dd, J = 6.1, 2.5 Hz, 1H), 
3.78 (t, J = 7.4 Hz, 1H), 3.73 (s, 3H), 3.64 (m, 3H); 13CNMR (125 MHz, CDCl3) δ 159.6, 138.9, 
138.5, 138.4, 134.8 (d, JC-F = 4.9 Hz), 130.2, 130.0, 128.6, 128.5, 127.9, 127.8, 127.7, 117.9 (d, 
JC-F = 12.7 Hz), 114.0, 90.2 (d, JC-F = 167.3 Hz), 75.3, 74.3, 74.0, 73.6, 73.3, 73.2, 71.8, 69.6 (d, 
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C-Fluorinated allyl alcohol 1.120 
 
            To a solution of 1.119 (mg, mmol) in CH2Cl2/H2O 10:1 (mL) was added DDQ (mg, 
mmol). The mixture was stirred at rt for 30 min. Excess solvent was then removed in vacuo at rt, 
and the residue was diluted with ethyl ether (mL). The organic layer was separated and washed 
with brine, dried (Na2SO4), filtered, and evaporated under vacuo at rt. The crude material was 
subjected to FCC 1.120 as a colorless oil, 1HNMR for major isomer (500Mz, CDCl3) δ 5.95 (m, 
1H), 4.45 (m, 1H), 5.31 (m, 1H), 5.08 (dtt, J = 47.4, 6.0, 1.5 Hz, 1H), 4.71 (d, J = 12.0 Hz, 1H), 
4.60-4.50 (m, 5H), 4.34 (m, 1H), 4.05 (m, 3H), 3.86 (m, 2H), 3.73 (dd, J = 11.8, 2.9 Hz, 1H), 
2.15 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 138.7, 138.5, 138.3, 133.7 (d, JC-F = 18.1 Hz), 
128.6, 128.0, 127.9, 127.8, 127.7, 118.7 (d, JC-F = 12.6 Hz), 92.7 (d, JC-F = 169.3 Hz), 77.4, 76.8, 
74.5, 73.4, 73.3, 72.2, 69.84 (d, JC-F = 24.3 Hz), 68.1, 65.8.  
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    NaBH4 (mg, mmol) was slowly added to a solution of aldehyde 1.118 (mg, mmol) in methanol 
(ml) at 0 oC. The reaction mixture was stirred for 30 min and then diluted with saturated solution 
of aqueous NH4Cl (mL). The volatiles were removed under reduced pressure. The residue was 
taken up in EtOAc (mL) and the solution was washed with NaHCO3 (ml) and brine (mL), dried 
(Na2SO4) and evaporated in vacuo. The residue wad purified using FCC to give the 
corresponding alcohol. 
          To a solution of resulting material from the previous step (mg, mmol) in CH2Cl2/H2O 10:1 
(mL) was added DDQ (mg, mmol). The resulting mixture was stirred at rt for 30 min. Excess 
solvent was concentrated in vacuo at rt and the crude material was dissolved in ethyl ether (mL). 
The organic layer was washed with brine, dried (Na2SO4), filtered, and evaporated in vacuo at rt. 
Crude material was subjected to FCC using 20% EtOAc/PE to give diol 1.121 as a colorless oil.  
         To a solution of diol 1.121 (mg, mmol) in CH2Cl2 (mL) was added at rt TEMPO (mg, 
mmol), nBu4NCl (mg, mmol), 0.5 M aqueous NaHCO3 (mL), and 0.05 M aqueous K2CO3 (mL). 
The mixture was vigorously stirred at rt for 30 min at which NCS (mg, mmol) was next added 
and stirring continued for 3 h. The organic layer was then separated and the aqueous layer 
extracted with CH2Cl2. The combined organic phase was washed with brine, dried (Na2SO4), 
filtered and concentrated in vacuo. Purification of the residue by FCC afforded lactone 1.122 (61 
%): Rf = 0.55 (20% EtOAc/PE); 1HNMR (500Mz, C6D6) δ 7.39-7.21 (m, 15H), 4.74 (d, J = 11.1 
Hz, 1H), 4.50 (ABq, J = 11.9 Hz, Δδ = 0.03 ppm, 2H), 4.44-4.38 (m, 3H), 4.31 (dd, J = 47.9, 
5.15 Hz, 1H), 4.21 (m, 1H), 4.03 (m, 2H), 3.82 (dd, J = 4.2, 2.2 Hz, 1H), 3.74 (dd, J = 9.7, 7.15 
Hz, 1H), 3.63 (dd, J = 9.7, 6.5 Hz, 1H), 3.53 (dd, J = 4.5, 1.8 Hz, 1H); 13C NMR (125 MHz, 
C6D6) δ 169.9 (d, JC-F = 22.8 Hz), 139.2, 139.0, 138.6, 129.1, 129.0, 128.9, 128.7, 128.5, 128.4, 
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128.3, 128.1, 85.5 (d, JC-F = 200.8 Hz), 80.3, 76.3, 75.3, 74.6, 73.8, 72.4, 69.2 (d, JC-F = 13.6 
Hz), 67.5.  
 
Fluorinated half phthalate ester 1.123 
 
Treatment of 1.120 under the conditions used for the synthesis of the 1.55 provided 1.123. 
1HNMR (500Mz, C6D6) δ 7.67 (d, J = 7.6 Hz, 1H), 7.60 (d, J = 6.9 Hz, 1H), 7.29 (m, 4H), 7.18-
7.00 (m, 11H), 6.86 (t, J = 6.7 Hz, 1H), 6.79 (t, J = 7.6 Hz, 1H), 6.19 (m, 1H), 5.90 (m, 1H), 5.52 
(m, 1H), 5.30 (dt, J = 47.0, 8.5 Hz, 1H), 5.14 (d, J = 10.9 Hz, 1H), 4.73 (t, J = 7.8 Hz, 1H), 4.63 
(ABq, J = 11.9Hz, Δδ = 0.016 ppm, 2H), 4.45 (t, J = 3.4 Hz, 1H), 4.42-4.36 (m, 6H), 4.22 (dd, J 
= 6.3, 3.1 Hz, 1H), 4.04 (dd, J = 11.9, 2.1 Hz, 1H). 13C NMR (125 MHz, C6D6) δ 171.2, 166.9, 
139.7, 139.2, 139.0, 135.1 (JC-F = 17.4 Hz), 132.3, 131.9, 131.6, 129.7, 129.3, 129.2, 129.1, 
129.0, 128.1, 127.9, 90.3 (JC-F = 169.0 Hz), 76.2, 73.9, 73.8, 73.6, 73.2, 71.6, 70.6, 68.9 (JC-F = 
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Fluorinated mixed phthalate 1.124 
 
Treatment of 1.123 under the conditions used for the synthesis of the 1.64 provided 1.124.  
1HNMR (500Mz, CDCl3) δ 7.78 (d, J = Hz, 1H), 7.45 (m, 3H), 7.19 (m, 20H), 6.75 (d, J = 8.6 
Hz, 2H), 5.86 (m, 2H), 5.54 (m, 1H), 5.38 (m, 1H), 5.35 (m, 1H), 5.23-5.18 (m, 3H), 4.84 (m, 
1H), 4.68 (s, 2H), 4.58 (d, J = 11.2 Hz, 2H), 4.50-4.36 (m, 6H), 4.30 (t, J = Hz, 2H), 4.28 (m, 
1H), 4.09 (t, J = 12.0 Hz, 1H), 3.99 (t, J = Hz, 1H), 3.94 (dd, J = Hz, 1H), 3.70 (m, 4H), 3.54 (m, 
1H), 1.49-1.39 (m, 3H), 1.18 (m, 24H), 0.81 (t, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
167.7, 165.6, 159.4, 138.8, 138.5, 134.1, 133.9 (d, JC-F = 18.3 Hz), 132.8, 132.2, 130.8 (d, JC-F = 
16.0 Hz), 130.3, 129.8, 129.6, 128.8, 128.7, 128.6, 128.5, 128.3, 128.1, 128.0, 127.9, 127.8, 
127.7, 118.8, 118.4 (d, JC-F = 12.4 Hz), 113.9, 89.9 (d, JC-F = 170.1 Hz), 80.2, 77.2 (d, JC-F = 31.9 
Hz), 75.6, 73.6, 73.5, 73.2, 72.6, 72.5, 71.5, 69.79 (d, JC-F = 1.9 Hz), 68.0 (d, JC-F = 28.0 Hz), 

















	   80	  
E-Fluorinated cyclic alkene 1.125   
 
 Treatment of 1.124 under the conditions used for the synthesis of the 1.65 provided 1.24 
1HNMR for major isomer (500Mz, CDCl3) δ 7.50 (m, 1H), 7.48-7.42 (m, 3H), 7.27-7.08 (m, 
22H), 6.73(d, J = 8.6 Hz, 2H), 6.20 (m, 1H), 5.92 (m, 1H), 5.50 (dd, J = 7.6, 3.0 Hz, 1H), 5.33 
(m, 1H), 5.03 (m, 1H), 4.63-4.31 (m, 10H), 3.88 (m, 1H), 3.75 (m, 1H), 3.70 (s, 1H), 3.67 (m, 
1H), 3.61 (dd, J = 11.1, 3.4 Hz, 1H), 3.54 (m, 1H), 1.47 (m, 4H), 1.19 (m, 24H), 0.81 (t, J = 6.8 
Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 167.7, 166.7, 159.4, 138.6, 138.2, 138.1, 132.9 (d, JC-F 
= 22.1 Hz), 131.6, 131.4, 131.2, 130.5, 130.2, 129.9, 128.7, 128.6, 128.5, 128.1, 128.0, 127.9, 
127.8, 127.7, 113.9, 89.9 (d, JC-F = 170.1 Hz), 78.4, 77.4, 76.6, 75.5, 73.7, 73.5, 73.4, 72.9, 72.7, 
72.0, 66.6, 32.1, 31.7, 29.9, 29.8, 29.7, 29.6, 25.6, 22.9, 14.3. 
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 Treatment of 1.125 under the conditions used for the synthesis of the 1.76 provided 1.126 
1HNMR for major isomer (500Mz, CDCl3) δ 7.31-7.08 (m, 17H), 6.80 (d, J = 8.6 Hz, 2H), 5.85 
(m, 2H), 5.08 (dt, J = 47.3, 5.2 Hz, 1H), 4.68-4.37 (m, 8H), 4.24 (m, 2H), 4.03 (m, 1H), 3.96 (m, 
2H), 3.86 (m, 1H), 3.78 (m, 1H), 3.72 (s, 3H), 3.64 (dd, J = 11.7, 2.8 Hz, 1H), 3.34 (m, 1H), 2.18 
(d, J = 4.4 Hz, 1H), 2.15 (t, J = 5.0 Hz, 1H), 1.34 (m, 2H), 1.19 (m, 24H), 0.81 (t, J = 6.8 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 159.5, 138.6, 138.5, 138.3, 134.0 (d, JC-F = 11.6 Hz), 130.7, 
129.7, 128.9, 128.6, 128.5, 128.2, 128.1, 128.0, 127.9, 127.8, 127.4, 127.3 (d, JC-F = 17.9 Hz), 
92.7 (d, JC-F = 169.0 Hz), 81.7, 77.5, 75.4, 73.4, 73.3, 72.7, 72.3, 72.2, 70.3 (d, JC-F = 27.6 Hz), 
68.3, 66.2, 55.5, 32.2, 31.5, 29.9, 29.6, 26.0, 22.9, 14.4. 
 
E-Fluorinated homoallyl carboimidothioate 1.127 
 
Treatment of 1.126 under the conditions used for the synthesis of the 1.92 provided 1.127 
1HNMR (500Mz, CDCl3) δ 7.27 (m, 30H), 5.91 (m, 2H), 5.30 (ddd, J = 8.3, 4.0, 3.5 Hz, 1H), 
5.10 (dt, J = 47.4, 8.1 Hz, 1H), 4.62-4.32 (m, 13H), 4.12-4.04 (m, 3H), 3.91 (t, J = 7.7 Hz, 1H), 
3.76 (m, 3H), 2.38 (s, 3H), 1.69 (m, 2H), 1.27 (m, 24H), 0.90 (t, J = 8.3 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 156.6, 141.0, 138.8, 138.5, 138.4, 138.0, 132.7 (d, JC-F = 11.5 Hz), 130.7 (d, JC-F 
= 17.0 Hz), 132.7, 130.7, 130.6, 128.6, 128.5, 128.4, 128.3, 128.2, 127.9, 127.8, 127.7, 127.6, 
127.5, 127.4, 126.5, 90.0 (d, JC-F = 166.2 Hz), 80.0, 78.1, 77.4, 75.1, 74.8, 74.3, 73.6, 73.3, 73.2, 
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1.1 Introduction 
          Allyl-metal addition to aldehydes is considered one of the ubiquitous and powerful 
reactions in organic synthesis. These reactions are popular for many reasons: (1) they are highly 
diastereo- and enantioselective; (2) the starting materials are easy to access; (3) the synthetic 
versatility of the homoallylic alcohol product make these reaction perfect for synthetic plan 
(Scheme 2.1).60  
 
 




















M = Mg, Zn, Li, 






















Scheme 1: Selected simple transformations for homoallyl alcohols
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           Allyl reagents with Group I and II metals are rarely used in asymmetric reactions because 
of their high reactivity and low selectivity. Thus, for Group I substituted allyl derivatives 
(crotyl), it is difficult to predict which end of the allyl system will react.60 In comparison, allyl- 
tin, silicon, boron, and chromium reagents are moderately reactive, but show high regio and 
stereoselectivity. In some cases special conditions are required, like high temperature, pressure 
or prior activation of the aldehyde by Lewis acids. Because of the different options that are 
available to induce their reactivity, allyl-tin, silicon and boron reagents are widely used in 
asymmetric syntheses. In this chapter, we will study Type II crotyltion reactions of sugar derived 
crotylstannane compounds.  
1.2 Types of allylation reactions based on diastereoselectivity  
Three types of crotylation reactions, Types I-III classified according to the trends in 
diastereoselectivity, have been defined.   
1.2.1 Type I allylation  
                      



























M = Al, B, Si, & Sn
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The first type is highly stereospecific, i.e. the addition is dependent on the geometry of the allyl 
reagent E versus Z. E alkenes lead to anti addition and Z alkenes give syn addition with respect 
to the substituents at the newly formed stereogenic centers. This class includes Al, B, Si, and Sn 
allyl reagents. The addition proceeds via closed six membered ring transition state (TS), where 
the metal coordinates with aldehyde such that the π system of the aldehyde and allyl reagent are 
syn and the aldehyde alkyl or aryl substituent is in a pseudo equatorial position to minimize 
interactions (Scheme 2.2). Forcing reaction conditions may be needed as in case of allyl tin and 
silicon reagents where high pressure and high temperature are required. 
 
1.2.2 Type II allylation 
 
Scheme 2.3 Type II allylation via open transition state  
 
          Type II allylation proceeds via open TS. Both E and Z prefer syn addition (Scheme 2.3). 
This class of reactions is driven by Lewis acid activation of the aldehyde prior to the addition of 
the crotylating agent. Antiperiplanar TS is suggested by Yamamoto to account for the syn 
diasteroselectivity. In the Yamamoto TS, the arrangement of the two pi systems would be 
















M = SiR3, SnR3
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crotylstannane. The alkyl substituents on both the aldehyde and the crotyl metal are anti to each 
other. Denmark has proposed another TS in which the crotyl metal and the aldehyde are arranged 
in synclinal arrangement. This arrangement is believed to take advantage of optimum overlap 
between the LUMO of the aldehyde and the HOMO of the allyllating metal reagent. Allyl silicon 
and allyl tin are the most common reagents in this class. These reagents are known for their 
moderate reactivity and have been used for enantioselective reactions using different chiral 
Lewis acids. 
 
1.2.3 Type III allylation 
           The third type of allylation reaction includes allyl- chromium, titanium, and zirconium 
reagents. The double bond isomerizes to give the thermodynamically stable E alkene, which then 
reacts via a closed six membered TSs to give the anti product (Scheme 2.4).   
 
 
Scheme 2.4 Type III allylation via closed transition state 
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1.3 Diastereoselctivity in Type II crotylation reactions 
1.3.1 Yamamoto’s model  
           Yamamoto and co-workers reported in 1980 the first acid mediated crotyl tributyltin 
addition to aldehydes.61,62 Crotylstannane 2.17 was added to benzyladehyde 2.18 which is 
activated with BF3.Et2O at -78 oC. High diasteroselectivity for the syn product was observed as 
shown in (Scheme 2.5).    
   
Scheme 2.5 Yamamoto’s first crotylation experiment 
 
              According to Yamamoto, diastereoselectivity can be explained by open TS with the 
C=O and C=C bonds are arranged in an antiperiplanar orientation, in the conformation that 
minimizes steric hindrance between the substituents in both reagents, i.e. TSs (Z(S) and E(S) in 
Scheme 2.6. TSs (E(A) and Z(A)) are not favored because of the steric interactions between the 
methyl group and the phenyl group. Accordingly, the double bond geometry of the 














2.17 > 90% Z
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Scheme 2.6 Antiperiplanar transition state proposed by Yamamoto 
 
             It is important to mention that crotylation reaction induced with Lewis acids produces 
syn adducts via acyclic TSs (Z(S) and E(S)) if the addition of the reaction components takes 
place under the following standard condition: (i) initial combination of  the aldehyde and  Lewis 
acid to ensure aldehyde-Lewis acid complexation, then (ii) addition of the crotylstannane. Pre-
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aldehyde leads to the anti adduct selectively (Scheme 2.4).63 The anti selectivity may be 
rationalized by the formation of crotyltitanium intermediate via transmetalation from tin to 
titanium (Scheme 2.4, M = Ti), which reacts with aldehyde through a closed TS (A) (Type III). 
Under the standard addition conditions, Yamamoto and co-worker ruled out the possibility of 
isomerization of the crotylstannane by stopping the reaction immediately after addition of the 
crotylstannane and analyzing the recovered reagent. No isomerization was observed.61 
1.3.2 Denmark’s model  
        Denmark studied Type II crotylation reactions in more detail and proposed a modified TS 
that is controlled by molecular orbital interactions.64’65 Denmark designed compound 2.26 
(Scheme 2.7) for an intramolecular crotylation reaction to evaluate the topicity of the two 
reacting π-systems (which controls diastereoselectivity), and also to study the relation between 
the carbonyl carbon (electrophile) and the metal electrofuge in SE2’ selectivity. In this case, there 
are only two reactive TSs. TS H resembles the antiperiplanar model that was suggested by 
Yamamoto, while in TS G the aldehyde and the double bond on the crotylstannane are oriented 
in a synclinal fashion. When the reaction was carried out using various Lewis acids, the proximal 
adduct 2.27 was found with agreement with TS G in 86%-99% vs 14%-1% for the distal product 
2.28 that is Consistent with TS H. As we see in the table in Scheme 2.7 there is no correlation 
between the stereoselectivty and the size of Lewis acid used.   
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1                     TiCl4                  88/12                  89/11           95/5             94/6                  99/1
 2                     SnCl4                  94/6                  86/14            95/5             91/9                   99/1
 3                     BF3.OEt2            86/14                  92/8            95/5             97/3                   99/1
 4                     CF3SO3H            97/3                 93/7                                  98/2
 5                    CF3CO2H           > 99/1                 93/7                                  98/2
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           Denmark also concluded that the selectivity for the (Z) products is a result of the preferred 
anti SE’2 pathway. According to Denmark, the synclinal transition state would minimize the 
charge separation in intermediate 2.30 (Scheme 2.8). Moreover, syn synclinal TS gives a better 
orientation for secondary orbital interaction between the HOMO of crotyltin and the LUMO of 
the activated aldehyde, which is absent in the antiperiplanar model (Scheme 2.6).     
  
Scheme 2.8 Synclinal transition state proposed by Denmark 
 
1.3.3 Keck’s model  
1.3.3.1 Effect of allylstannane geometry and different Lewis acids. 
            Keck and co-workers performed a detailed study on the effect of crotylstannane 
geometry, Lewis acids, and aldehyde substituents on diastereoselectivity.66’67 The intramolecular 
Lewis acid catalyzed reaction of E and Z substrates were investigated (Scheme 2.9). The Lewis 
acid induced cyclization of Z-2.32 or E-2.33 at -78 oC gave products 2.34 and 2.35 respectively. 
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is expected based on the Yamamoto model. These results contradict the Yamamoto proposal that 
the crotylstannanes geometry is unimportant. Keck suggested a synclinal transition states in 
which the C=C is gauche to the carbonyl group and the vinylic C=CCH2Sn bond is syn to the 
carbonyl group. This result matches with the Denmark hypothesis.  
  
Scheme 2.9 Keck’s model for intramolecular crotylation reactions 
    
            Keck also studied the intermolecular crotylation reaction, in a similar experiment to that 
done by Yamamoto. Benzaldehyde was reacted with crotylstannane 2.17 after activation with 
BF3.Et2O at -78 oC (Scheme 2.10). The E enriched reagents showed essentially identical syn 
selectivity to Yamamoto’s experiment. However, Keck observed that enriched Z crotylstannane 
was appreciably lower in syn selectivity. Similar trends were observed when different aldehydes 
were used. In the case of cyclohexanecarboxyaldehyde and BF3.Et2O as Lewis acid, the 
selectivity with E-reagent was high (15:1), whereas that for Z was poor (1.4:1).68 These results 
appear to be more consistent with the synclinal open TS model proposed by Denmark and Keck 
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Scheme 2.10 Stereoselectivity in reaction of E/Z crotylstannane with simple aldehydes 
 
            Keck explains the higher syn selectivity observed for E-crotylstannane compared to the Z 
reagents in terms of the TSs shown in Scheme 2.11. 66 Assuming that the complexation of the 
aldehyde with BF3.OEt2 exists in anti fashion to the R group of the aldehyde. TSs pair Z3 and 
E4 resembles to the antiperiplanar TS recommended by Yamamoto to explain the syn selectivity. 
These are preferred over the anti TSs Z4 and E3 because of the destabilizing steric interactions 
between R and CH3 groups in Z4 and E3. The steric interactions between the Lewis acid and the 
CH3 group in Z3 and E4 are assumed to be less severe. This model suggests that the E-
crotylstannane should be less syn selective than the Z-crotylstannane because of the interactions 
between R and the allylSnBu3 residue. 
         The syn-synclinal TSs  (Z1 and Z2), which could benefit from the favorable secondary 
orbital overlap are characterized in each case with steric interactions between the methyl or 

























Scheme 10  Stereoselectivity in Reactions of E/Z crotylstannaes with simple aldehydes
2.18
2.19 2.20
	   94	  
any TS structures in the Z group, all pairs have similar steric interactions. This might explain the 
lower selectivity with the Z-stannane (Scheme 2.10). Keck proposes that the reaction with E-
stannane proceeds through a synclinal array E2, which has no steric problems, and also could 
benefit from the secondary orbital overlap. 
 
Scheme 2.11 Staggered T.S for reaction of E/Z crotylstannanes with simple aldehydes 
  
          For addition of crotylstannanes to simple aldehydes induced by BF3.EtO2, syn selectivity is 
enriched remarkably by using 2 equiv of the crotylstannane (Scheme 2.12); it is shown that E-
isomer reacts relatively faster than the Z-isomer and also gives higher syn selectivity.  Both 
MgBr2 and SnCl4 give mixtures of syn, and anti, and linear products.63  
















































Z1 (S) Z2 (A)
Z4 (A)Z3 (S)
Z-Crotylstannane reaction with aldehyde
Scheme 11 Staggered transition states for reaction of E/Z crotylstannanes with simple aldehydes.
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Lewis acid 2.22 2.23 2.24 2.25
2.17
E/Z
BF3.OEt2 74:26 86 14 0 0
BF3.OEt2 56:43 96.1 3.9 0 0(2 eq)












SnCl4 90:10 23 26 36 15: : :
MgBr2 90:10 52
36 12 0: : :
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1.3. 3.2 Keck’s study on α-oxygenated aldehydes1 
               The diastereoselectivity in the reactions of crotylatannane with α-oxygenated aldehydes 
is sensitive to the Lewis acids and the nature of the α-substituent.68 Keck examined the effect of 
different Lewis acids on the reaction of crotylstannane with α-oxygenated aldehydes (Scheme 
2.13). Syn-selectivity was observed for addition of enriched E-crotylstannane 2.17 to α-
cyclohexyl-α-benzyloxy acetaldehyde 2.32. The syn/syn’ 2.33 and syn/anti’ 2.35 were collected 
as a major products when a non-chelated Lewis acid BF3.OEt2 was used. High syn selectivity 
(92%) was also observed with MgBr2.OEt2. However, TiCl4 gave apparently lower syn 
selectivity (syn/anti: 63:37) (Scheme 2.13). 
 
Scheme 2.13 Addition of crotylstannane to α-oxygenated aldehydes using different Lewis acids  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	   In	   this	   report,	   for	   clarity,	   we	   will	   refer	   to	   the	   stereochemistry	   with	   respect	   to	   the	   newly	   formed	   bond	  
between	  crotylstannane	  and	  the	  α-oxygenated aldehyde by syn or anti, while the stereochemistry with respect to 


































BF3.OEt2                   66      :        1    :      26     :          7
TiCl4                         63       :       37  :         0    :           0
MgBr2.OEt2             92       :          8   :         0   :           0
+
+
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Keck also studied the role of the crotylstannane geometry in chelation model in effort to trace the 
origin of the syn-selectivity. Reacting aldehyde 2.37 with E or Z enriched stannanes using 
MgBr2.OEt2 exhibited great preference to syn/syn’ products 2.38 in both E and Z alkenes 
(Scheme 2.14). However, the differences in syn selectivity between E an Z Stannanes are much 
smaller than those found in BF3.OEt2-induced additions. The syn/anti ratio was evaluated based 
on the ratio of 2.38:2.40, since 2.39 and 2.41 were not formed in detectable amounts. Thus, syn 
selectivity ranges from 3.7:1 to 13.6: 1. The highest selectivity is again observed with the E 
stannane.  
  
































90:10                   93                     7                13.6:1                    89
76:24                  91.2                  8.8               10.4:1                   79
12:88                  78.6                 21.4              3.7:1                     82
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        For the reactions with chelating Lewis acids, Keck examined six possible staggered TSs for 
E and Z crotylstannanes (Scheme 2.15).66 Only four structures seem favorable E1, E4, Z3, and 
Z6. These four TSs are favored because they hold an H atom over the interior of the five 
membered chelate ring. All other TSs are high in energy and suffer from major steric 
interactions, where non-hydrogen substituent clashes with chelate ring. The antiperplanar TSs E4 
and Z3 are consistent with the observed syn stereochemistry. The synclinal TSs E1 and Z6 have 
no serious steric interactions but both lead to anti products and therefore are not consistent with 
the Keck results.  
        
Scheme 2.15 Staggered T.S for reaction of E/Z crotylstannanes with α-oxygenated aldehyde 
 
 





























































Z-Crotylstannane reaction with aldehyde
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1.3.4 Nishigaichi’s studies 
          Nishigaichi and co-workers studied the crotylation reaction of γ-disubstituted and γ-
monobstituted crotylstannanes with α-alkoxy aldehydes. In his study, Nishigaichi linked the 
selectivity to the stannane’s geometry. γ,γ-Disubstituted stannanes addition to activated 
aldehydes with BF3.OEt2 found to be stereospecific. E-stannanes give syn products while Z-
stannanes lead to anti products. In contrast, γ-monosubstituted stannanes were found to favor the 
syn products under the same conditions regardless of the alkene geometry.69 In case of the 
BF3.OEt2, reaction of alkoxy aldehyde 2.116 with both E-2.17 and Z-2.118 gave mainly syn 
products 2.117 and 2.119 respectively (Scheme 2.16). The syn selectiviy was much lower for Z-
2.118.  The lower syn selectivity for the Z-stannane agreed with Keck’s earlier results. 66  
 














































































Sche e 16 Syn-selective crotylation reactions induced by non-chelating Lewis acid (BF3.OEt2).
E1(S)E2(A)
Z2(A) Z1(S)
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             Nishigaichi explained the syn-selectivity by syn-synclinal TS models as suggested earlier 
by Denmark64 and Keck66 (Scheme 2.16). Nishigaichi’s model is slightly different by 
highlighting the importance of unfavorable steric interactions between the Lewis acid and the 
SnBu3 group. As depicted in Scheme 2.16, all four TSs benefit from the stereoelectronic factors 
in the syn-synclinal TSs and BF3.OEt2 coordinates with the aldehyde in an anti fashion to the 
aldehyde substituent. For the E-stannane, TS E1(S) which gives the syn product, is more 
energetically favored than E2(A), which leads to the anti product. In E1(S), the crotylstannane 
approaches the C=O from the opposite side of the coordinating acid, whereas in E2(A) the Bu3Sn 
and the Lewis acid are on the same side of the C=O.  
            In the case of Z-stannane, both TSs Z1(S) and Z2(A) suffer from steric interactions. 
Z1(S) suffers from steric interactions between the CH2SnBu3 group and the Lewis acid. Z2(A) 
also suffers from the interactions between the CH2CH3 group and the Lewis acid. The low 
preference preference for Z2(A) over Z1(S)  does not explain the low syn selectivity for the Z-
stannane Z-2.118.70      
         Nishigaichi also studied the reactions of the same substrates using a chelating Lewis acid. 
TiCl4.2OEt2 was used because of its ability to restrain Ti-Sn transmetaltion. Stannane E-2.17 was 
not selective and gave both syn-2.117 and anti-2.117 in (1:1) ratio (Scheme 2.17). In contrast, 
stannane Z-2.118 showed higher syn selectivity and gave exclusively syn-2.119. These results 
contradict to some extant the results collected by Keck. In the MgBr2.OEt2 experiment (Schemes 
13 and 14), both E and Z stannanes showed high syn affinity when reacted with α-alkoxy 
aldehydes. Nishigaichi used the same syn-syclinal model to explain the syn selectivity in the case 
of the Z-stannane (Scheme 2.17). Thus, in TS Z3(S) the Bu3Sn group approaches the C=O from 
the opposite direction to the chelating ring, This facilitates the SE2’ elimination step and leads to 
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syn-2.119. TS Z4(A) is not favored because steric hindrance between the SnBu3 group and the 
chelating ring.  Regarding the E-stannane E-2.17, TS E4(A) does not suffer from steric 
interctions. The H atom is placed over the interior of the chalating ring and the SnBu3 is loacted 
in the opposite direction to the chelating ring. Thus, TS E4(A) should be highly favored over the 
congested TS E3(S). As a result only anti product is expeted from this model. Therefore, the 
Nishigaichi model does not explain the lack of selectivity in the case of stannane E-2.17. A 
comptetion between syn synclinal E4 (A) and antiperipalanar TS E6(S) may explain this result.  
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1.3.5 Jarosz study on sugar-substituted crotylstannanes       
             Jarosz and co-workers reported high syn selectivity in the BF3.OEt2 catalyzed reaction of 
α-oxygenated aldehyde 2.45 and the E-enriched crotylstannane 2.44. The homoallyl alcohol 2.46 
was obtained as the only product in 81% yield (Scheme 2.18).71  
  
Scheme 2.18 Sugarstannane addition to α-oxygenated aldehydes 
         The antiperiplanar TS model was used to explain the syn stereochemical outcome (Scheme 
2.19). This result suggests that both the E and Z crotylatannane showed high syn selectivity. 
Thus, the facial selectivity on both aldehyde and the stannane appears to be high. The attack of 
the activated aldehyde 2.45 may take place either from the front or from behind of the sugar ring 
of 2.44. The attack from the front (Re face of C=C and Si face of the aldehyde) is more favorable 
(TS P, Scheme 2.19). On the other side, TS P’ is disfavored because of steric interactions might 
arise from the OBn group at C4 of the Si face of the Crotylstannane 2.44 (TS P’ (Scheme 2.19). 
Steric repulsions may also arise between the isopropylidene groups on the Re face of the 
aldehyde and the CH2SnBu3 group.  
      This facial selectivity on the aldehyde can be explained by the use of Felkin Anh model. The 
expected Nucleophile addition by Felkin Anh Q’ is inoperative in this case because the 
sugarstannane 2.44 (Nucleophile) might suffer from steric hindrance that originates from the bis-
isoproplyidene groups on the aldehyde. Alternatively, the crotylstannane might prefer the attack 

















	   103	  
controlled by the configuration of the substituents on the α, β and γ carbons and also by the 
conformation of the two isopropylidene groups. The foregoing examples illustrate the difficulty 
in predicting diastereoselectivity in crotylation reactions for highly substituted substrates. In this 




Scheme 2.19 Suggested transition states for Jarosz’s reaction 
  











Felkin Anh polar model requires that the polar group on the a-carbon be 
orthogonal to C=O.  Nucleophile attack is favored along Burgi-Dunitz trajectory 
closer to the smaller of the two other groups on the a-carbon.In this case the 
trajectory close to the smaller group (i.e. "H") is blocked because of the 




























































Si face of C=C is blocked by OBn 
at C-4 of the sugar ring & Re face 




Scheme 19 Suggested transition staes for Jarosz's reaction
	   104	  
 2.1.1 A crotylation approach to C-KRN7000 analogues  
           Our initial goal was to use sugar substituted crotylstannane to synthesize O- and C- 
GalCer libraries 2.47-2.49 (Scheme 2.20). These analogues can be obtained from homoallyl 
alcohol 2.50, via oxidative degradation of the alkene to carboxylic acid and Curtius 
rearrangement on the derived acyl azide. Coupling the sugar crotylstannane 2.51 with α-alkoxy 
aldehyde 2.52 provides a convergent route to 2.50.  
       The C-glycoside analogue of 2.50 was the first target of the crotylation methodology. Thus, 
syn addition was expected for the reaction of 2.51 (X = CH2) regardless of the E/Z geometry of 
the crotylstannane reagent. Diastereoselectivity in the crotylation reaction could be controlled by 
varying the protecting group on 2.52 and the Lewis acid promoter.  
 
Scheme 2.20 Crotylation methodology for C-glycolipids  
 
2.1.2 Synthesis of the C-glycoside crotylstannane 
          The weak character and more polar nature of C-Sn bond compared to C-Si and C-C bonds 
make organostannanes more reactive and more useful in organic chemistry.72’73’74 For example, 






























X = O , KRN7000 2.47
X = CH2, C-KRN7000 2.48
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strength, while allylsilicon reagents require stronger acids. Although allylstannanes are more 
reactive than allylsilanes, they are less reactive than allylic agents with Group I-III metals, and 
can be purified using standard extraction and chromatographic procedures. 2’9’75  
                  Allylstannanes can be prepared through transmetalation of allylic Grignard reagents 
with triaryl or trialkyl-tin chlorides in THF (eq 1 Scheme 2.21).76 An alternative procedure uses 
zinc in aqueous THF containing NH4Cl.77 E/Z isomerisation was observed when crotylbromide 
is subjected to this procedure (eq 2 Scheme 2.21). Primary allyllic alcohols can be converted to 
allylic stannanes through in situ formation of the corresponding mesylate at -78 oC followed by 
addition of Bu3SnLi (eq 3 Scheme 2.21).78    
  
Scheme 2.21 Common procedures for allylstannanes preparations 
        Here, we adopted the method reported by Jarosz and other researchers, which is compatible 
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Scheme 2.22 Synthesis of sugarstannane 2.64 
 
              Sequential reaction of 2.61 with NaH, CS2 and MeI afforded xanthate 2.62 in 95% yield. 
Then thermal rearrangement of 2.62 gave thiocarbonate 2.63, which upon treatment with 
Bu3SnH and AIBN at reflux gave the required allylstannane 2.64 in 60%yield, as a mixture of 
alkenes (E/Z ca. 1.6:1). 
2.1.3 Synthesis of the α-alkoxy aldehyde  
       The known aldehyde 2.69 was obtained in six steps from commercially available 









































Conditions and reagents: a) ref 22. b) 1.NaH/THF/ 1 h, rt. 2. CS2, 30 min, rt. 3.MeI,  2 h, rt. 95%. 
c) Toluene, reflux, 120 oC. d) Bu3SnH, AIBN, reflux, 20 min.
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pentadecanal via a HWE reaction afforded E-α,β unsaturated ester 2.66. Sharpless asymmetric 
dihydroxylation with AD-mix β and catalytic K2OsO482 produced (2S, 3R) diol 2.67. 
Methoxybenzylidene formation on 2.67 and reductive acetal cleavage with concomitant 
reduction of the ester group using DIBAL-H provided the lipid diol 2.68 in 93% yield from 2.67. 
Treatment of diol 2.68 with NaIO4 afforded aldehyde 2.69 in 95% yield. The enantioselectivity 
in the Sharpless dihydroxylation was determined to be greater than 95% by NMR analysis of the 
Mosher ester derivative of diol 2.68.  
   
Scheme 2.23 Synthesis of α-alkoxy aldehyde 
 
2.1.4 Crotylation reaction and stereochemical assignment of crotylation products   
           First, we investigated the crotylation reactions using the monodentate Lewis acid 
BF3.OEt2 following Yamamoto’s protocol. Treatment of aldehyde 2.69 with BF3.Et2O at -78 oC 


















Reagents and conditions: a) 1. O3, Zn. 2. Ph3P=CHCO2Me, CH3CN, reflux. b) t-BuOH/H2O, KFeCN,
 K 2CO3, methanesulphoneamide, K 2OsO4, AD-mix b, 0 oC for 48 h. C) 1. DCM, anisaldehyde 
dimethyl acetal, CSA,  rt, 3 h. 2. DIBAL-H/ DCM, -78 oC to rt, 3 h, 92% two steps. d) NaIO 4, 
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of three diastereoisomers 2.70 (38%), 2.71 (37%), and 2.72 (11%). The three diastereomers were 
separable after careful chromatography (Scheme 2.24).  
  
Scheme 2.24 Preliminary crotylation reaction with BF3.OEt2 as Lewis acid 
                To help with establishing the stereochemical relationship of these products, the major 


































Reagents and Conditions: a) DMP/DCM, rt, 20 min. b) 1. NaBH4/MeOH, rt, 20 min. 
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alcohol 2.70 gave ketone 2.74, which on reduction afforded alcohol 2.73 and the original alcohol 
2.70. Similarly, 2.71 gave ketone 2.75, which was different from 2.74, and afforded 2.71 and 
2.72 after reduction. These results suggest that: (i) 2.70 and 2.73 are epimers at C3, (ii) 2.71 and 
2.72 are epimers at C3, (iii) 2.70 and 2.71 are epimers at C2 (Scheme 2.24).         
                We next tried to assign the relative stereochemistry in 2.70 and 2.71 by 1HNMR 
analysis of the lactones 2.78 and 2.81 (Scheme 2.25). These lactones were derived by first 
converting alkenes 2.70 and 2.71 to the primary alcohols 2.76 and 2.79 respectively, via a 
standard sequence of reactions, alcohol benzylation and alkene hydroboration-oxidation. 
Treatment of 2.76 and 2.79 with SnCl4 cleaved the PMB groups. Subsequent oxidation of the 
respective diols using TEMPO and NCS provided lactones 2.78 and 2.81. To investigate the 
stereochemistry of 2.78 and 2.81, we initially carried out 2D NOESY experiments with both 
lactone derivatives. For lactone 2.78, a positive NOE was observed between H4 and H2 and 
between H4 and Ha (Scheme 2.25). This NOE observation suggests that H4 and H2 are on the 
same side of the lactone ring. The NOE correlation between H4 and Ha is greater than that of H4 
and H2, signifying that the conformation of the lactone ring adopts a boat-like conformation. 
Coupling constant analysis for 2.78 showed J3,4 and J2,3 of 7.9 and 3.5 Hz respectively. J3,4 of 7.9 
Hz is consistent with the trans diaxial-like relationship between H3 and H4. The small J2,3 of 3.5 
Hz also agrees with the boat like conformation shown. Based on this analysis, the 
stereochemistry of 2.70 is syn/anti’ as depicted in Scheme 2.25. This assignment was eventually 
confirmed by conversion of 2.70 to the known target C-KRN7000. Similarly, the data for lactone 
2.81 reveals NOEs between H3 and Ha and H4 and Ha. This suggests that H3, H4, and Ha are on 
the same side. The small coupling constants for J2,3 < 1 Hz  and J3,4 < 2 Hz in 2.81 are consistent 
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with dihedral angle close to 90o and 30o respectively. These results support a boat-like 
conformation, as was the case for 2.78.  
 




Reagents and Conditions: a) 1. NaH, DMF, BnBr, rt, 1 h. 2. 9BBN, THF, ultrasound, 1h,  rt, 16 h , 











































2.78 3J2,3 = 3.5 Hz
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Because of the small amount of 2.72, we were unable to prepare a lactone derivative for NMR 
analysis. The anti stereochemistry in 2.72 was deduced from the conclusion in the early 
oxidation-reduction experiments. i.e. we found that 2.71 and 2.72 are epimeric at C3 (Scheme 
2.24).    
          The NOE experiment and coupling constants analysis for the major products 2.70 and 2.71 
in the crotylation reaction in Scheme 2.24 revealed that the major products in the crotylation 
reaction of 2.64 and 2.69 were syn with different facial selectivity. Based on the results collected 
by Keck, Nishgaichi and others, we believe that the geometry of the crotylstannane could affect 
the selectivity of this reaction. However, in the case of γ-mono-substituted stannanes, the 
geometry effect was very minimal. The syn selectivity in our reaction is consistent with these 
results, albeit in our case the syn selectivity is somewhat lower (syn: anti = 6.8:1). The combined 
yield for the syn products (75%) correlates well with the ratio of the E-stannane in the starting 
material 2.64 (62% E). but this correlation does not necessarily prove the origin of the syn 
selectivity. According to Keck, in acyclic systems, E-stannane are more reactive and syn 
selective than Z-stannane, but also Z-stannanes were found to be syn selective though in lower 
selectivity than E-stannanes.66 To validate this assumption, E and Z enriched 2.64 are needed. 
Unfortunately, we were unable to obtain such materials because they were inseparable by 
chromatography.  
       This crotylation method is attractive for the synthesis of complex carbohydrate derivatives 
because: (i) the starting materials can be easily obtained, and (ii) the resulting homoallyl alcohols 
can be transformed into a variety of different frameworks. Before we unveil the synthetic 
flexibility of this methodology, it is important to explore the diasteroselectivity of this reaction in 
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more detail. Since we are unable to get pure E and Z stannanes, we will study the 
diasteroselectivity of the reaction of E/Z 2.64 using different Lewis acids and aldehydes partners.  
 
2.1.5 Effect of Lewis acid 
              The intrinsic facial selectivity of the sugar stannane 2.64 was first assessed by reacting 
2.64 with the achiral α-oxygenated aldehyde 2.113 using BF3.OEt2 (Scheme 2.26).  This reaction 
produced mainly two major diastereomers 2.114. Unfortunately, the diastereomeric mixture was 
inseparable. In order to determine the stereochemistry of these products, we decided to convert 
the diastereomeric mixture to 1,3-O-isopropylidene 2.115. However, this mixture was also 




Scheme 2.26 Reaction of crotylstannane 2.64 with achiral α-alkoxy aldehyde 2.113  
 
       As we discussed earlier, four diastereomers can be produced in the reaction of a chiral 
crotylstannane and a chiral α-oxygenated aldehyde. In general, addition of monosubstituted 
crotylstannanes to α-oxygenated aldehydes in the presence of chelating Lewis acid show high 
facial selectivity on the aldehyde (i.e. syn’ products), but the syn/anti ratio with respect to the 
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(Scheme 2.13).66 The stereochemistry of these reactions has been explained in terms of chelation 
of the α-oxygen and the carbonyl oxygen. As discussed earlier, Keck observed that both E and Z 
crotylatannaes with MgBr2.OEt2 and TiCl4 gave high facial selectivity on the aldehyde (syn’). 
MgBr2.OEt2 gave high syn selectivity (syn/anti, ca. 12:1) with respect to the new C-C bond, but 
with TiCl4 this selectivity was low (syn/anti, ca. 2:1). In contrast, reactions promoted by 
BF3.OEt2 gave high (syn/anti, ca. 92:1) selectivity with respect to the new C-C bond, but poor 
aldehyde facial selectivity. In a study with an achiral α-oxygenated aldehyde, Nishigaichi found 
that BF3.OEt2 gave high syn selectivity for E-crotylstannane and moderate syn selectivity for the 
Z-isomer. With TiCl4.2OEt2, the Z alkene gave high syn selectivity but the E-isomer showed no 
selectivity. 
          The effect of different Lewis acids on the diastereoselectivity in the reaction of aldehyde 
2.69 and sugarstannane 2.64 was next investigated (Table 2.1). In addition to BF3.OEt2, five 
other Lewis acids, MgBr2.OEt2, ZnCl2, InCl3, SnCl4, and TiCl4 were evaluated. All reactions 
were carried out using dichloromethane as solvent except in the case of using InCl3, where 
acetone was used as a solvent. In all cases, one equiv of crotylstannane 2.64 (E/Z 1.6:1) was 
added to two equiv of aldehyde 2.69. The aldehyde 2.69 was activated with two equiv of Lewis 
acid prior to addition of the crotylstannane. The results are summarized in (Table 2.1). In the 
case of the chelating Lewis acids MgBr2.OEt2, ZnCl2, InCl3 high facial selectivity (syn’/anti’) 
was observed, accompanied with low syn/anti selectivity. SnCl4 was unusual in that only 
evedance of syn, syn’ diastereomer was observed. However, the product showed cleavage of the 
PMB ether and was obtained in only 28% yield, so the decomposition of the other isomers 
cannot be excluded. The TiCl4 promoted reaction gave the product from protodestanylation of 
the crotyltin. In contrast, the non-chelating Lewis acid BF3.OEt2 showed a relatively high 
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syn/anti selectivity and low syn’/anti’ facial selectivity. Thus, the reaction of stannane 2.64 and 
aldehyde 2.69 follow standard stereoselectivity trends to those reported for less substituted 
substrates and BF3.OEt2, but in partial agreement with trends reported for chelating Lewis acids.  
 
Table 2.1 Lewis acid effect on crotylation reactions  
 
         Direct influence on diastereoselectivity from the sugar ring is unexpected because the sugar 
ring is distal from the reaction center by two methylene groups. Thus, the chiral aldehyde partner 
should primarily control the stereoselectivity. In the case of monodentate Lewis acid, BF3.OEt2 is 
expected to coordinate with the carbonyl oxygen in an anti fashion to the R group of the 
aldehyde.83 Considering the TSs proposed by Yamamoto and Keck (Scheme 2.27). Either 
antiperiplanar or syn-synclinal TSs might be operative to explain the syn selectivity in our 
reaction. The underlying concepts are illustrated for E-2.64, the major isomer in the mixture. 















































BF3.OEt2                   86%                      7                                 7                                            2                                     0                        7:1a                7:9
MgBr2.OEt2e                                             0                                  3                                            0                                    5                        3:5b             only syn'
ZnCl2/BF3.OEt2                                      0                                  3                                            0                                     1                        3:1b             only syn'
InCl3c                                                       0                                  1                                            0                                     1                        1:1b             only syn'
SnCl4                                                        0                                  1d                                          0                                     0                    only syna         only syn'
TiCl4                                            Only protodestannylation was observed
a) Ratio determined by isolated yield, b) Ratio determined by 1HNMR, c) Solvent = acetone, Reaction temperature = rt, d) Compound 2.71 was collected as diol
e) Reaction temperature = -25 0C
	   115	  
TS-III and TS-IV give the anti products 2.72 and 2.73 respectively. In TS-I and TS-II, the 
substituents on crotylstannane 2.64 and aldehyde 2.69 are arranged in anti fashion to minimize 
steric hindrance between the substituents. However, TS-I and TS-II suffer from steric hindrance 
between the Lewis acid and the sugar ring. 
  
Scheme 2.27 Plausible transition states for our crotylation reaction  
 











































































































2.71 syn/syn' 2.70 syn/anti' 2.72 anti/anti' 2.73 anti/syn'
Antiperiplanar TSs
syn-Synclinal TSs
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VII and TS-VIII give the anti products. TS-V and TS-VI are favored over TS-VII and TS-VIII, 
because steric interactions between the Lewis acid and the Bu3Sn group are more important than 
interactions between the aldehyde substituents and Bu3Sn. Moreover, in TS-V and TS-VI, the 
crotylstannane approaches the aldehyde from the opposite direction to the coordinated Lewis 
acid. This orientation facilitates an anti SE2’ elimination pathway.65 With regards to facial 
selectivity on the aldehyde, the syn product 2.70 and the anti product 2.72 are favored based on 
Felkin Anh model, where the crotylstannane is expected to attack the aldehyde from the opposite 
direction to the electronegative α-substituent (Scheme 2.28). However, 2.72 is disfavored for the 
reasons stated before. The formation of 2.71 (which is disfavored according to the Felkin Anh 
model) may be a result of the similar steric demands of the alkoxy and alkyl substituents on the 
aldehyde i.e. “medium” and “large” groups.  
 
 
Scheme 2.28 Felkin Anh model for the facial selectivity on aldehyde 
           
 In the chelating Lewis acid experiments, the high syn’ facial selectivity on the aldehyde is as 
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Scheme 28 Felkin Anh model for the facial selectivity on aldehyde
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competition between two possible TSs. Following the Yamamoto model, the syn TS-IX is 
favored and according to the syn-synclinal model the anti TS-XII is favored. Both TSs TS-X and 
TS-XI are disfavored because a large group is placed over the interior of the chelating ring 
(Scheme 2.29). Note that TS-XII does not suffer from serious steric interactions, TS-XII might 
explain the slight bias to the anti product in the MgBr2.OEt2 experiment, and both products 2.71 
and 2.73 were collected in 3:5 ratio respectively based on 1HNMR.  
            In the other two cases ZnCl2/ BF3.OEt2 and InCl3/acetone, other variables were involved 
in both experiments. In the case of ZnCl2/BF3.OEt2, two Lewis acids were used in the same 
reaction; it is not clear which one contributes to the observed selectivity. In the InCl3, different 
solvent and different temperature were employed. As a result we are unable to evaluate the 
stereoselectivity for these reactions. More investigations are needed for clear understandings of 
the selectivity trends.  
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Scheme 2.29 Plausible transition state for our crotylation reaction in presence of chelating 























































2.71 syn/syn' 2.73 anti/syn'
Antiperiplanar TSs
syn-Synclinal TSs
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2.1.6 Effect of Protecting groups on diastereoselectivity 
         In order to install different protecting groups on the α-oxygenated aldehyde 2.69, we 
needed allyl alcohol 2.85 (Scheme 2.30), which can be made from diol 2.67 in four steps. Diol 
2.67 was converted to isopropylidene 2.82 in 90% yield. A sequential transformation of 2.82 
with DIBAL-H, iodination, and zinc reductive elimination afforded 2.85 in 55% from 2.82. 
Protecting 2.85 as the TBDPS ether followed by ozonolysis gave the corresponding α-
oxygenated aldehyde 2.86. Likewise, protecting 2.85 with acetate followed by ozonlysis gave 
aldehyde 2.87.  
 
Scheme 2.30 Synthesis of α-alkoxy aldehydes with different protecting groups  
        Aldehydes 2.86 and 2.87 were subjected to the standard BF3.OEt2 catalyzed crotylation 







Reagents and conditions: a) 1. DMP, CSA, DCM,  rt,  20 min. b) DIBAL-H, DCM, -78 oC, 2h, 
MeOH,  2M NaOH. c) PPh3, Imidazole, I2, toluene,  40 oC,  1 h. d) Zn dust, reflux in EtOH for 2 h.
 e) 1. TBDPSCl, imidazole, DMF,  rt, 1 h.  2. O3, DCM -78 oC, PPh3,  rt, 2 h. f) 1. Ac2O, DMAP, 








2.82 2.83 X = OH




















Scheme 31 Synthesis of the alpha alkoxy aldehydes  with different protecting groups
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was necessary in order to remove complications due to migration of the protecting groups on the 
readialy formed products. The PMB group was cleaved using CAN in aqueous acetone. The 
TBDPS group was cleaved using TBAF in THF. The acetate was cleaved under basic conditions, 
using NaOMe in methanol. The overall yields for the resulting diols were calculated for the two-
step crotylation-deprotection sequence (Scheme 2.31).             
                As described on Scheme 2.31, syn/anti ratios ranging from 5.7:1 in the acetate case to 
8.1:1 in the TBDPS ether case. Thus, relative to the change in protecting group didn’t have a 
significant effect on the syn/anti selectivity. Concerning the facial selectiviy on the aldehyde, 
there was a modest preference for the anti’ products (i.e. 2.88 and 2.90) over the syn’ products 
(2.89 and 2.91) for the TBDPS and acetate aldehydes, compared to the PMB aldehyde, which 
showed no syn’/anti’ bias. As described earlier, the facial selectivity on the aldehyde can be 
predicted by the Felkin Anh model. According to this model, increasing the size and the 
electronegativity of the alcohol-protecting group should increase the selectivity for the anti 
product i.e. (attack from the Si face of the aldehyde (Scheme 2.28). These results appear to 
support this analysis. By extrapolation, we must expect that a bulky electronegative protecting 
group as a pivalate to show higher anti’ selectivity.  
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Scheme 2.31 Protecting groups effect on crotylation reactions  
 
         In conclusion, diastereoselectivity in this reaction can be manipulated by changing the 
Lewis acid type or the protecting groups on the aldehyde. Controlling the diastereoselectivity is 







33% 32% 8.9% 73.5
72.648% 16.6% 8.0%
45% 24.2% 12.1 % 81.3















2.69 R = PMB
2.86 R = TBDPS
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head of the lipid in C-KRN7000 is very important in producing bioactive targets. The C2 epimer 
of C-KRN7000 for example failed to activate the iNKT cells to produce cytokines. In the next 
section we will describe how these homoallyl alcohols can be converted into analogues of C-
KRN7000.  
 
2.1.7 Synthesis of C-KRN7000 via Curtius rearrangement  
               Conversion of the crotylation products 2.70 and 2.89 to C-KRN7000 analogues was 
used as test cases (Scheme 2.32). Benzylation of the alcohol 2.70 followed by oxidative cleavage 
of the alkene with ozonolysis, and Pinnick oxidation of the resulting aldehyde gave acid 2.94 in 
85% yield from 2.92. Treating acid 2.94 with DPPA and Et3N in toluene followed by addition of 
BnOH and heating the reaction mixture at 100 oC for 12 h furnished carbamate 2.95.   Advancing 
2.95 to C-KRN7000 definitively confirmed the absolute stereochemistry at C2 and C3. Thus, 
deprotection of benzyl groups using transfer hydrogenation followed by amidation with p-
nitrophenyl hexacosanoate afforded 2.96 in 55% yield. The 1HNMR and 13CNMR of the final 
compound 2.96 were essentially identical to that of C-KRN7000 obtained from the 
intramolecular nitrogen delivery strategy in Chapter I.  
        Diol 2.89 was subjected to a similar protocol to generate the C2-epimer of C-KRN7000 
(Scheme 2.32). Isopropylidene formation on 2.89 gave 2.97. Ozonolysis followed by Pinnick 
oxidation on 2.97 provided acid 2.99. Subjecting 2.99 to Curtius rearrangement as described 
above afforded the carbamate 2.100, which upon deprotection and amidation protocols gave 
2.101 in 55% yield. The epimer 2.101 (2R, 3R) is essentially different from the known (2R, 3S) 
C-KRN7000 epimer made by Pu and Franck et al.81 By these results, we achieved a robust 
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synthesis for C-KRN7000 and its analogues in only seven steps from known starting materials 
using crotylation chemistry and Curtius rearrangement.  
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Reagents and Conditions: a) NaH, DMF, BnBr, rt, 2 h. b) 1. O3 stream, DCM, -78 oC 2. PPh3, rt, 2h. c)
NaOCl2, t-BuOH/H 2O, NaH 2PO4. d) 1.DPPA, Et 3N, Toluene, rt, 3h 2. BnOH, reflux 100 oC, 16 h. 
e) 1. Pd/C, MeOH, cyclohexene, HCl, reflux at 65 oC, 5 h. 2. p-NO2-Phenyl hexacosenoate ester, DMAP, 
THF, rt, 16 h. f)  dimethoxy propane, CSA, rt, 20 min.
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2.1.8 Synthesis of Fluorinated C-KRN7000 
            Since our long-term plan is to develop a convergent synthetic methodology for a wide 
range of carbohydrate derivatives. It is important to test the compatibility of the crotylation 
methodology with different functional groups. In this context, we next applied this chemistry to 
C-glycosides with fluorine at the pseudo anomeric carbon. This synthesis started with the 
fluorinated C-allyl galactose 2.102 that was previously described in Chapter 1.   
 
 
Scheme 2.33 Synthesis of fluorinated crotylstannane reagent  
 
             Hydroboration-oxidation on 2.102 using 9-BBN and NaBO3.H2O as a mild oxidant went 
smoothly in 81% yield (Scheme 2.33). As expected, introducing the fluor group increased the 
reactivity of the aldehyde. The first trial to get the α-fluoro aldehyde 2.103 failed under Swern 
oxidation protocol. Only the α,β-unsaturated aldehyde was detected by NMR. Apparently, β-
elimination of the fluorine occurred under the basic condition of the Swern oxidation. Oxidation 
with Dess-Martin periodinane (DMP) was successful with greater than 90% yield. Standard 
































Reagents and conditions a) 9BBN, THF, 0 oC to rt, 16 h, EtOH, NaBO3.H2O. rt, 3h. 2. DCM,
DMP, rt, 30 min. b) Ph3P=CCO2Me, CH3CN, rt, 16 h. c) 1. DIBAL-H, DCM, -78 oC, 3 h.
2. THF, NaH, CS 2, rt, 1 hr, then MeI, rh, 2 hr. 3. Toluene, reflux, 100 oC, 3h. 4. AIBN,
 Bu3SnH, reflux, 30 min.
F
2.105
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conjugated ester 2.104 gave the required allyl alcohol in 60% yield, which was transformed to 
crotylstannane 2.105 via xanthate intermediate as described previously. Compound 2.105 was 
collected as E/Z mixture (1.6:1) in 45% from ester 2.104 (Scheme 2.34). 
 















































































Reagents and Conditions: a) aldehyde 2.69, BF3.ether, DCM, -78 oC, 3 h. b) 1. NaH, DMF, BnBr,  rt, 2 h.
2. O 3 stream, DCM, -78 oC 3. PPh 3, rt, 2h. c) NaOCl 2, t-BuOH/H 2O, NaH 2PO4. d) 1.DPPA, Et 3N, 
Toluene, rt, 3h 2. PMBOH, reflux 100 oC, 16 h. e) 1. Pd/C, MeOH, cyclohexene, HCl, reflux at 65 oC, 
5 h. 2. p-NO2-Phenyl hexacosenoate ester, DMAP, THF, rt, 16 h. f) 1.Pd/C, EtOH, rt, 16h.
2.106 2.107 R = H
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Having crotylstannane 2.105 in hand, we turned our attention to synthesis of the fluorinated C-
KRN7000 analogue (Scheme 2.34). Crotylation on 2.105 and aldehyde 2.69 using BF3.OEt2 as 
Lewis acid went as expected. Three diastereomers were produced in 58 % total yield. We were 
able to isolate one of these diastereomers 2.106 by careful chromatography. Next, 2.106 was 
converted to the fluorinated carboxylic acid 2.108 via a reaction sequence involving benzylation, 
ozonolysis, and Pinnick oxidation. Treating 2.108 with DPPA and Et3N at rt followed by 
addition of PMBOH and reflux for 16 h afforded carbamate 2.109 in 54% yield. Urea 2.110 was 
observed as a side product. The urea product might be produced because of traces of Et2N in the 
Et3N used in the reaction. The choice of PMB carbamate as an orthogonal protecting group will 
facilitate the amidation step and as a result improve the purification of the final compound.  
            By this, we established a robust method not only for synthesis C-KRN7000 but also for 
analogues with electronegative moieties adjacent to the anomeric position like fluorinated C-
KRN7000 2.112. It is also important to mention here that new isoelectronic analogues for C-
KRN7000 can be made by simple amidation of carboxylic acid like 2.108 with fatty amines. This 
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3.1 Conclusions  
         In summary, we have developed a robust and stereoselective methodology to make C-
glycolipids from C-glycoside crotylstannanes. Our methodology centers on the Lewis acid 
induced crotylation reaction with chiral α-oxygenated aldehyde. Diasteroselectivity can be 
controlled by changing the Lewis acid or the protecting group on the aldehyde part. This method 
is compatible with introducing electronegative moiety in the pseudo anomeric carbon in the 
crotylstannane reagent, and was applied to new C-glycoside analogues of the immunostimulatory 
C-KRN7000. Further applications of this methodology to pseudodisaccarides will be explored in 
the next chapter.    
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4.1 Experimental  
4.1.1 General   
       Unless otherwise stated, all reactions were carried out under a nitrogen atmosphere in oven-
dried glassware using standard syringe and septa technique. 1H and 13C NMR spectra were 
obtained on a Bruker (500, 400, and 600 MHz) spectrometers. Chemical shifts are relative to the 
deuterated solvent peak or the tetramethylsilane (TMS) peak at (δ 0.00) and are in parts per 
million (ppm). Assignments for selected nuclei were determined from 1H COSY experiments. 
Thin layer chromatography (TLC) was done on 0.25 mm thick pre-coated silica gel HF254 
aluminum sheets. Chromatograms were observed under UV (short and long wavelength) light, 
and/or were visualized by heating plates that were dipped in a solution of ammonium (VI) 
molybdate tetrahydrate (12.5 g) and cerium (IV) sulfate tetrahydrate (5.0 g) in 10% aqueous 
sulphuric acid (500 mL). Flash column chromatography (FCC) was performed using silica gel 60 
(230-400 mesh) and employed a stepwise solvent polarity gradient, correlated with TLC 
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E/Z C-galactosyl stannane 2.64  
 
      To a solution of alcohol 2.61 (1200 mg, 1.97 mmol) in dry THF (20 mL) was added sodium 
hydride (ca. 60% suspension in mineral oil, 158 mg, 3.95 mmol) followed by a catalytic amount 
of imidazole (ca. 5 mg). The mixture was stirred at rt under N2 atmosphere for 1 h. Carbon 
disulfide (240 µL, 3.98 mmol) was added and the mixture was stirred for another 30 min. MeI 
(250 µL, 3.98 mmol) was then added, the mixture was stirred for 2 h at rt, diluted with brine (10 
mL) and extracted with ether. The organic layer was separated, washed with water, dried 
(Na2SO4), concentrated, and purified by FCC to give xanthate 2.62 (95%): Rf = 0.61 (20% 
EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.22 (m, 20H), 5.76 (m, 1H), 5.58 (m, 1H), 4.94 (d, J = 
6.7 Hz, 2H), 4.69-438 (m, 10 H), 3.87 (m, 4H), 3.70 (m, 3H), 3.64 (dd, J = 7.3, 2.7 Hz, 1H), 3.56 
(dd, J = 10.5, 4.9 Hz, 1H), 2.47 (s, 3H), 2.10 (m, 1H), 1.95 (m, 1H), 1.68 (m, 1H), 1.51 (m, 1H). 
13C NMR (125 MHz, CDCl3) δ 215.8, 138.8, 138.7, 138.5, 137.8, 128.6, 128.5, 128.2, 128.1, 
128.0, 127.9, 127.8, 127.7, 123.3, 77.5, 77.2, 77.0, 76.9, 74.6, 73.5, 73.3, 73.2, 28.7, 19.2. 
HRMS (ESI, MNa+) m/z calc for C41H46NaO6S2 721.2634 found 721.2653.  
           A solution of xanthate 2.62 from the previous step in dry toluene (20 mL) was purged 
with N2 gas and heated at reflux until TLC (PE/EtOAc, 9:1) indicated disappearance of the 
starting material and formation of a new slightly less polar product (ca. 2-3 h). Bu3SnH (1.5 mL, 
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was continued until TLC (10%EtOAc/PE) indicated disappearance of starting material and 
formation of a new less polar product (ca. 30 min). The solvent was evaporated in vacuo and the 
product was purified using FCC to give 2.64 (62%): Rf = 0.57 (10% EtOAc/ PE); 1HNMR for 
major isomer (500Mz, CDCl3) δ 7.21 (m, 20 H), 5.46 (m, 1H), 5.12 (m, 1H), 4.71-4.37 (m, 8H), 
3.91 (m, 3H), 3.72 (m, 2H), 3.64 (m, 1H), 3.59 (m, 1H), 2.01 (m, 1H), 1.83 (m, 1H), 1.63 (m, 
3H), 1.41 (m, 6H), 1.2 (m, 7H), 0.81 (m, 16H). 13C NMR (125 MHz, CDCl3) δ 138.9, 138.8, 
138.7, 138.6, 129.8, 128.5, 128.1, 128.0, 127.8, 127.7, 127.6, 125.2, 77.1, 77.0, 74.8, 74.7, 73.5, 
73.3, 73.2, 73.1, 72.3, 72.2, 68.0, 27.7, 27.6, 27.5, 27.3, 14.3, 14.0, 9.3. HRMS (ESI, MH+) m/z 
calc for C51H71O5Sn 883.4323 found 883.3867.  
 
(E)-methyl heptadec-2-enoate 2.66. 
 
               A stream of O3 gas was passed through a solution of hexadecene (10.0 g, 44.55 mmol) 
in CH2Cl2 (200 mL) at -78 oC to -25 oC for 15 min. Then, zinc dust (14.5 g, 222.8 mmol) was 
added to the reaction mixture. The reaction mixture was warmed to rt slowly and stirred for 2 h. 
The reaction mixture was filtered over a Celite pad. The organic solvent was removed in vacuo. 
To a solution of the residue (6.0 g, ca 26.5 mmol) in CH3CN (150 mL), was added methyl 
triphenylphosphoranylidene acetate (17.2 g, 53.0 mmol). Then, reaction mixture was heated at 
80 oC for 4 h. The organic solvent was then removed in vacuo, and the crude material was 
purified by FCC: Rf = 0.9 (5% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 6.95 (m, 1H), 5.79 (dt, J 
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3H), 13C NMR (125 MHz, CDCl3) δ 167.4, 150.1, 121.0, 51.6, 32.4, 32.1, 29.9, 29.8, 29.7, 29.6, 
29.3, 28.2, 22.9, 14.3. HRMS (ESI, MH+) m/z calc for C18H35O2 283.2637 found 283.2491. 
 
(2S, 3R)-methyl 2,3-dihydroxyheptadecanoate 2.67 
 
         To a solution of KFeSCN (3.5 g, 10.5 mmol) in 3 mL H2O was added anhydrous K2CO3 
(1.5 g, 10.5 mmol), methanesulfonamide (1.0 g, 10.5 mmol), K2OsO4 (0.6 mg, 0.00175 mmol), 
and (DHQD)2PHAL (7.0 mg, 0.00875 mmol), after stirring for 15 min at 0 oC. Unstaurated ester 
2.66 (1.0 g, 3.5 mmol) and tert-butyl alcohol (3 mL) were then added to the reaction mixture. 
The slurry was stirred vigorously for 24 h at 5 oC, and stirring was continued for 2 d at rt. The 
mixture was then quenched with saturated aqueous solution of Na2SO3 (10 mL) and extracted 
with EtOAc (10 mL x 3). The combined organic layer was washed with brine, dried (Na2SO4), 
filtered, and concentrated in vacuo. The rsidue was purified by FCC to give diol 2.67 (830 mg, 
75 %): Rf  = 0.22 (20% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 4.03 (dd, 1H), 3.85 (q, 1H), 3.83 
(s, 3H), 2.98 (d, J = 5.3 Hz, 1H), 1.85 (d, 1H), 1.58 (m, 3H), 1.41 (m,1H), 1.23 (m, 24 H), 0.84 
(t, J = 13.9 Hz, 3H). 13C NMR (125 MHz, CDCl3 ) δ 174.4, 73.2, 72.7, 53.1, 34.0, 32.2, 29.9, 
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(2R, 3R)-3-((4-methoxybenzyl)oxy)heptadecane-1,2-diol 2.68  
  
                 To a solution of 2.67 (1.4 g, 4.4 mmol) in dry CH2Cl2 (40 mL) were added  
CSA (102.2 mg, 0.44 mmol) and p-anisaldehyde dimethyl acetal (2.3 ml, 13.2 mmol). The 
reaction mixture was stirred at rt for 3 h, then diluted with saturated aqueous NaHCO3 and 
extracted with CH2Cl2 (3 x 10 mL).  The organic phase was washed with brine, dried (Na2SO4) 
filtered, and evaporated in vacuo. FCC of the residue afforded the corresponding PMB acetal as 
a mixture (1:3) (1.92 g, 99%): Rf = 0.5 (20% EtOAc/PE); 1HNMR for major isomer (500Mz, 
CDCl3) δ 7.41 (d, J = 6.8 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.92 (s, 1H), 4.24 (m, 2H), 4.11 (q, J 
= 12.1, 6.7 Hz, 1H), 3.79 (s, 3H), 1.80 (m, 2H), 1.41 (m, 2H), 1.23 (m, 24H), 0.86 (6, J = 7.1 Hz, 
3H). 13C NMR (125 MHz, CDCl3) δ 171.6, 160.9, 128.6, 113.9, 105.0, 81.1, 79.0, 61.6, 55.5, 
33.9, 32.1, 29.9, 29.8, 29.7, 29.6, 25.7, 22.9, 14.4 
          To a solution of the resulting acetal (1.9 g, 4.37 mmol) in DCM (90 mL), was added 
(dropwise during 1h) at -78 oC 1M DIBAL-H solution in heptane (26.4 mL, 26.4 mmol).  
Reaction mixture was stirred at -78 oC for 3 h and left to warm up to rt overnight. Then reaction 
was stopped at 0 oC by adding MeOH (5 mL) and 2 M NaOH solution (5 mL). After stirring at rt 
for 2 h, solid Na2SO4 was added, and the reaction mixture was filtered over celite pad. Organic 
solvent was concentrated in vacu. FCC of the residue afforded 2.68 as white solid  (1.65 g, 92%): 
Rf = 0.2 (20% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.22 (d, J = 6.7 Hz, 2H), 6.87 (d, J = 6.7 
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5.8 Hz, 1H), 2.50 (d, J = 5.3 Hz, 1H), 2.11 (t, J = Hz, 1H), 1.61 (m, 4H), 1.23 (m, 24H), 0.86 (6, 
J = 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 159.6, 129.8, 114.2, 79.6, 72.8, 72.0, 64.4, 55.5, 
32.1, 30.3, 30.0, 29.9, 29.8, 29.6, 25.3, 22.9, 14.3. HRMS (ESI, MNa+) m/z calc for C25H44NaO4 




             To a solution of 2.68 (50 mg, 0.12 mmol) in 60% aq MeCN (1.0 mL) was added at 0 oC 
NaIO4 (50 mg, 0.23 mmol) in one portion. The mixture was stirred for 1 h at rt and diluted with 
H2O (5 mL). aq layer was extracted with EtOAc (5.0 mL x 3). Organic layer was washed with 
brine, dried (Na2SO4), filtered, and concentrated in vacuo. . FCC of the residue afforded 2.69 (44 
mg, 95%): Rf = 0.56 (10% EtOAc/PE); 1HNMR (500Mz, CDCl3) 9.64 (d, J = 2.15 Hz, 1H), 7.30 
(d, J = 8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 4.56 (ABq, J = 11.4 Hz, Δδ = 0.089, 2H), 3.83 (s, 
3H), 3.74 (dd, J = 2.1, 7.1 Hz, 1H), 1.68 (m, 1H), 1.39 (m, 2H), 1.27 (m, 22 H), 0.90 (t, J = 7.1 
Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 204.3, 159.7, 129.9, 129.6, 114.1, 83.4, 72.4, 55.5, 32.1, 
30.3, 29.9, 29.8, 29.7, 29.6, 25.0, 22.9, 14.3. HRMS (ESI, MNa+) m/z calc for C24H40NaO3 
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Homoallyl alcohols 2.70, 2.71, and 2.72  
 
         To a solution of aldehyde 2.69 (102.5 mg. 0.273 mmol) in DCM (3.0 mL) was added 
BF3.OEt2 (35 uL, 0.273 mmol) at -78 o, reaction was stirred for 15 min, and then compound 2.64 
(200 mg, 0.226 mmol) in 2 mL DCM was added dropwise (during 30 min) down the side of the 
flask to allow for efficient cooling. Then the reaction mixture was stirred at this temperature for 
2 h, the reaction was quenched by addition of saturated aqueous NaHCO3 (5 mL) at -78 oC, then 
warmed to rt, and extracted with EtOAc (3 x 3.0 mL). The organic layer was washed with brine, 
dried (Na2SO4), filtered and concentrated in vacuo. Careful column chromatography purifiation 
(No flash) of the residue afforded 2.70 (83 mg, 38 %): Rf = 0.14, 2.71 (81 mg, 37 %): Rf = 0.24, 
and 2.72 (25 mg, 11%): Rf = 0.17 (20% EtOAc/PE); 
 
For homoallyl alcohol 2.71 
    1HNMR (500Mz, CDCl3) δ 7.21 (m, 22H), 6.85 (d, J = 8.6 Hz, 2H), 5.42 (m, 1H), 5.02 (m, 
2H), 4.72-4.32 (m, 10H), 3.91 (m, 3H), 3.75 (m, 5H), 3.65 (m, 3H), 3.33 (m, 1H), 2.15 (m, 1H), 
2.03 (m, 2H), 1.65 (m, 1H), 1.44 (m, 2H), 1.24 (m, 24H), 0.86 (t, J = 6.8 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ 159.5, 138.9, 138.8, 138.7, 138.6, 138.4, 130.8, 129.7, 128.5, 128.2, 128.1, 
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47.0, 32.1, 29.9, 29.8, 29.6, 27.7, 27.3, 25.9, 22.9, 14.3. HRMS (ESI, MNa+) m/z calc for 
C63H84NaO8 991.6064 found 991.57722. 
 
For homoallyl alcohol 2.72 
    1HNMR (500Mz, CDCl3) δ 7.26 (m, 22H), 6.85 (d, J = 8.6 Hz, 2H), 5.49 (m, 1H), 5.00 (m, 
2H), 4.76-4.33 (m, 10H), 3.96 (m, 2H), 3,87 (m, 2H), 3.77 (s, 3H), 3.69 (m, 2H), 3.58 (dd, J = 
10.1, 5.3 Hz, 1H), 3.42 (m, 1H), 3.22 (t, J = 7.9 Hz, 1H), 2.18 (m, 1H), 2.05 (m, 1H), 1.70 (m, 
1H), 1.58 (m, 1H), 1.44 (m, 2H), 1.24 (m, 24H), 0.86 (t, J = 6.8 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 159.4, 140.0, 138.9, 138.8, 138.7, 138.6, 138.4, 130.9, 129.6, 128.5, 128.2, 128.0, 
127.9, 127.8, 127.7, 127.6, 117.3, 114.0, 78.6, 77.9, 77.4, 75.2, 74.8, 73.5, 73.3, 73.2, 71.8, 55.5, 
48.1, 32.1, 31.0, 30.1, 29.9, 29.6, 26.4, 25.7, 22.9, 14.3. HRMS (ESI, MNa+) m/z calc for 
C63H84NaO8 991.6064 found 991.57722. 
 
For homoallyl alcohol 2.72 
    1HNMR (500Mz, CDCl3) δ 7.26 (m, 22H), 6.85 (d, J = 8.6 Hz, 2H), 5.66 (m, 1H), 5.10 (m, 
2H), 4.77-4.34 (m, 10H), 3.95 (m, 2H), 3,85 (m, 2H), 3.77 (m, 4H), 3.67 (m, 2H), 3.60 (m, 2H), 
3.36 (m, 1H), 2.27 (m, 1H), 1.91 (m, 1H), 1.67 (m, 1H), 1.55 (m, 1H), 1.43 (m, 2H), 1.23 (m, 
24H), 0.86 (t, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 159.4, 139.1, 138.9, 138.7, 138.6, 
138.5, 130.8, 129.7, 129.6, 128.6, 128.5, 128.3, 128.2, 128.0, 127.9, 127.8, 127.6, 117.8, 114.0, 
79.9, 77.4, 73.8, 73.5, 73.4, 73.2, 71.5, 68.3, 55.5, 45.7, 32.1, 30.2, 30.0, 29.9, 29.6, 28.8, 26.6, 
25.5, 22.9, 14.4. HRMS (ESI, MNa+) m/z calc for C63H84NaO8 991.6064 found 991.57722. 
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Homoallyl alcohol 2.73 
 
                To a solution of alcohol 2.70 (50 mg, 0.052 mmol) in dry DCM (2.0 mL) at 0 oC was 
added dropwise Dess-Martin periodinane (DMP) as a 15% solution in DCM (0.22 mL, 0.08 
mmol). The reaction mixture was stirred at rt for 30 min, then was passed through a short pad of 
silica gel. The filtrate was concentrated under reduced pressure to give the derived ketone 2.74 
(45 mg, 90 %): Rf = 0.7 (20% EtOAc/PE); 1HNMR (500 Mz, CDCl3) δ 7.26-7.14 (m, 20H), 6.76 
(d, J = 8.6 Hz, 1H), 5.52 (m, 1H), 5.08 (m, 2H), 4.66-4.38 (m, 10H), 4.11 (d, J = 11.4 Hz, 1H), 
3.88 (m, 2H), 3.83 (m, 2H), 3.80-3.71 (m, 5H), 3.61 (dd, J = 10.2, 5.3 Hz, 1H), 3.55 (dd, J = 
10.2, 4.3 Hz, 1H), 3.36 (dd, J = 10.2, 4.3 Hz, 1H), 1.77 (m, 1H), 1.50 (m, 5H), 1.18 (m, 24H), 
0.81 (t, J = 6.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 211.9, 159.5, 138.8, 138.7, 136.6, 138.5, 
136.5, 130.1, 129.8, 128.8, 128.7, 128.5, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 118.8, 113.9, 
83.5, 77.3, 77.1, 76.9, 74.6, 73.5, 73.4, 73.3, 73.2, 72.3, 72.2, 71.9, 67.9, 55.4, 52.9, 32.1, 29.9, 
29.8, 29.7, 29.6, 29.5, 27.4, 25.9, 22.9, 14.3. HRMS (ESI, MNa+) m/z calc for C63H82NaO8 
989.5907 found 989.5840. 
     Compound 2.74 (45 mg, 0.042 mmol) was dissolved in MeOH (1.0 mL) and treated with 
NaBH4 (10 mg, 0.27 mmol) at 0 oC. The reaction mixture was warmed to rt and stirred at this 
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the mixture was extracted with EtOAc (2 mL x 3). The organic phase was washed with brine, 
dried (Na2SO4), filtered and concentrated in vacuo. FCC of the residue afforded 2.73  (20%): Rf 
= 0.42 (20% EtOAc/PE); 1HNMR (500 Mz, CDCl3) δ 7.25-7.17 (m, 20H), 6.79 (d, J = 8.7 Hz, 
1H), 5.68 (m, 1H), 5.01 (m, 2H), 4.66-4.37 (m, 10H), 4.30 (d, J = 10.8 Hz, 1H), 3.89 (m, 2H), 
3.81 m, 1H), 3.71 (m, 5H), 3.63 (m, 1H), 3.56 (dd, J = 9.9, 3.9 Hz, 1H), 3.39 (m, 1H), 3.28 (q, J 
= 11.3, 5.6 Hz, 1H), 2.29 (m, 1H), 2.00 (m, 1H), 1.41 (m, 3H), 1.18 (m, 24), 0.81 (t, J = 6.8 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 159.5, 138.9, 138.8, 138.6, 138.5, 129.6, 128.5, 128.2, 
128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 117.1, 114.1, 80.8, 77.3, 77.1, 74.8, 74.6, 73.5, 73.2, 
72.2, 68.3, 55.5, 46.9, 32.2, 30.3, 29.9, 29.6, 28.6, 25.0, 22.9, 14.4. HRMS (ESI, MNa+) m/z calc 
for C63H84NaO8 991.6064 found 991.57722. 
 
Lactone 2.78  
 
          To a solution of 2.92  (45 mg, 0.043 mmol) in 1.0 mL of THF was added a 0.5 M solution 
of 9-BBN in THF (0.42 mL, 0.2 mmol). The resulting solution was stirred for 10 min and then 
placed in a water bath and sonicated at 60 Hz for 30 min. The flask was removed from the 
sonication bath and left stirring at rt for 16 h. The reaction mixture was quenched with EtOH (0.5 
mL) and diluted with water (1.0 mL). The mixture was next treated with NaBO3.H2O (31 mg, 0.2 
mmol) and the resulting solution was stirred for 4 h. The volatiles were removed in vacuo, and 
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organic extract was dried (Na2SO4,), filtered, and concentrated in vacuo. FCC of the residue 
afforded 2.76 (23 mg, 50%). 
        To a solution of 2.76 (12 mg, 0.01) in CH2Cl2 (1.0 mL) was added SnCl4 (10 ul, 0.08 mmol) 
at -78 oC. The mixture was warmed up 0 oC and stirred for 30 min, reaction was warmed to 0 oC 
then quenched with saturated aqueous NaHCO3, and extracted with EtOAc (3 X 2 mL). The 
organic phase was dried (Na2SO4,), filtered, and concentrated in vacuo. FCC of the residue 
afforded diol 2.77 (9 mg, 86%).  
       To a solution of 2.77 (9 mg, 0.01 mmol), in CH2Cl2 (1.0 mL) were added TEMPO (1.5 mg, 
0.01 mmol), TBACl (2.78 mg, 0.01 mmol), and 0.5 M NaHCO3 (1.0 mL), and 0.05 M K2CO3 
(1.0 mL). The mixture was vigorously stirred at rt, then solid NCS (17.4 mg, 0.13 mmol) was 
added. Stirring was maintained for 2 h. After TLC indicated complete disappearance of the 
starting material, the organic layer was separated, and the aqueous layer was extracted with 
CH2Cl2 (3x3ml). The organic phase was washed with brine, dried (Na2SO4), filtered and 
concentrated in vacuo. The crude material was purified by FCC to give 2.78 (7 mg, 73 %): Rf =  
(20% EtOAc/ PE); 1HNMR (500Mz, CDCl3) δ 7.22 (m, 25H), 4.63-4.31 (m, 12H), 3.97 (m, 2H), 
3.89 (m, 1H), 3.76 (m, 2H), 3.60 (m, 2H), 3.55 (dd, J = 10.9, 4.1 Hz, 1H), 3.06 (dd, J = 7.5, 3.0 
Hz, 1H), 2.65 (dd, J = 16.0, 6.0 Hz, 1H), 2.21 (dd, J = 16.0, 4.4 Hz, 1H), 2.02 (m, 1H), 1.57 (m, 
1H), 1.52 (m, 3H), 1.18 (m, 24H), 0.81 (t, J = 5.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 172.4, 
138.7, 138.6, 138.5, 138.3, 137.7, 128.7, 128.6, 128.5, 128.3, 128.2,128.1, 128.0, 127.8, 127.7, 
80.9, 80.8, 76.8, 76.3, 74.36, 73.4, 73.1, 72.9, 72.4, 71.0, 67.5, 37.4, 33.4, 32.9, 32.1, 30.3, 29.9, 
29.8, 29.7, 29.6, 29.5, 25.2, 22.9, 14.3. HRMS (ESI, MH+) m/z calc for C62H81O8 953.5931 
found 953.58199. 
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Lactone 2.81  
 
 Treatment of the alkene 2.71 (45 mg, 0.046 mmol) under the conditions applied to 2.70 provided 
2.81 (7 mg, 20 % from 2.70): Rf = (20%EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.25 (m, 25H), 
4.66-4.28 (m, 10H), 4.03 (t, J = 6.1 Hz, 2H), 3.90 (m, 2H), 3.78 (m, 2H), 3.65 (m, 2H), 3.53 (dd, 
J = 10.3, 3.5 Hz, 1H), 3.22 (m, 1H), 2.62 (dd, J = 16.1, 6.0 Hz, 1H), 2.07 (m, 2H), 1.75 (m, 1H),  
1.56 (m, 3H), 1.18 (m, 24H), 0.81 (t, J = 5.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 171.6, 
138.7, 138.5, 138.3, 138.0, 128.7, 128.6, 128.5, 128.3, 128.2, 128.0, 127.9, 79.2, 77.4, 76.7, 76.0, 
74.4, 73.4, 73.3, 72.6, 71.1, 67.7, 34.6, 32.8, 32.1, 31.0, 29.9, 29.8, 29.7, 29.6, 25.6, 22.9, 14.3. 
HRMS (ESI, MH+) m/z calc for C62H81O8 953.5931 found 953.58199. 
 
(2S, 3R)-O-isopropylidene heptadecanoate methyl ester 2.82  
 
         To a solution of 2.67 (500 mg, 1.6 mmol) in CH2Cl2 (5 mL) was added at 0 oC CSA (50 
mg, 0.215 mmol) and 2,2-dimethoxypropane (1.0 mL, 11.3 mmol). The mixture was stirred at rt 
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The aqueous layer was extracted with EtOAc (3 x 5.0 mL). The organic layer was washed with 
brine, dried (Na2SO4), filtered and concentrated in vacuo. . FCC of the residue afforded 2.82 
(500 mg, 88 %): Rf = 0.92  (20% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 4.11 (m, 2H), 3.73 (s, 
3H), 1.68 (m, 2H), 1.49(s, 3H), 1.39 (s, 3H), 1.21 (m, 24 H), 0.82 (t, J = 7.1 Hz, 3H). 13C NMR 
(125 MHz, CDCl3) δ 171.7, 111.0, 79.4, 79.3, 52.6, 33.7, 32.1, 29.9, 29.8, 29.7, 29.6, 27.4, 25.7, 
22.9, 14.3. 
 
(2R, 3R)-O-isopropylidene heptadecan-1-ol 2.83  
 
           To a solution of ester 2.82 (3.0 g, 8.40 mmol) in DCM (10.0 mL), was added (dropwise 
during 30 min) at -78 oC 1M DIBAL-H solution in heptane (20.6 mL, 20.6 mmol). Then, the 
mixture was stirred at -78 oC for 3 h and warmed to rt. Then reaction was quenched at 0 oC with 
MeOH (5.0 mL), then diluted with 2 M NaOH (5.0 mL). After stirring at rt for 2 h, solid Na2SO4 
was added, and the reaction mixture was filtered over a Celite pad. The organic solvent was 
removed in vacuo. FCC of the residue afforded 2.83 as white solid  (2.5 g, 91 %): Rf = 0.4 (20% 
EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 3.72 (m, 1H), 3.66 (m, 1H), 3.64 (m, 1H), 3.52 (m, 1H), 
1.80 (dd, J = 7.5, 5.2 Hz, 2H), 1.35(s, 3H), 1.33 (s, 3H), 1.19 (m, 24 H), 0.81 (t, J = 7.1 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ 108.8, 81.8, 77.1, 62.3, 33.3, 32.1, 29.9, 29.8, 29.7, 29.6, 27.6, 
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(2S, 3R)-O-isopropylidene-1-iodoheptadecane 2.84 
 
        To a stirred solution of alcohol 2.83 (255 mg, 0.78 mmol) in Dry CH2Cl2 (15 mL) was 
added PPh3 (310 mg, 1.16 mmol) and imidazole (78.2 mg, 1.16 mmol). Then, the reaction 
mixture was stirred at rt for 15 min. I2 (295 mg, 1.16) was added and stirring continued at rt for 
45 min. The mixture was quenched with saturated aqueous Na2S2O3 solution. The aqueous layer 
was extracted with EtOAc (3 x 15 mL). The organic phase was washed with brine, dried 
(Na2SO4), filtered and concentrated in vacuo. The residue was purified by FCC to give 2.84 as 
colorless oil (53%): Rf  =  (10 % EOAc/PE); 1HNMR (500Mz, CDCl3) δ 3.73 (m, 1H), 3.61 (m, 
1H), 3.23 (dq, J = 10.6, 5.3 Hz, Δδ = 0.029, 2H), 1.58 (m, 2H), 1.41(s, 3H), 1.38 (s, 3H), 1.23 
(m, 24 H), 0.85 (t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 109.2, 81.7, 80.0, 33.7, 32.2, 




                  To a stirred solution of 2.84 (250 mg, 0.57 mmol) in EtOH (2 mL) was added activated 
Zn dust (186 mg, 2.85 mmol). The reaction was heated at reflux for 1 h. After completion of the 
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reduced presurre. The residue was purified by FCC to give 2.85 as colorless oil (100 mg, 69%): 
(Rf = 0.68 (20% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 5.85 (m, 1H), 5.18 (m, 2H), 4.07 (q, J = 
13.0, 6.5 Hz, 1H), 1.45(m, 4H), 1.23 (m, 24 H), 0.86 (t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 141.5, 114.7, 73.5, 37.3, 32.1, 29.9, 29.8, 29.7, 29.6, 25.5, 22.9, 14.3.  
(R)-2-((tert-butyldiphenylsilyl)oxy)hexadecanal 2.86  
  
         To a stirred solution of alcohol 2.85 (350 mg, 1.37 mmol) in dry DMF (3.0 mL) were 
added TBDPSCl (0.4 mL, 1.5 mmol) and imidazole (93.2 mg, 1.37 mmol). The reaction mixture 
was stirred at this temperature for 30 min, and then quenched with brine. The aqueous layer was 
extracted with EtOAc (3 x 15 mL) and the organic phase was washed with brine, dried (Na2SO4), 
filtered and concentrated in vacuo. The residue was purified by FCC to give the corresponding 
silyl ether as a colorless oil (500 mg, 75%): Rf = 0.9 (10 % EOAc/PE); 1HNMR (400Mz, CDCl3) 
δ 7.69 (m, 4H), 7.41 (m, 6H), 5.80 (m, 1H), 4.96 (m, 2H), 4.14 (q, J = 13.0, 6.5 Hz, 1H), 1.44 
(m, 2H), 1.23 (m, 24 H), 1.15 (s, 9H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (MHz, CDCl3) δ 141.2, 
136.2, 136.1, 134.8, 134.6, 129.7, 129.6, 127.7, 127.5, 114.3, 74.9, 37.8, 32.2, 30.0, 29.9, 29.8, 
29.6, 27.3, 24.7, 22.9, 14.4. 
         A stream of O3 gas was passed through a solution of the material from the previous step 
(500 mg, 1.01 mmol) in CH2Cl2 (10 mL), at -78 oC for 10 min. Then, PPh3 (550 mg, 2.0 mmol) 
was added and the reaction mixture was warmed to rt and stirred for 2 h. The organic solvent 
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0.8 (10% EtOAc/PE); 1HNMR (400Mz, CDCl3) δ 9.49 (d, J = 1.6 Hz, 1H), 7.55 (m, 4H), 7.28 
(m, 6H), 3.94 (m, 1H), 1.52 (m, 2H), 1.18 (m, 24 H), 1.03 (s, 9H), 0.79 (t, J = 7.0 Hz, 3H). 13C 
NMR (MHz, CDCl3) δ 204.0, 136.0, 136.0, 133.4, 133.3, 130.2, 130.1, 128.0, 127.9, 78.3, 33.1, 
32.1, 29.9, 29.8, 29.7, 29.6, 29.5, 27.2, 24.2, 22.9, 19.5, 14.3. 
 
(R)-1-oxohexadecan-2-yl acetate 2.87  
 
             To a stirred solution of alcohol 2.85 (200 mg, 0.79 mmol) in EtOAc (5.0 mL) were 
added Ac2O (200 uL, 2.11 mmol) and DMAP (2 crystals). The mixture was stirred at this 
temperature for 10 min, and then the reaction mixture was quenched with brine. The aqueous 
layer was extracted with EtOAc (3x 5 mL). The Organic phase was washed with brine, dried 
(Na2SO4), filtered, and concentrated in vacuo. The residue was purified by FCC to give acetate 
derivative as colorless oil (200 mg, 89%): Rf = 0.88 (10% EOAc/PE); 1HNMR (400Mz, CDCl3) 
δ 5.74 (m, 1H), 5,17 (m, 3H), 2.04 (s, 3H), 1.57 (m, 2H), 1.23 (m, 24 H), 0.86 (t, J = 7.04 Hz, 
3H). 13C NMR (MHz, CDCl3) δ 170.6, 136.9, 116.7, 75.1, 34.4, 32.1, 29.9, 29.8, 29.6, 25.3, 
22.9, 21.5, 14.3. 
         A stream of O3 gas was passed through a solution of resulting acetate (200 mg, 0.67 mmol) 
in CH2Cl2 (10 mL), at -78 oC for 10 min. Then, PPh3 (351 mg, 1.34 mmol) was added and the 
reaction mixture was warmed to rt and stirred for 2 h. The organic solvent was concentrated in 
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EtOAc/PE); 1HNMR (400Mz, CDCl3) δ 9.47 (d, J = 0.7 Hz, 1H), 4.94 (dd, J = 8.4, 4.8 Hz, 1H), 
2.13 (s, 3H), 1.70 (m, 2H), 1.22 (m, 24 H), 0.84 (t, J = 7.0 Hz, 3H). 13C NMR (MHz, CDCl3) δ 
198.5, 170.8, 78.5, 32.1, 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 28.8, 25.1, 22.9, 20.8, 14.3. 
Diols 2.88 and 2.89  
 
              To a solution of aldehyde 2.86 (56 mg. 0.113 mmol) in DCM (1.0mL) was added 
BF3.OEt2 (14 uL, 0.113 mmol) at -78 oC and the reaction was stirred for 15 min. Sugarstannane 
2.64 (50 mg, 0.06 mmol) in 1.0 mL DCM was added dropwiseover 30 min, then the reaction 
mixture was stirred at this temperature for 2 h. The reaction mixture was quenched with saturated 
aqueous NaHCO3 (5.0 mL) at -78 oC and left to warm to rt.  The aqueous layer was extracted 
with EtOAc (3 x 3.0 mL). The organic layer was washed with brine, dried (Na2SO4), filtered, and 
concentrated in vacuo, and the residue was purified by FCC to give a mixture of compounds. The 
crude material (45 mg, 0.42 mmol) was dissolved in THF (1.0 mL) and then treated with TBAF 
1M solution in THF (0.126 mL, 0.126 mmol). The reaction was stirred at rt for 2 h, then reaction 
mixture was treated with water (1mL). The aqueous layer was extracted with EtOAc (3 x3 mL). 
The organic phase was washed with brine, dried (Na2SO4), filtered, and concentrated in vacuo, 
and the residue was purfied by FCC to afford diol 2.88 as major product (26 mg, 48% over two 



















	   145	  
5.02 (m, 2H), 4.70-4.41 (m, 8H), 3.90 (m, 3H), 3.86 (m, 2H), 3.67 (dd, J = 7.2, 2.8 Hz, 1H), 3.50 
(m, 2H), 3.37 (dd, J = 8.2, 4.2 Hz, 1H), 2.12 (m, 1H), 1.83 (m, 1H), 1.49 (m, 4H), 1.22 (m, 24H), 
0.85 (t, J = 6.8 Hz, 1H). 13C NMR (MHz, CDCl3) δ 139.0, 138.8, 138.6, 138.4, 128.6, 128.5, 
128.2, 128.1, 127.9, 127.8, 127.7, 117.0, 77.3, 77.0, 74.7, 73.6, 73.4, 73.3, 73.2, 72.8, 72.3, 72.2, 
68.3, 47.5, 32.1, 30.1, 29.9, 29.8, 29.6, 26.8, 26.0, 22.9, 14.3.  
 
Diols 2.88 and 2.89  
 
            To a solution of aldehyde 2.87 (36.0 mg. 0.12 mmol) in DCM (1.0 mL) was added 
BF3.OEt2 (14 uL, 0.12 mmol) at -78 oC. The mixture was stirred for 15 min, and then the sugar 
stannane 2.64 (60 mg, 0.07 mmol) in DCM (1.0 mL) was added dropwise over 30 min. The 
reaction mixture was maintained at this temperature for 2 h, then was quenched by addition of 
saturated aqueous NaHCO3 at -78 oC and warmed to rt. The aqueous layer was extracted with 
EtOAc (3 x 3.0 mL), and the organic phase was washed with brine, dried (Na2SO4), filtered, and 
concentrated in vacuo. FCC of the residue afforded a mixture of compounds. This material (50 
mg, 0.067 mmol) was dissolved in MeOH (1 mL) and then treated with 1M NaOMe solution in 
MeOH (0.3 mL, 0.3 mmol), the mixture was stirred at rt for 2 h, then adjusted to pH ca 7 by 
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FCC of the residue afforded a mixture of diols 2.88 (26 mg, 45%), 2.89 (14 mg, 24%), (another 
unidentified isomer around 8%).  
General Procedure for the Lewis acid Promoted addition of crotylstannane 64 to alpha 
alkoxy aldehyde 69 using MgBr2.ether  
Preparation of 0.75 M MgBr2.OEt2 solution: (200 mg, 8.33 mmol) of Mg metal was 
suspended in anhydrous THF (10 mL). To this suspension was added dropwise (1.5 mL, 17.3 
mmol) of dibromoethane. The reaction mixture was stirred at rt until all Mg metal disappeared. 
Benzene (0.5 mL) was added to affect the miscibility.   
      
    Crotylation procedure:  
          To a solution of aldehyde 2.69(25.6 mg, 0.07 mmol) in DCM (1.0 mL), was added at -23 
oC a solution of 0.75 M MgBr2.OEt2 in ethyl ether (0.2 mL, 0.14 mmol) was added in one 
portion. The mixture became cloudy, and then over the next 10 min the solid material partially 
dissolved and the solution became slightly yellow. After 15 min sugar stannane 2.64 (50 mg, 
0.057 mmol) was added dropwise via syringe down the side of the flask to allow for ample 
cooling. The mixture was stirred for an additional 2 h at -23 oC before the reaction mixture was 
allowed to warm to rt. After stirring for another 2 h. saturated aqueous NaHCO3 (3.0 mL) was 
added, and stirring was continued for 25 min. The mixture was extracted with CH2Cl2 (4 x 3.0 
mL), organic layer was dried over Na2SO4, filtered and the solvent was removed in vacuo. The 
products ratio was determined based on the 1HNMR of the crude mixture. 
 
General Procedure for the InCl3 promoted crotylation reactions  
           To a stirred solution of InCl3 (15.5 mg, 0.07 mmol) in acetone 2 mL, was added at rt 
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aldehyde 2.69 (25.6 mg, 0.07 mmol). After stirring for 30 min at rt, sugar stannane 2.64 (50 mg, 
0.057 mmol) was added, and the stirring continued for 2 h. The reaction was quenched with 1 M 
HC1 and extracted with ether. The organic phase was washed with brine, dried over (Na2SO4), 
filtered, and evaporated in vaccuo. 
 
General Procedure for the ZnCl2 promoted crotylation reactions  
              To a stirring solution of aldehyde 2.69 (25.6 mg, 0.07 mmol) in CH2Cl2  (3 mL) was 
added anhydrous ZnCl2 (19.0 mg, 0.14 mmol) as a solid in one portion. Reaction mixture was 
cooled down to -78 oC. After 10 min, sugarstannane 2.64 (50 mg, 0.057 mmol) was added 
dropwise as a solution in CH2Cl2 via syringe pump. The reaction mixture was then warmed to rt 
and stirred at this temperature for additional h. At this time, no product was formed, so the 
reaction was cooled down to -78 oC and then treated with BF3.OEt2 (12 uL, 0.07 mmol). After 
stirring at -78 oC for 2 h, the reaction mixture was quenched with saturated aqueous NaHCO3 (2 
mL) and diluted with ethyl ether (5 mL). The organic phase was washed with brine, dried 
(Na2SO4), filtered, and concentrated in vacuo. The Products ratio was determined based on the 
1HNMR analysis for the crude material.  
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To a solution of aldehyde 2.69 (25.6 mg. 0.07 mmol) in DCM (1.0 mL) was added SnCl4 (16 uL, 
0.14 mmol) at -78 oC. The reaction was stirred for 5 min, then sugar stannane 2.64 (50 mg, 0.057 
mmol) in DCM (1.0 mL) was added dropwise over 30 min. Then the reaction mixture was stirred 
at this temperature for 30 min. The reaction was quenched at -40 oC by addition of 2 mL of 
saturated solution of NaHCO3 and left to warm to rt. The aqueous layer was extracted with 
EtOAc (3 x 2.0 mL). The organic layer was washed with brine, dried (Na2SO4), filtered, and 
concentrated in vacuo. FCC of the residue afforded 2.89 (38%): Rf = 0.28 (20% EtOAc/PE); 
1HNMR (500Mz, CDCl3) δ 7.28 (m, 20H), 5.49 (m, 1H), 5.08 (m, 2H), 4.69-4.22 (m, 8H), 3.89 
(m, 3H), 3.71 (m, 2H), 3.64 (dd, J = 7.4, 2.7 Hz, 1H), 3.51 (m, 2H), 3.12 (dd, J = 7.9, 2.1 Hz, 
1H), 2.20 (m, 1H), 1.65 (m, 2H), 1.34 (m, 2H), 1.18 (m, 24H), 0.85 (t, J = 6.3 Hz, 3H). 13C NMR 
(125 MHz, CDCl3) δ 139.7, 139.0, 138.8, 138.7, 138.6, 128.6, 128.5, 128.2, 128.0, 127.9, 127.8, 
127.7, 117.2, 76.1, 74.9, 73.6, 73.5, 73.4, 73.3, 72.2, 71.5, 68.4, 47.4, 34.7, 32.1, 29.9, 29.6, 26.3, 
26.1, 22.9, 14.4,  
 
Alkene 2.92  
 
To a solution of 2.70 (35 mg, 0.036 mmol) in dry DMF (1 ml) was added at 0 oC NaH, 60% 
dispersed in mineral oil (3 mg, 0.072 mmol). The reaction mixture was stirred at this temperature 
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an additional 2h. The reaction mixture was diluted with water (2 mL) and extracted with EtOAc 
(2.0 mL x 3). The organic layer was washed with saturated aqueous NaHCO3 and brine, dried 
(Na2SO4), and evaporated in vacuo. FCC of the residue gave compound 2.92  (35 mg, 92%): Rf = 
0.2, (10% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.28 (m, 27H), 6.84 (d, J = 10 Hz, 2H), 5.51 
(m, 1H), 4.99 (m, 2H), 4.69-4.32 (m, 12H), 3.86 (m, 3H), 3.77 (m, 4H), 3.61 (m, 4H), 3.45 (m, 
2H), 2.14 (m, 1H), 1.92 (m, 1H), 1.62 (m, 2H), 1.49 (m, 2H), 1.24 (m, 24H), 0.86 (t, J = 5 Hz, 
3H). 13C NMR (125 MHz, CDCl3) δ 159.3, 139.9, 139.3, 139.0, 138.9, 138.7, 138.6, 131.2, 
129.7, 128.8, 128.5, 128.1, 128.4, 128.1, 128.0, 127.9, 127.8, 127.6, 127.5, 127.2, 116.9, 113.9, 
82.3, 81.1, 77.4, 74.7, 74.3, 73.5, 73.2, 73.1, 71.5, 68.0, 65.7, 55.5, 47.4, 32.2, 30.0, 29.9, 29.6, 
29.3, 27.5, 26.1, 22.9, 14.3. HRMS (ESI, MH+) m/z calc for C70H91O8 1059.6714 found 
1059.6765. 
 
Carboxylic acid 2.94 
 
        A stream of O3 gas was passed through a solution of 2.92 (35 mg, 0.033 mmol) in CH2Cl2 
(2.0 mL) at -78 oC for 5 min. Then, PPh3 (50 mg, 0.19 mmol) was added to the reaction mixture. 
The reaction mixture was warmed to rt and stirred for 2 h. The organic solvent was concentrated 
in vacuo. FCC of the residue afforded aldehyde 2.93 Rf = 0.13 (10% EtOAc/PE); 1HNMR 
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12H), 3.93 (m, 1H), 3.89(m, 1H), 3.83 (m, 2H), 3.77 (m, 6H), 3.60 (dd, J = 7.6, 2.7 Hz, 1H), 
3.55 (dd, J = 10.3, 4.5 Hz, 2H), 3.41 (dd, J = 10.2, 5.8 Hz, 1H), 2.63 (m, 1H), 1.85 (m, 1H), 1.62 
(m, 4H), 1.24 (m, 24H), 0.86 (t, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 203.7, 159.3, 
138.9, 138.8, 138.6, 138.5, 138.3, 130.6, 129.8, 128.7, 128.6, 128.5, 128.4, 128.2, 128.1, 128.0, 
127.9, 127.8, 127.6, 127.7, 127.6, 113.9, 79.8, 79.4, 77.1, 74.6, 73.6, 73.5, 73.4, 73.2, 72.2, 71.7, 
68.2, 55.4, 54.5, 32.1, 30.5, 30.1, 29.9, 29.6, 25.2, 22.9, 21.9, 14.3. HRMS (ESI, MNa+) m/z calc 
for C69H88NaO9 1083.6326 found 1083.6356. 
          To a solution of aldehyde 2.93 (35 mg, 0.032 mmol) in tert-butanol 0.75 mL and 0.25 mL 
water was added Sodium chlorite (3.6 mg, 0.04 mmol), NaH2PO4 (15 mg, 0.096 mmol), 2,3-
dimethyl-2-butene  (8 uL, 0.08 mmol). Stirring was continued for 2 h at rt and the mixture was 
then adjusted to pH 6 and diluted with CH2Cl2 (5 mL). The organic phase was separated, washed 
with brine (2 x 2 mL) and dried (Na2SO4). FCC of the residue afforded 2.94 (29 mg, 84% from 
2.92): Rf = 0.33 (20% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.25 (m, 27H), 6.76 (d, J = 8.5 
Hz, 2H), 4.72-4.39 (m, 11H), 4.31 (dd, J = 12, 4.7 Hz, 2H), 3.89 (m, 2H), 3.82 (t, J = 3.0 Hz, 
1H), 3.80 (dd, J = 7.5, 3.7 Hz, 1H), 3.74 (t, J = 8.2 Hz, 1H), 3.69 (s, 3H), 3.64 (m, 1H), 3.56 (dd, 
J = 7.1, 2.7 Hz, 1H), 3.47 (dd, J = 10.7, 4.3 Hz, 1H), 3.34 (ddd, 7.5, 4.0, 3.3 Hz, 1H), 2.69 (m, 
1H), 1.87 (m, 1H), 1.69-1.32 (m, 5H), 1.24 (m, 24H), 0.81 (t, J = 6.8 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ 176.0, 159.3, 138.7, 138.6, 138.5, 138.4, 138.1, 130.7, 129.7, 128.6, 128.5, 
128.4, 128.2, 128.1, 127.9, 127.8, 127.7, 127.6, 113.6, 80.5, 77.6, 77.4, 77.3, 77.1, 74.4, 73.4, 
73.3, 73.2, 72.4, 71.5, 67.8, 55.4, 47.3, 32.1, 30.1, 29.9, 29.8, 29.6, 26.0, 25.8, 22.9, 14.3. HRMS 
(ESI, MNa+) m/z calc for C69H88NaO10 1099.6275 found 1099.6349. 
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O-Benzyl Carbamate 2.9584 
 
                Carboxylic Acid 2.94 (25 mg, 0.23 mmol) was dissolved in toluene (0.5 mL). Et3N 
(17uL, 0.116 mmol) and DPPA  (7 uL, 0.0276 mmol) were added and the mixture was stirred at 
rt under nitrogen gas for 2 h. Then BnOH (25 uL, 0.23 mmol) was introduced and the mixture 
heated to 100 oC for 16 h. The solvent was evaporated under reduced pressure and the residue 
was purified using CC to give 2.95 (18 mg, 67%): Rf = 0.43 (20% EtOAc/PE); 1HNMR (600Mz, 
C6D6) δ 7.18 (m, 32 H), 6.82 (d, J = 8.4 Hz, 2H), 5.13 (ABq, J = 12.3 Hz, Δδ 0. 08, 2H), 5.07 
(dd, J = 18.5, 9.1 Hz, 1H) 4.78 (t, J = 11.3 Hz, 1H), 4.58 (m, 4H), 4.48 (m, 4H), 4.35 (m, 2H), 
4.24 (m, 1H), 4.15 (m, 1H), 4.00 (m, 3H), 3.89 (m, 1H), 3.80 (m, 2H), 3.73 (m, 1H), 3.62 (d, J = 
6.4 Hz, 1H), 3.31 (s, 3H), 2.26 (m, 1H), 1.87 (m, 4H), 1.63 (m, 2H), 1.56 (m, 2H), 1.32 (m, 
24H), 0.91 (t, J = 6.7 Hz); 13C NMR (125 MHz, C6D6) δ 160.1, 156.7, 139.9, 139.7, 139.6, 
138.2, 130.1, 129.0, 128.9, 128.9, 114.5, 83.3, 80.7, 78.9, 78.2, 76.1, 74.5, 74.4, 73.9, 73.8, 73.6, 
72.2, 69.5, 67.0, 55.2, 53.8, 32.7, 31.3, 30.8, 30.6, 30.5, 30.2, 30.0, 28.4, 26.8, 23.5, 14.7. HRMS 
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3,4 O-Isopropylidene 2.97  
 
        To a solution of 2.89 (25 mg, mmol) in CH2Cl2 (1 mL) was added CSA (5 mg, mmol) and 
Dimethoxy propane (40 ul) at 0 oC for 5 min. The mixture was stirred at rt for another 30 min 
and the mixture was quenched saturated aqueous NaHCO3 (0.5 mL). The aqueous layer was 
extracted with EtOAc (3 x 2.0 mL). The organic phase was washed with brine, dried (Na2SO4), 
filtered and concentrated in vacuo. . FCC of the residue afforded 2.97 (25 mg, 98 %): Rf = 0.62  
(20% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.25 (m, 20H), 5.41 (m, 1H), 5.01 (m, 2H), 4.71-
4.35 (m, 8H), 3.90 (m, 2H), 3.81 (m, 2H), 3.64 (m, 3H), 3.53 (m, 1H), 3.40 (m, 1H), 2.05 (m, 
1H), 1.65 (m, 2H), 1.46 (m, 2H), 1.31 (s, 3H), 1.25 (s, 3H), 1.14 (m, 24H), 0.77 (t, J = 6.3 Hz, 
3H). 13C NMR (125 MHz, CDCl3) δ 138.9, 138.8, 138.6, 128.6, 128.5, 128.4, 128.3, 128.2, 
128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 117.6, 108.1, 83.3, 80.3, 77.5, 77.4, 77.3, 77.1, 77.0, 
74.7, 73.8, 73.5, 73.3, 73.2, 72.0, 71.8, 68.2, 48.9, 34.3, 32.1, 29.9, 29.8, 29.6, 27.7, 27.6, 27.2, 
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 Carboxylic Acid 2.99  
 
Treatment of 2.97 (25 mg, 0.028 mmol) under the ozonolysis conditions used for the preparation 
of 2.94 provided the aldehyde 2.98 (21.9 mg, 88 %): Rf = 0.40 (10% EtOAc/PE); 1HNMR 
(500Mz, CDCl3) δ 9.59 (d, J = 2.5 Hz, 1H), 7.23 (m, 20H), 4.70-4.37 (m, 8H), 3.89 (t, J = 3.0 
Hz, 1H), 3.86 (m, 2H), 3.82 (dd, J = 7.8, 5.3 Hz, 1H), 3.77 (m, 1H), 3.70 (m, 2H), 3.61 (dd, J = 
7.7, 2.8 Hz, 1H), 3.52 (dd, J = 10.2, 5.1 Hz, 1H), 2.39 (m, 1H), 1.87 (m, 1H), 1.66 (m, 1H), 1.40 
(m, 2H), 1.31 (s, 3H), 1.29 (s, 3H), 1.19 (m, 24H), 0.81 (t, J = 6.8 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 203.5, 138.8, 138.7, 138.5, 128.7, 128.6, 128.5, 128.2, 128.1, 128.0, 127.9, 127.8, 
127.7, 108.7, 79.6, 79.1, 77.5, 77.4, 77.2, 77.0, 74.6, 73.7, 73.5, 73.3, 73.2, 71.9, 68.2, 53.7, 33.6, 
32.1, 29.9, 29.8, 29.6, 27.5, 27.3, 26.3, 22.9, 21.3, 14.3 
             Treatment of 2.98 (21 mg, 0.0235 mmol) under the Pinnick conditions used in 
preparation of 2.94 provided 2.99 (21 mg, 98 %): Rf = 0.2 (10% EtOAc/PE); 1HNMR (500Mz, 
CDCl3) δ 7.33 (m, 20H), 4.67-4.37 (m, 8H), 3.89 (m, 3H), 3.74 (m, 4H), 3.62 (dd, J = 7.5, 2.5 
Hz, 1H), 3.54 (dd, J = 10.4, 4.8 Hz, 1H), 2.50 (m, 1H), 1.83 (m, 1H), 1.74 (m, 1H), 1.61 (m, 2H), 
1.40 (m, 2H), 1.29 (s, 3H), 1.26 (s, 3H), 1.17 (m, 24H), 0.81 (t, J = 6.8 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ 176.7, 138.8, 138.5, 138.3, 128.7, 128.6, 128.5, 128.2, 128.1, 128.0, 127.9, 
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73.2, 71.9, 68.1, 48.2, 34.0, 32.1, 29.9, 29.8, 29.6, 27.7, 27.4, 26.2, 22.9, 21.3, 14.3. HRMS 
(ESI, MNa+) m/z calc for C57H78NaO9 929.5544 found 929.5515. 
 
O-Benzyl Carbamate 2.100  
 
           Treatment of 2.99 (20 mg, 0.022 mmol) under the conditions used in the preparation of 
2.95 provided 2.100 (14 mg, 63%). 1HNMR (500Mz, C6D6) δ 7.22-7.09 (m, 25 H), 5.08 (ABq, J 
= 12.4 Hz, Δδ = 0.12 ppm, 2H), 4.76 (d, J = 11.7 Hz, 1H), 4.59-4.37 (m, 9H), 4.26-4.01 (m, 6H), 
3.91 (m, 1H), 3.81 (dd, J = 10.6, 5.2 Hz, 1H), 3.66 (dd, J = 5.3 Hz, 1H), 3.52 (t, J = 7.3 Hz, 1H), 
1.99 (m, 2H), 1.56 (m, 2H), 1.54 (m, 2H), 1.43 (s, 3H), 1.41 (s, 3H), 1.33 (m, 24), 0.93 (t, J = 6.8 
Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 156.8, 139.9, 139.8, 139.6, 139.5, 137.9, 129.0, 128.9, 
128.9, 128.8, 128.7, 128.5, 128.3, 128.1, 128./1, 108.9, 84.4, 80.0, 78.1, 76.0, 74.3, 74.0, 73.6, 
73.5, 67.1, 53.8, 53.8, 35.3, 32.7, 30.6, 30.5, 30.2, 28.2, 27.6, 27.2, 23.5, 14.7. HRMS (ESI, 
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C-KRN7000 epimer 2.101  
 
            Treatment of 2.100 (12 mg, 0.012 mmol) under the conditions used in preparation of 2.96 
provideds 2.101 (6 mg, 59% over two steps): Rf = 0.143 (10% MeOH/CHCl3); 1HNMR (500Mz, 
C5D5N) δ 8.60 (d, J = 8.8 Hz, 1H), 5.14 (bm, 6H), 4.79 (dd, J = 16.7, 7.9 Hz, 1H), 4.74 (dd, J = 
8.7, 5.5 Hz, 1H), 4.50 (dd, J = 11.1, 6.6 Hz, 1H), 4.42 (dd, J = 11.2, 4.9 Hz, 1H), 4.38 (dd, J = 
8.7, 3.4 Hz, 1H), 4.31 (m, 1H), 4.18 (m, 1H), 3.75 (dd, J = 8.0, 2.0 Hz, 1H), 2.65 (m, 1H), 2.50 
(m, 3H), 2.42 (m, 1H), 2.12 (m, 2H), 1.85 (m, 4H), 1.65 (m, 2H), 1.30 (m, 79H), 0.88 (m, 6H). 
13C NMR (125 MHz, C5D5N) δ 173.0, 75.1, 73.7, 72.3, 70.5, 69.2, 68.7, 68.6, 50.5, 35.0, 32.4, 
30.3, 28.5, 28.4, 28.2, 28.1, 28.0, 27.8, 26.4, 25.1, 24.7, 21.1, 21.0, 12.5 
 
α-Fluoro aldehyde 2.103   
 
            0.5M solution of 9-BBN in THF (7.2 mL, 3.6 mmol) was added dropwise to a stirred 
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stirred at rt for additional 16 h, then cooled down to 0 oC and Water (1 mL) were successively 
added. Then the reaction mixture was treated with NaBO3.H2O (550 mg, 3.6 mmol). The mixture 
was stirred at rt for 3 h. then diethyl ether (10 mL) and water (10 mL) were added. The organic 
phase was separated, and the aqueous layer was extracted with diethyl ether (15mLX3). The 
combined organic phase was dried (Na2SO4), filtered and evaporated in vacuo to give after 
purification the corresponding primary alcohol (580 mg, 81%), Rf = 0.36 30% EtOAc/PE); 
1HNMR (500 Mz, CDCl3) δ 7.25 (m, 20H), 4.73 (dq, J = 46.6, 14.4, 6.1 Hz, 1H), 4.51-4.33 (m, 
8H), 4.26 (t, J = 7.8 Hz, 1H), 4.12 (t, J = 11.6 Hz, 1H), 3.93 (dd, J = 6.3, 2.2 Hz, 1H), 3.87 (dd, J 
= 8.7, 4.1 Hz, 1H), 3.70 (m, 2H), 3.65 (m, 3H), 2.03 (bs, 1H), 1.95 (m, 2H); 13C NMR (125 
MHz, CDCl3) δ 138.5, 138.4, 138.2, 138.0, 128.6, 128.4, 128.2, 128.1, 128.0, 127.9, 127.8, 
127.7, 89.8 (d, JC-F = 165.1 Hz), 74.8, 74.5, 74.1, 73.6, 73.5, 73.4, 73.3, 71.7, 68.6 (d, JC-F = 29.3 
Hz), 65.5, 58.9 (d, JC-F = 6.3 Hz), 36.0 (d, JC-F = 19.3 Hz).  
To a solution of the resulting alcohol (220 mg, 0.0.36 mmol) in dry DCM (20 mL) at 0 oC was 
added dropwise DMP as a 15% solution in DCM (3.0 mL, 1.06 mmol). The reaction mixture was 
stirred at rt for 30 min, then passed through a pad of silica gel. The filtrate was concentrated 
under reduced presurre to give aldehyde 2.103 (200 mg, 93%), which was used in the next step 
without further purification. Rf = 0.6 (20% EtOAc/PE). 1HNMR (500 Mz, CDCl3) δ 9.68 (s, 1H), 
7.25 (m, 20H), 5.09 (ddt, J = 45.0, 10.0, 5.0 Hz, 1H), 4.56-4.34 (m, 8H), 4.25 (t, J = 10 Hz, 1H), 
4.05 (t, J = 10.0 Hz, 1H), 3.93 (dd, J = 5.0, 2.2 Hz, 1H), 3.80 (t, J = 5.0 Hz, 1H), 3.63 (m, 3H), 
2.89 (m, 1H), 2.66 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 199.4, 138.5, 138.4, 138.2, 138.0, 
128.7, 128.6, 128.4, 128.3, 128.0, 127.9, 127.8, 86.3 (d, JC-F = 168.7 Hz), 74.9, 74.4, 73.6, 73.5, 
73.4, 73.3, 71.8, 68.3 (d, JC-F = 28.2 Hz), 65.5, 46.57 (d, JC-F = 20.5 Hz). 
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δ-Fluoro-α ,β  unsaturated ester 2.104  
 
    To a solution of aldehyde 2.103 (200 mg, 0.33 mmol) in CH3CN (1.0 mL), was added methyl 
triphenylphosphoranylidene acetate (340 mg, 1.0 mmol). The mixture was stirred at rt for 16 h. 
The organic solvent was concentrated in vacuo, and the crude material was purified by FCC to 
give ester 2.104 (191 mg, 88%): Rf = 0.38 (20% EtOAc/PE); 1HNMR (500 Mz, CDCl3) δ 7.31-
7.17 (m, 20 H), 7.00 (m, 1H), 5.93 (d, J = 15.7 Hz, 1H), 4.72 (m, 1H), 4.57-4.38 (m, 8 H), 4.31 
(t, J = 7.6 Hz, 1H), 4.09 (t, J = 9.2 Hz, 1H), 3.97 (dd, J = 6.3, 2.8 Hz, 1H), 3.77 (m, 1H), 3.74-
3.68 (m, 6H), 3.66 (m, 1H), 2.76 (m, 1H), 2.46 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 166.9, 
144.0 (JC-F = 2.1 Hz), 138.7, 138.4, 138.3, 137.9, 128.7, 128.6, 128.5, 128.4, 128.3, 128.1, 128.0, 
127.9, 127.8, 127.7, 124.2, 89.3 (JC-F = 169.6 Hz), 75.0, 74.8, 74.4, 73.7, 73.6, 73.5, 73.4, 73.3, 
73.2, 71.7, 68.1 (JC-F = 28.7 Hz ), 65.7, 51.7 (JC-F = 12.8 Hz), 35.0 (JC-F = 19.7 Hz), 29.9.  
 
Fluorinated sugarstannane 2.105 
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added dropwise over 30 min at -78 oC 1M DIBAL-H solution in heptane (2.0 mL, 2.0 mmol). 
The reaction mixture was stirred at -78 oC for 3 h and left to warm to rt. Then the reaction was 
quenched at 0 oC with MeOH (0.5 mL) and saturated aqueous Rashel salt (10.0 mL). After 
stirring at rt for 12 h, the aqueous layer was extracted from EtOAc (3 x 10 mL). The organic 
phase was dried (Na2SO4), filtered, and concentrated in vacuo to give the corresponding primary 
alcohol (255 mg, 57%): Rf = 0.5 (30% EtOAc/PE).  
           To a solution of the resulting allyl alcohol from the previous step (255 mg, 0.4 mmol) 
in dry THF (4.0 mL) was added NaH (ca. 60% suspension in mineral oil, 32.5 mg, 0.8 mmol). 
The mixture was stirred at 0 oC under an nitrogen atmosphere then warmed to rt and stirred for 1 
h. Carbon disulfide (50 µL, 0.8 mmol) was added, and then the mixture was stirred for another 
30 min. MeI (50 µL, 0.8 mmol) was then added, the mixture was stirred for another 2 h at rt, 
diluted with brine (10 mL) and extracted with ether. The organic layer was separated, washed 
with water, dried (Na2SO4), concentrated in vacuo and purified to give the corresponding 
xanthate(230 mg, 80.2): Rf = 0.27 (10%EtOAc/PE); 1HNMR (500 Mz, CDCl3) δ 7.24-712 (m, 20 
H), 5.85 (m, 1H), 5.74 (m, 1H), 4.97 (d, J = 6.4 Hz, 2H), 4.61 (ddt, J = 47.2, 8.8, 3.0 Hz, 1H), 
4.51-4.34 (m, 8H), 4.26 (t, J = 7.2 Hz, 1 H), 4.04 (dd, J = 11.7, 9.0 Hz, 1H), 3.93 (dd, J = 6.3, 2.7 
Hz, 1H), 3.74 (dd, J = 8.8, 3.2 Hz, 1H), 3.67 (dd, J = 13.8, 2.0 Hz, 1H), 3.64 (t, J = 3.7 Hz, 1H), 
3.60 (m, 1H), 2.61 (m, 1H), 2.48 (s, 3H), 2.32 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 215.7, 
138.7, 138.5, 138.3, 138.0, 132.3, 128.7, 128.6, 128.5, 128.4, 128.2, 128.0, 127.9, 127.8, 126.5, 
90.0 (JC-F = 168.7 Hz), 75.0, 74.5, 74.3, 73.7, 73.6, 73.5, 73.4, 73.3, 73.2, 71.7, 68.0 (JC-F = 28.8 
Hz), 65.9, 35 (JC-F = 19.5 Hz), 30.0, 19.7.  
        A solution of the resulting xanthate (230 mg, 0.32 mmol) in dry toluene (5.0 mL) was 
purged with nitrogen gas and heated at reflux for 3 h. Bu3SnH (0.23 mL, 0.8 mmol) and AIBN 
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(10 mg) in toluene (1 mL) was added dropwise over 5 min, and heating was continued until TLC 
(PE/EtOAc, 9:1) indicated disappearance of starting material and formation of a new less polar 
product (ca. 30 min). The solvent was evaporated in vacuo and the product was purified using 
FCC to give 2.105 (170 mg, 59%): Rf = 0.68 (10% EtOAc/ PE); 1HNMR for the major isomer 
(500Mz, CDCl3) δ 7.22-7.11 (m, 20H), 5.61 (m, 1H), 5.19 (m, 1H), 4.64 (m, 1H), 4.52-4.32 (m, 
8H), 4.26 (m, 1H), 4.03 (t, J = 11.5 Hz, 1H), 3.93 (m, 1H), 3.71 (m, 2H), 3.66 (m, 2H), 2.50 (m, 
1H), 2.20 (m, 1H), 1.61 (m, 2H), 1.40 (m, 8H), 1.21 (m, 10H), 0.78 (m, 9H); 13C NMR (125 
MHz, CDCl3) δ 138.8, 138.6, 138.4, 133.1(JC-F = 21.4 Hz), 128.8, 128.6, 128.5, 128.4, 128.3, 
128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 119.81, 91.3  (JC-F = 168.2 Hz), 75.1, 74.5, 73.9, 
73.6, 73.5, 73.4, 73.3, 73.2, 71.7, 68.5 (JC-F = 28.8 Hz), 65.9, 35.8 (JC-F = 19.8 Hz), 29.3, 27.6, 
14.0, 9.3.     
Fluorinated homoallyl alcohol 2.106 
 
Treatment of 2.105 (E/Z 1.6:1) (150 mg, 0.167 mmol) under the conditions were used in 
preparation of 2.70 provided 2.106 (35 mg, 24.2%): Rf = 0.25 (20%ETOAc/PE); 1HNMR 
(500Mz, CDCl3) δ 7.28 (m, 20H), 6.85 (d, J = Hz, 2H), 5.62 (m, 1H), 5.05 (m, 1H), 4.85 (m, 
1H), 4.60-4.31 (m, 10 H), 4.11 (t, J = 11.8 Hz, 1H), 3.99 (m, 1H), 3.78 (m, 5H), 3.70 (m, 4 H), 
3.35 (d, J = 8.2 Hz, 1H), 2.43 (m, 1H), 2.34 (m, 1H), 1.73 (m, 1H), 1.44 (m, 3H), 1.24 (m, 24), 
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Fluorinated carboxylic acid 2.108  
 
         Treatment of 2.106 (35mg, 0.04 mmol) under the conditions were used in preparation of 
2.92 provided a the corresponding benzylated alkene (38 mg, 99 %): Rf = 0.64 (30%EtOAc/PE). 
1HNMR (500Mz, CDCl3) δ 7.19 (m, 25 H), 6.83 (d, J = Hz, 2H), 5.75 (m, 1H), 5.02 (m, 2H), 
4.77 (m, 2H), 4.53-4.29 (m, 12 H), 4.24 (t, J = Hz, 1H), 4.04 (t, J = Hz, 1H), 3.93 (dd, J = 5.9, 
2.8 Hz, 1H), 3.77 (m, 4H), 3.66 (m, 3H), 3.55 (dd, J = 7.5, 2.9 Hz, 1H), 3.46 (m, 1H), 2.53 (m, 
1H), 2.35 (m, 1H), 1.78 (m, 1H), 1.54 (m, 2H), 1.40 (m, 1H), 1.23 (m, 24 H), 0.85 (t, J = Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 159.5, 138.8, 138.6, 138.4, 138.3, 131.1, 129.8, 129.7, 
128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 116.3, 113.9, 
91.2 (JC-F = 167.0 Hz), 82-66,  55.5, 43.8, 34.4 (JC-F = 34.1 Hz), 32.2, 30.1, 30.0, 29.9, 29.6, 
29.3, 25.9, 22.9, 14.4.  
          Treatment of the alkene from the previous step (38 mg, 0.04 mmol) under the conditions 
were used in preparation of aldehyde 2.93 provided 2.107 (33 mg, 95 %): Rf = 0.57 (20% 
EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 13C NMR (125 MHz, CDCl3) δ 204.0, 159.3, 138.7, 
138.5, 138.4, 138.1, 129.9, 128.6, 128.5, 128.3, 128.1, 127.9, 127.8, 127.7, 113.9, 91.3 (JC-F = 
167.1 Hz), 79.8, 79.5, 75.0, 74.6, 73.9, 73.6, 73.5, 73.3, 73.2, 71.7, 71.6, 69.6, 65.9, 55.4, 51.5, 
32.2, 30.5, 30.1, 29.9, 29.6, 28.8, 28.6, 25.0, 22.9, 14.4. 
Treatment of 2.107 (33 mg, 0.031 mmol) under the conditions were used in preparation of 2.94 
provided 2.108 (25 mg, 71%): Rf = 0.29 (20% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.30- 













	   161	  
(t, J = 9.3 Hz, 1H), 3.93 (dd, J = 6.2, 2.1 Hz, 1H), 3.88 (dd, J = 9.0, 4.5 Hz, 1H), 3.81 (dd, J = 
7.3, 3.8 Hz, 1H), 3.74 (s, 3H), 3.66 (m, 3 H), 3.39 (m, 1H), 2.87 (m, 1H), 2.29 (m, 2H), 1.53 (m, 
2H), 1.23 (m,24 H), 0.86 (t, J =  6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 175.7, 159.3, 
138.4, 138.2, 138.1, 138.0, 130.6, 129.9, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 127.9, 127.8, 
127.7, 113.9, 90.0 (JC-F = 166.6 Hz), 80.1 (JC-F = 64.0 Hz), 77.8, 74.9, 74.5, 74.2, 73.6, 73.3, 
73.2, 71.6, 68.8 (JC-F = 29.3 Hz), 66.0, 55.4, 44.2 (JC-F = 3.9 Hz), 32.1, 31.7 (JC-F = 20.6 Hz), 
30.0, 29.9, 29.6, 25.6, 22.9, 14.3.  
 
Fluorinated Carbamate 2.109 
 
            Carboxylic acid 2.108 (20 mg, 0.02 mmol) was dissolved in toluene (0.5 mL). Et3N (16 
uL, 0.11 mmol) and DPPA (6.0 uL, 0.026 mmol) were added and the mixture was stirred at rt 
under nitrogen gas for 2 h. Then PMBOH (23 uL, 0.22 mmol) was introduced and the mixture 
heated to 100 oC for 16 h. The solvent was evaporated and the residue was purified by FCC to 
give 2.109  (11 mg, 53%): Rf = 0.39 (20% EtOAc/ PE); 1HNMR (600Mz, C6D6) δ 7.39-7.00 (m, 
29 H), 6.82 (d, J = 8.5 Hz, 2H), 6.73 (d, J = 8.5 Hz, 2H), 5.53 (d, J = 9.1 Hz, 2H), 5.33 (m, 1H), 
5.22 (ABq, J = 11.9 Hz, Δδ = 0.1 ppm, 2H), 4.72-4.11 (m, 12 H), 3.89 (m, 2H), 3.84 (m, 1H), 
3.78 (m, 1H), 3.71 (m, 1H), 3.30 (s, 3H), 3.24 (s, 3H), 2.83 (m, 1H), 2.34 (, 1H), 1.87 (m, 2H), 
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CDCl3) δ 160.3, 160.0, 156.7, 139.8, 139.7, 139.3, 139.2, 139.1, 131.8, 130.8, 130.3, 130.1, 
129.0, 128.9, 128.8, 128.0, 127.9, 127.8, 127.7, 114.5, 114.4, 91.0 (JC-F = 166.5 Hz), 83.4, 80.1, 
75.4, 75.3, 74.7, 74.4, 74.2, 73.9, 73.6, 73.4, 72.1, 72.0, 69.1 (JC-F = 34.1 Hz), 67.0, 66.3, 55.1, 
55.0, 33.4 (JC-F = 23.3 Hz), 32.7, 30.7, 30.6, 30.5, 30.2, 26.5, 23.5, 14.7. 
 
Homoallyl alcohol mixture 2.114. 
 
            To a solution of aldehyde 2.11385 (20.0 mg. 0.136 mmol) in DCM (3 mL) was added 
BF3.ether (17 uL, 0.136 mmol) at -78 o, reaction was stirred for 15 min, and then sugarstannane 
2.64 (60 mg, 0.068 mmol) in DCM (2.0 mL ) was added dropwise over 30 min. The reaction 
mixture was stirred at this temperature for 2 h. Then, the reaction was quenched with saturated 
aqueous NaHCO3 (5 mL) and left to warm to rt. The aqueous layer was extracted with EtOAc (3 
x 2.0 mL). The organic layer was washed with brine, dried (Na2SO4), filtered and concentrated in 
vacuo. FCC of the residue afforded 2.114 as an inseparable mixture (45 mg, 85%): Rf = 0.24, (30 
% EtOAc/PE); 1HNMR for major isomer (500Mz, C6D6) δ 7.30-7.01 (m, 22 H), 6.73 (d, J = 11.7 
Hz, 1H), 5.47 (m, 1H), 4.93 (m, 2H), 4.74 (m, 1H), 4.50-4.20 (m, 10 H), 3.94 (m, 2H), 3.92-3.82 
(m, 6 H), 3.63 (m, 2H), 3.39 (m, 1H), 3.22 (s, 3H), 2.19 (m, 2H), 1.29 (m, 2H); 13C NMR (125 
MHz, CDCl3) δ 160.2, 140.1, 139.0, 139.7, 139.6, 131.1, 129.9, 128.7, 128.5, 128.3, 128.1, 
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1.0 Introduction 
          Inositol glycans (IGs) are pseudodisaccharides in which a sugar residue is linked to an 
inositol segment. The more Well-known IGs comprise galactose, glucose, or mannose linked in 
α or anomeric configuration to myo- or chiro-inositol segments. Biologically important IGs that 
are relevant to the synthetic goals of this research are discussed below.  
 
   1.1 (3-O-methyl-D-chiro-inositol)β-1, 4 linked to galactosamine (INS2) 
 
                  IGs with insulin like properties were first identified in 1986.86 These IGs are believed 
to modulate insulin-controlled functions by acting as second messengers of insulin.86 Two types 
of insulin mimicking IGs have been isolated from natural resources: IGs with D-glucoseamine 
and myo-inositol 3.1 87 and ones made up of D-galactoseamine and chiro-inositol 3.2.88 
                 Seminal work in this area came from the Saltiel group, which synthesized the cyclic 
phosphate 3.1 and found it to stimulate lipogenesis in rat adipocytes with similar activity to 
incompletely characterized glucoseamine-myoinositols that were isolated from bovine liver.88 
Subsequently, Larner and co-workers published the isolation, purification, and synthesis of IG 
3.2 called INS2 (Figure 3.1).  
 
























3.2  X = O; Y = NH2       (INS-2)
3.3  X = CH2 Y = NH2   (C-INS-2)
3.4  X = CH2 Y = OH    (C-INS-2-OH)
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Chemically synthesized INS2 elicited dose-dependent reduction of glucose concentration in 
streptozotocin (STZ) diabetic rats at low micromolar concentrations. INS2 also, activated 
pyruvate dehydrogenase phosphatase (PDH) in vitro and enhanced insulin-stimulated 
incorporation of 14C-glucose into 14C-glycogen in hepatoma H4.89 INS2 was also found to 
sensitize insulin reduction of hyperglycemia in vivo. INS2 by itself did not promote a reduction 
in blood glucose, but if administrated 15 min prior to treatment with INS2 led to a 50% reduction 
in blood glucose.90 It was suggested that these in vivo effects are linked to the ability of INS2 to 
activate protein phosphatase 2C (PP2C) and mitochondrial PDH, which are associated with 
glucose metabolism. Brautigan and co-workers hypothesized that INS2 activates PP2C and PDH 
enzymes by mechanism in which INS2 binds into an allosteric pocket and interacts with Asp-243 
of PP2C or Glu-351 of PDH, and this leads to increased activity in the active site (Figure 3.2). 
These reports on the insulin mimetic effects of IGs promoted much interest in their use in new 
diabetes treatments and gave rise to the screening of IGs libraries for insulin action modulating 
activity.91  
                                              
                                             Figure 3.2 INS2 Hydrogen bonding90 
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         Very recently, Chin Li and co-workers confirmed that INS2 stimulates insulin secretion in 
pancreatic β cells and enhances glucose-induced insulin secretion. They found that INS2 
controls insulin production by closing of ATP sensitive potassium channels (KATP) and this 
effect of INS2 requires PP2C enzyme.92 Muller suggested an alternative mechanism for the 
secondary messenger action of IGs (Figure 3.3).93 (1) Insulin stimulates a 
glycosylphosphatidylinosiol-specific phospholipase C (GPI-PLC) that (2) lipolytically cleaves 
GPI-anchored proteins and free GPIs on the outer leaflet of the cell membrane. (3) The 
lipolytically cleaved protein-IG conjugates and then dissociates from the receptor and are 
transported into the cell, where (4-8) they mediate the recrutment of insulin receptor proteins 
(IRS) for recognition by PI-3 kinase. This triggers a phosphorylation cascade that intersects with 
the classical mechanism of insulin action. D’Alarcao and co-workers supported this mechanism 
by showing that fluorescent IGs were transported into rat adipocytes and stimulated lipogenesis.  
                         
Figure 3.3 Mechanism of inositol glycan (inositolphosphate glycan) action on cell surface93 
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            However, Seeberger and co-workers have questioned the ability of IGs to mimic insulin. 
IG 1 was synthesized and reevaluated and did not induce insulin effector functions in adipose 
tissue.94 The GPI-like glycans IPG4 and IPG5 that were previously reported to be active by 
Muller were also found to be inactive (Figure 3.4). Seeberger attributed the lack of insulin-
mimetic activity of these synthetic IGs to the following (i) cleaved GPI molecules are further 
modified in situ before taking action; (ii) the bioactive material from natural sources maybe a 
completely novel type of GPI-anchor that may have been present in the material that was 
originally tested, but was neither detected nor characterized or (iii) the entire concept of insulin-
mimetic inositol phosphoglycans is flawed. 94 
 
Figure 3.4 GPI-like glycans IPG4 and IPG5 
              The conflicting data on the insulin mimetic effects of IPGs calls for more research on 
the isolation, characterization, synthesis, and biological evaluation  of new inositol analogues. 


































































Figure 4 GPI-like glycans IPG4 and IPG5
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discovery.  We have been interested in C-glycosides of INS2 because of their potential as 
hydrolytically stable anti-diabetes drugs. C-INS295 was prepared using new synthetic 
methodology based on an oxocarbenium ion cyclization (vide infra). In biological studies, C-
INS2 activated PDHP similar to the O-glycoside INS2, but failed to activate PP2C, illustrating 
an intriguing selectivity of C-INS2. This result suggests that the inositol glycan binding sites on 
the two enzymes are distinct. In other words C-INS2 could selectively activate one of the two 
pathways of glucose disposal (glucose oxidation) but not (glycogen synthesis).  
1.2 α-D-mannose-(16)-D-myo-inositol 
                The emergence of new strains of tuberculosis (TB) is a growing health concern. 
According to the World Health Organization (WHO), in 2012, there were an estimated 8.6 
million new cases of TB and 1.3 million people died from TB.96 More than 20% of the treated 
cases are estimated to have multidrug-resistant (MDR-TB). The high mortality rate and 
increasing drug resistance are attributed to the causative agent Mycobacerium tuberculosis 
(Mtb). Mtb is a gram-positive bacterium with waxy coating on its cell surface. The mycobacerial 
envelope is critical for survival inside the host in the initial stages of infection. This envelope has 
three segments: plasma membrane, cell wall core, and outer capsule. The cell wall core consists 
of mycolyl-arabinogalactan covalently attached to peptidoglycan (Figure 3.5). 97 
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                         Figure 3.5 Mycobacterium cell wall componants.97 
 
          The external capsule is made up of a variety of non-covalently attached glycolipids, 
polysaccharides, and proteins. The most ubiquitous components of the mycobacterial cell 
envelope are phosphatidylinositol mannosides (PIMs), lipomannan (LM), and 
lipoarabinomannan (LAM). PIMs, LM, and LAM are biosynthetically related (Figure 3.6).98 
PIM2, the smallest precursor for the biosynthesis of these highly D-mannosylated molecules, has 
a glycerophospholipid (GPL) moiety at O1 of myo-inositol and two linked D-mannose sugars at 
O2 and O6; the GPL-linked myo-inositol with D-mannose at O2 is often designated as PIM1. 
Elongation at O6 of the D-mannosyl unit attached at the 6-O position of myoinositol by α-(1-6) 
and then α- (1-2)-linked D-mannosyl residues leads to higher PIMs.  
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                      Figure 3.6 Structures of PIMs, LM, LAM.98 
PIMs, LM, and LAM are important virulence factors in the pathogenesis of TB. 99 Accordingly, 
inhibition of the biosynthesis of LAM is a potential therapeutic strategy and the 
pseudotrisaccharide PIM2 an early stage intermediate is an attractive target because it is unique 
to mycobacteria (Figure 3.7).100 An α-mannose transferase that catalyzes the synthesis of PIM2 
from GDP mannose and the pseudodisaccharide PIM1 has recently been isolated, and this 
presents an opportunity for rational drug design. The C-glycoside analogue of α-D-mannose-
(16)-D-myo-inositol, which may act as hydrolytically stable, bi-substrate mimetic of the 
transition state leading to PIM2 (Figure 3.7). Such C-glycosides are of interest as pharmaceutical 
leads and for enzyme studies. Small PIM fragments have also shown interesting 
immunomodulatory activities and their C-glycosides may also find applications as probes of the 
underlying mechanisms.100 However, while the synthesis of O-glycoside analogues is well 
documented, studies on C-glycosides thereof, are not.   
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Figure 3.7 Biosynthesis and C-glycoside analogues of PIM2 
 
              In this chapter we disclose a new synthetic procedure for C-glycoinositols that is based 
on the crotylation chemistry developed in Chapter II. C-manno-inositols and C-galactoseamine 
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2.0 Previous synthesis  
          We previously developed a synthesis of C-glycoinositols in which the key step entails 
formation of the “glycone” segment via an oxocarbenium ion cyclization on a thioacetal-enol 
ether intermediate.  The later was derived from esterification of glycone and aglycone fragments. 
For β-galactoseamine-(14)-3-O-methyl-D-chiro-inositol (C-INS-2), the precursors were 1-
phenythio-1,2-O-isopropylidene 3.10101 and  inositol-acid derivative 3.9. Inositol 3.9 was made 
from commercially available D-chiro-inositol in four steps. The known pinnitol derivative 3.5 
was transformed to thiocarbonate 3.6, which was subjected to Keck free radical allylation to 
afford the C-allyl derivative 3.7, in 51% yield over two steps. Ozonolysis and Pinnick oxidation 
on 3.7 gave the carboxylic acid 3.9 in 60% over two steps. DCC coupling of alcohol 3.10 and 
acid 3.9 followed by Tebbe olefination of the resulting ester gave 3.12, the key precursor for the 
oxocarbenium cyclization step.  Treatment of 3.12 with methyl triflate in the presence of 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) provided cyclic enol-ether 3.13 in 77%. Hydroboration-
oxidation of 3.13 gave C-pseudodisaccharide 3.14 as a single diastereomer. Alcohol 3.14 was 
elaborated to the galactose amine moiety by oxidation and subsequent formation of oxime 
derivative 3.16. Treatment of 3.16 with Bu3SnH and BF3.OEt2 provided 3.17 in 82% yield. 
Cleavage of the silyl ether followed by methoxylamine reduction and cleavage of the acetal 
protecting groups provided C-INS-2 in 73% overall yield.95 The oxocarbenium ion cyclization 
on thioacetal-enol methodology was also used to make C-glycoside analogue of α-D-mannose-
(16)-D-myo-inositol. 100 
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Scheme 3.1 Previous synthesis of β-galactoseamine-(1->4)-3-O-methyl-D-chiro-inositol  
             The above synthetic strategy is not ideal for preparing libraries of C-glycoinositols with 




































































3.5 3.6 3.7 3.8 R = H







3.11 X = O
3.12 X = CH2
f
Reagents and conditions: a) PhOSCl, toluene, pyridine, DMAP, 96% b) allyltributyltin, toluene, AIBN, 
110 oC, 56%. c) O3,MeOH/CH2Cl2, -78 oC, then Ph3P, rt, 85%. d) NaClO2, CH3CN/H2O, NaH2PO4, 75%.
e) DCC, CH2Cl2, DMAP, 89%. f)Tebbe reagent, toluene/THF, pyridine, - 78 oC to rt, 75%. g) MeOTf,
DTBMP, CH 2Cl2, MS 4 Å , 77%. h)BH 3Me2S, THF; then Na 2O2, 76%. i) 1. PCC, NaOAc, florisil, 
MS , CH 2Cl2, 95%.  2.  NH 2OMeHCl, NaOAc, THF/MeOH/H 2O, 86%. j) Bu 3SnH, BF 3.OEt2. 
k) 1. Na, NH3, -78 oC. 2. TBAF, THF, rt, 3. HCl in ether, CH3OH. 92% 3 steps.
Scheme 1: Previous synthesis of b-galactoseamine-(1-->4)-3-O-methyl-D-chiro-inositol
3.13
3.14 3.15 X = O
3.16 X = NOMe
3.17 C-INS-2 3.3
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by a lengthy sequence for formulation of amino-sugar residue. We envisaged a more practical 
approach that revolves around the crotylation methodology from Chapter II.  
 
3.0 Methodology and general retrosynthetic analysis 
              The reaction of crotylstannane 3.21 and aldehyde 3.22 was expected to give primarily 
syn products 3.20, the preference for one over the other being unpredictable at this stage 
(Scheme 3.2). RCM on 3.20 followed by dihydroxylation of cyclohexene 3.19 gives a C-
glycoinositol 3.18. For a crotylstannane with a given sugar motif, the stereoselectivity of 
crotylation reaction can be controlled by the choice of Lewis acid and the stereochemistry of the 
aldehyde partner. Different alkene functionalization reactions on the RCM product 3.19 lead to 
inositol segments with different functional groups and stereochemistry. Thus, a variety of 
different glycoinositols can be prepared using different combinations of crotylstannane and 
aldehydes. Importantly, as discussed earlier, these precursors can be readily accessed from 
known sugar precursors.    
 






























	   175	  
4.0 Results and discussions 
4.1 C-pseudodisaccharides of galactose  
            The methodology was first tested on a C-galactosyl crotylstannane 3.25, which was 
prepared from the C-allyl galactose 3.23 (Scheme 3.3). Ozonolysis on 3.23 followed by standard 
homologation using HWE olefination on the aldehyde product and reduction of the resulting 
conjugated ester afforded E-allyl alcohol 3.24 in a good yield. Compound 3.24 was then 
converted to crotylstannane 3.25 via the previously described rearrangement-elimination 
sequence on the xanthate derivative of 3.24.102   Crotyltin 3.25 was collected as E/Z mixture 
(5:1) in 54% yield from 3.24. Slow addition of 3.25 to the known aldehyde 3.26103 (three steps 
from ribose) in the presence of BF3.OEt2 at -78 oC, gave bis alkene 3.27 as the major compound 
in 50%. Another isomer was obtained but was not quantified nor stereochemically characterized. 
The stereochemistry for the newly formed centers in 3.27 was assigned by coupling constant 
analysis and 2D nOe on the cyclic structure 3.29 (vida infra). RCM on 3.27 using 5% GII 
catalyst went smoothly. Acetylation of the product furnished 3.28 in 80% yield from 3.27. The 
1HNMR of 3.28 was not well resolved, so the isopropylidene in 3.28 was cleaved and the 
resulting diol was acetylated to give triacetate 3.29. The 1HNMR for 3.29 showed a large J1, 6 of 
10.0 Hz, which is consistent with the trans diaxial arrangment of H1 and H6 and indicated syn 
selectivity in the crotylation reaction. The relative stereochemistry at C1 and C3 was assigned 
from a clear nOe between H1 and H3. J1,2 and J2,3 values of less than 2 Hz supported the all syn 
arrangment of the 1,2,3-tri-O-acetate segment in 3.29 (Scheme 3.3).  
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Scheme 3.3 Synthesis of C-pseudodisaccharide 3.39 using crotylation chemistry 
 
4.2 C-pseudodisaccharides of mannose 
           To explore a more benign procedure for transforming C-allyl-sugar precursors like 3.23 to 
allylic alcohols like 3.24, we next tested a CM approach104 on the synthesis of the crotyltin 3.32, 




















Reagents and Conditions: a) 1. O3 stream, DCM/MeOH, -78 oC, then Ph3P, rt, 2h. 2. Ph3P=CCO2Me, CH3CN,
reflux, 2h. 3. DCM, DIBAL-H -78 oC. b) 1. NaH, THF, imidazole (cat.) CS2, rt, 1h, then MeI, 2h. 2. Toluene, 
reflux, 110 oC, 3h, then AIBN (cat.) and Bu3SnH, refluxt 30 min. c) DCM. BF3.OEt2, -78 oC, 3 h.  d) 1.DCM, 
5% GII, reflux, 30 min. 2. Ac 2O, EtOAc, DMAP. rt, 5 min. e) 1. MeOH, AcCl, rt, 2h. 2. Ac 2O, EtOAc
















J1,6 = 10.0 H Hz
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        Scheme 3.4 Crotylation chemistry on mannose derivative 
              Thus, CM using Grubbs I catalyst with α-C-allyl-mannose 3.30 and three equivalents of 
Z-2-butene-di-(tert-butyldimethylsilyl ether), followed by cleavage of the silyl ether group gave 
a mixture of E/Z homoallyl alkene 3.31 (E/Z ~ 2:1) in 65% yield from 3.30. The mixture was 
separable after careful chromatography, and the individual isomers were subjected to the 
standard stannylation protocol. An approximately 3:2 E/Z mixture of crotylstannanes 3.32 was 
obtained in both cases. The E/Z was determined by 1HNMR, with the major isomer assumed to 
be the thermodynamically more stable E-crotylstannane.  
The crotylation partner, aldehyde 3.33 was obtained in nine steps from L-tartaric acid.105 
Standard crotylation conditions on 3.32 and 3.33 at -78 oC with BF3.OEt2 gave syn adduct 3.34 
















































Conditions and reagents: a) 1. Z-2-butene-di (tert-butyldimethylsilyl ether), GI, DCM, reflux, 16 h. 2. THF, 
TBAF, er, 30 min. b) 1. THF, NaH, imidazole, CS2, rt, 1h, then MeI, rt, 2h. 2. Toluene, reflux, 3h, 110 oC,
then AIBN, Bu3SnH, 30 min, reflux. c) DCM, BF3.ether, -78 oC, 3h
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Scheme 3.5 Stereochemistry assignments for the mannose crotylation products 
The stereochemistry for both epimers was assigned by NMR analysis of later derivatives 
(Scheme 3.5). Thus, RCM on 3.34 using 10% Grubbs II catalyst, followed by cleavage of the 
isopropylidene group under acidic conditions gave triol 3.36. No diagnostic nOe correlations 
were observed for triol 3.36 or for the peracetylated derivative 3.38. The stereochemistry in 3.38 
OH
a
a) 1.DCM, 5% GII, reflux, 40 oC, 20 min. 2. MeOH, AcCl (cat.), rt, 30 min. b) 1. 2,2 dimethoxy propane, CSA, 
20 min, rt. 2. EtOAc, Ac2O, DMAP, rt, 5 min. d) 1. DCM, TMEDA, OSO4/t-BuOH, -78 oC, 1 h. 2. Ethylene 



























































H3 J1,2  = 2.7 Hz
J1,2 and J2,3 << 1 Hz
H6
J1,6 = 11.8 Hz
J1,2  = 5.04 Hz





































J2.3  = 3.2 Hz
J3,4  = 9.7 Hz
J4,5 = 8.9 Hz
J5,6 = 3.5 Hz
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was assigned based on the analysis of coupling constants, A J1,2 = 5.05 Hz, J2,3 = 2.7 Hz 
suggested 3.38 orignated in a syn crotylation product. From the coupling constants we concluded 
that H1 and H2 are both in equatorial positions and H2 and H3 are syn to each other. To confirm 
this result, triol 3.36 was treated with dimethoxypropane and CSA followed by acetylation of the 
resulting alcohol to confrm the syn relation between H2 and H3, as expected a new isopropylidine 
derivative 3.37 was formed cleanly without any evidance of the formation of other isomers. The 
attempted directed dihydroxylation on 3.36 using OsO4/t-BuOH and TMEDA106 did not give the 
expected product, but instead provided the product resulting from dihydroxylation on the less 
hindered face of the alkene. The stereochemistry of the dihydroxylation product was assigned 
through 1HNMR analysis of the pent-O-acetate 3.39. H1, and H6 were overlabed and it was 
difficult to extract the coupling constant. But the analysis of the coupling constant of the other 
resolved Protons proved the structure assigned for 3.39. J2,3 = 3.2 Hz, J3,4 = 9.7 Hz , J4,5 = 8.9 
Hz, J5,6 = 3.5 Hz suggested all axial arrangment of H3, H4, and H5.  Similarly, compound 3.35 
was subjected to RCM conditons and gave triol 3.40 after cleavage of the isopropylidene group. 
Acetylation of 3.40 gave the peracetate 3.41. The relative stereochemistry for the newly formed 
centers in 3.41 was assigned from a clear nOe between H1 and H3 and small coupling constants 
J1,2 and J2,3. Dihydroxylation on 3.40 under the same reaction conditions applied on 3.36 gave 
one major isomer, which was characterized as the per acetylated neo-inositol 3.42. The 
stereochemistry in 3.42 was assigned based on the coupling constants J1,2 = 2.7 Hz and J1,6 = 
11.8 Hz. Thus from these sterecochemical analysis neither of the crotylation products 3.34 and 
3.35 has the desired stereochemistry for the D-myo-inosistol target 3.43 (Figure 3.7). The 
stereochemistry in D-myo-inositiol 3.43 calls for the other syn diasteromer of 3.34. to this end we 
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decided to study the effect of using different Lewis acids on the stereochemistry of the 
crotylation reaction. 
            MgBr2.OEt2 and SnCl4 were tested because these catalysts gave different stereochemical 
results in the earlier experiments in Chapter II. However, the reaction with MgBr2.OEt2 gave 
only 3.44 (Scheme 3.6), the product from protodestannylation, and SnCl4 led to a complex 
mixture of unidentified materials. We speculate that MgBr2.OEt2 does not form stable chelate 
with aldehyde 3.33 because of the strain caused by the isopropylidene ring. As a result, the 
Lewis acid is not able to activate the aldehyde and in the presence of traces of water, 
protodestannylation is the major pathway. In the case of the more acidic SnCl4, the low reactivity 
of the aldehyde to nucleophilic addition results in substrate decomposition before addition of the 
crotyltin to the aldehyde (Scheme 3.6). The stereochemistry f the crotylation reaction may also 
be controlled by the alcohol protecting groups in the aldehyde. This is a direction for future 
study.  
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Scheme 3.6 Crotylation reactions under different Lewis acid conditions  
 
4.3 C-pseudodisaccharides of galactosamine  
         C-INS2 could be accessed by functionalization of the C-glycoside-cyclohexene 3.43, 
which comes from a RCM protocol on bis alkene 3.45 (Scheme 3.6). Homoallaylic alcohol 3.45 
and its 1,2 syn diastereomer are expected to be the major products from the reaction of the 
galactosamine crotylstannane 3.46 and aldehyde 3.47. Both precursors can be prepared from 
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                 Scheme 3.7 Retrosynthetic analyses for INS-2 
        The synthesis of 3.46 started from the known β-C-allyl-2-nitro galactose 3.49,107 which was 
obtained from nitro-galactal 3.48.108 Reduction of 3.49 with Zn/HCl109 followed by protection of 
the resulting amine as the phthalimide provided 3.50. CM on 3.50 and 3.51 followed by 
treatment the product with TBAF gave allylic alchohol 3.52 as an E/Z mixture, which was 
contaminated with an unidentified material. Compound 3.52 was then converted to 
crotylstannane 3.46 via the standard stannylation protocol. A 3/2 E/Z mixture of 3.46 was 
obtained in 13% overall from the C-allyl glycoside 3.50. It should be possible to improve the 
yield of this transformation by optimizing the CM and desilylation steps. For the aldehyde 
partner, the lyxose derivative 3.53 110 was converted to the primary iodide, which was subjected 
to Zn promoted reductive elimination to give 3.47 in 65% over two steps. The isopropylidene 
derivative of 3.47 is more directly available from D-lyxose than 3.47. However, the dibenzyl 
derivative 3.47 was preferred as the crotylation partner because of the potentially lower reactivity 
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Scheme 3.8 Synthesis of precursors for C-INS-2 
          The crotylation of 3.46 and 3.47 promoted by BF3.OEt2 at -78 oC showed syn selectivity, 
although with low facial selectivity on the alkene. This result was expected from the earlier 
examples. After acetylation of the products, the bis alkenes 3.54 and 3.55 were obtained in 62% 
and 31% yield respectively. The bis alkenes were next subjected to RCM. Unlike the previous 
examples, the RCM was very slow and took approximately 16 h for completion in both cases. 
The slower cyclization could be due to the absence of the conformationally restraining 

















































Conditions and reagents : a) ref 13 b) 1. pyridine, phthalic anhydride, rt, 16 h. 2. Ac2O, DMAP, 16h, rt. 
c)1. DCM, 41, 10% GI, reflux 16 h. 2. THF, TBAF, rt, 30 min. d) 1. THF, NaH, CS2, rt, 1 h, then MeI, rt, 2 h.
2. Toluene,  reflux 110 oC, 3h, then, AIBN, Bu3SnH, reflux, 30 min. e) ref 110. f) 1. Ph3P, DCM, imidazole, I2, 
rt, 3 h. 2. EtOH, Zn dust, reflux, 1 h.
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Scheme 3.9 Crotylation reactions of galactosamine derived crotylstannane  
Cyclohexene intermediates 3.56 and 3.58 were collected in 86% and 82 % respectively. NMR 
analysis of 3.56 and 3.58 suggests that both are products of syn addition. For 3.58, nOe between 
H1 and H3 suggest that both protons are on the same side. The stereochemistry for H2 was 
confirmed from a large J1,2 of 8.1 Hz (Scheme 3.9). Similarly, the configuration at C1 in 3.56 
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J1,2 = 8.1 Hz
J2,3 = 9.1 Hz
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OBnAcO
J1,2 = 10.1 Hz
J1,6 = 11.7 Hz















Conditions and reagents:a) 1. DCM, BF3.ether, -78 oC, 3h. 95% 2. EtOAc, Ac2O, DMAP, rt, 5 min, 99%. 
b) DCM, ethylene gas, 20% Grubbs II , reflux, 16h. c) 1. Acetone, water, NMO, OsO 4, rt, 24h.
2. EtOAc, Ac2O, DMAP, rt, 10 min. 85%.
b c
b c
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attack from the less hindered face of the alkene to give D-chiro inositol 3.59 in a good yield. The 
stereochemistry for the newly formed hydroxyl groups was confirmed from J analysis in the 
triacetate derivative 3.59 (J1,2 = 10.1 Hz and J1,6 = 11.7 Hz. Likewise, dihydroxylation on 3.56 
proceeded smoothly and gave only one diastereomer 3.57. Inositol 3.57 was characterized as 
neo-inositol. Thus, J4,5 = 10.6 Hz secured the diaxial relationship between H4 and H5. 
 
5.0 General diastereoselectivity trends for the reactions of C-glycoside crotyltins and chiral 
a-oxygenated aldehydes.  
              The reactions of the different sugar crotyltins examined to date and a-oxygenated 
aldehydes, favor syn selectivity (v.s. anti) with respect to the newly formed C-C bond when 
BF3.OEt2 is the Lewis acid (Scheme 3.10). This trend holds for aldehydes of different degrees of 
oxygenation and protecting groups. However, the facial selectivity on the alkene was generally 
low. This is not surprising because the chiral sugar residue is somewhat remote from the reacting 
center on the alkene (i.e. separated by one or two methylenes), and for a non-coordinating Lewis 
acid such as BF3.OEt2, α-oxygenated aldehydes do not generally exert a high facial bias on the 
carbonyl group. This said, the one case for which high syn selectivity was observed might have 
been controlled by the aldehyde partner. Thus, the reactions of crotyltins 2.64, 3.25 and 3.46 
with aldehydes 2.69, 3.26 and 3.47 respectively, showed no or modest preference for one syn 
diastereomer over the other (Entries 1 – 3, Scheme 3.10). In contrast, the reaction of crotyltin 
3.32 and aldehyde 3.33 was highly stereoselective, giving almost exclusively the syn/anti 
diastereomer 3.34. It is possible that the higher stereoselectivity seen in the latter case was 
controlled by the aldehyde partner.  
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                With chelating Lewis acids, varying degrees of syn/anti selectivity with respect to the 
newly formed C-C bond as a function of different Lewis acids was observed. However, in 
agreement with the established Cram’s chelate model, all the chelating Lewis acids screened 
effected high syn facial selectivity on the aldehyde. However this study was limited to a single 
crotyltin – aldehyde pairing, so the generality of this observation is unknown.  
                The results of this preliminary study on sugar crotyltins and a-oxygenated aldehydes 
follow the trends for the reactions of relatively simple achiral crotyltins and a-oxygenated 
aldehydes, when promoted by monodentate or chelating Lewis acids. A more systematic 
evaluation of substituent effects is needed to establish clearer rules for stereochemical control. 
Notwithstanding, the compatibility with sugar derived substrates, the wide functional group 
compatibility, and the versatility of the crotylation products; make this a potentially robust and 
broad-based methodology for the synthesis of glycomimetics. 
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only one product (Ref 71)
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6.0 Summary 
In summary, a methodology for rapid entry to diverse C-pseudodisaccharides has been 
developed. The key steps in this approach are the Lewis acid induced reaction of a C-glycoside 
crotyltin and an a-oxygenatged unsaturated aldehyde, and a RCM on the crotylation product. 
This methodology was applied to C- galacto, manno, and galactosamine pseudodisaccharides, 
including the C-glycosides of the biologically active glycoinositols, α-D-mannose-(16)-myo-
inositol and β-galactosamine-(16)-D-chiro-inositol. More careful examination of the 
stereochemical aspects of the pivitol crotylation reaction, and the extension of this methodology 
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7.0 Experimental  
7.1 General Experimental Information 
Unless otherwise stated, all reactions were carried out under a nitrogen atmosphere in oven-dried 
glassware using standard syringe and septa technique. 1H and 13C NMR spectra were obtained on 
Bruker 500, 400, or 600 MHz spectrometers. Chemical shifts are relative to the deuterated 
solvent peak or the tetramethylsilane (TMS) peak at (δ 0.00) and are in parts per million (ppm). 
Assignments for selected nuclei were determined from 1H COSY experiments. Thin layer 
chromatography (TLC) was done on 0.25 mm thick pre-coated silica gel HF254 aluminum 
sheets. Chromatograms were observed under UV (short and long wavelength) light, and/or were 
visualized by heating plates that were dipped in a solution of ammonium (VI) molybdate 
tetrahydrate (12.5 g) and cerium (IV) sulfate tetrahydrate (5.0 g) in 10% aqueous sulphuric acid 
(500 mL). Flash column chromatography (FCC) was performed using silica gel 60 (230-400 
mesh) and employed a stepwise solvent polarity gradient, correlated with TLC mobility. 
Petroleum ether used for FCC had a boiling point in the 40-60 oC range.   
 
α-C-galactosyl crotylstannane 3.25 
 
        To a solution of alcohol 3.34 (400 mg, 0.68 mmol) in dry THF (3 mL) was added sodium 
hydride (ca. 60% suspension in mineral oil, 41 mg) followed by a catalytic amount of imidazole 
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µL, 1.4 mmol) was added and the mixture was stirred for another 30 min. MeI (127 µL, 2 mmol) 
was then added, the mixture was stirred for 2 h at rt, then partitioned between ether (10 mL) and 
brine (10 mL). The organic layer was separated, washed with water, dried (Na2SO4), and 
concentrated in vacuo. A solution of the corresponding xanthate in dry toluene was purged with 
N2 gas and heated under reflux until TLC (PE/EtOAc, 5:1) indicated complete disappearance of 
the starting material and formation of a new slightly less polar product thiocarbonate. Bu3SnH 
(2.9 mL, 11 mmol) and AIBN (5 mg) in toluene (5 mL) was added dropwise over 5 min, and 
heating continued until TLC (PE/EtOAc, 6:1) indicated complete conversion of the starting 
material to a less polar product (ca. 30 min). The solvent was evaporated in vacuo and the 
product purified by FCC to give 3.25 (10% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.22 (m, 
20H), 5.51 (m, 1H), 5.06 (m, 1H), 4.65-4.34 (m, 8H), 3.97 (m, 1H), 3.92 (m, 1H) 3.85 (m, 1H), 
3.77 (m, 1H), 3.70 (m, 1H), 3.64 (m, 2H), 2.22 (m, 2H), 1.60 (m, 1H), 1.49 (m, 1H), 1.38 (m, 
6H), 1.21 (m, 6H), 0.81 (m, 15 H). 13CNMR (125 MHz, CDCl3) δ 138.9, 138.8, 138.7, 138.6, 
131.9, 128.5, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 121.5, 76.7, 74.6, 73.4, 73.3, 73.2, 73.1, 
67.5, 29.4, 29.3, 27.6, 27.5, 14.6, 14.0, 13.9, 9.6, 9.3. 
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C-galactose crotyltin 3.25 (87 mg, 1 mmol) and aldehyde 3.26 (19 mg, 1.2 mmol) were dissolved 
in anhydrous DCM (3.0 mL) under an N2 atmosphere and was cooled to −78°C. BF3.OEt2 (0.15 
mL, 1.2 mmol) was added via syringe in one portion and the mixture was stirred for 3 h Water 
(3.0 mL) was added, the organic layer was separated and the aqueous phase was extracted with 
EtOAc (3×5.0 mL). The combined organic phase was washed with water (3.0 mL), brine (3.0 
mL), dried (Na2SO4), and evaporated in vacuo. FCC of the residue afforded 3.27 (54%): Rf = 
0.18 (30% EtOAc/PE); 1HNMR (500Mz, CDCl3) δ 7.22 (m, 20H), 5.95 (m, 1H), 5.85 (m, 1H), 
5.16 (m, 2H), 5.03 (m, 1H), 4.61-4.37 (m, 11H), 4.12 (m, 1H), 4.03 (m, 2H), 3.87 (m, 1H), 3.76 
(m, 1H) 3.61 (m, 2H), 3.50 (m, 1H), 2.65 (m, 1H), 2.52 (m, 1H), 1.88 (m, 2H), 1.36 (s, 3H), 1.23 
(s, 3H). 13CNMR (125 MHz, CDCl3) δ 139.3, 138.8, 138.6, 138.5, 138.4, 135.2, 128.5, 128.5, 
128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 117.8, 116.6, 108.7, 79.2, 78.4, 76.8, 74.3, 74.3, 73.3, 




      Ethylene gas was passed through a solution a solution of bis alkene 3.27 (20 mg, 0.027 
mmol) in dry DCM (10 mL) for 1 h. Grubb’s II catalyst (1.15 mg, 0.00136 mmol) was added and 
the reaction mixture was refluxed at 40 oC for 2 h. The excess organic solvent was evaporated in 
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DMAP (5 mg). The excess solvent was evaporated under reduced pressure and the crude mixture 
was purified by FCC to give 3.28 Rf = 0.25 (30% EtOAc/PE), 1HNMR (500Mz, CDCl3) δ 7.23 
(m, 20H), 5.75 (d, J = 10.1 Hz, 1H), 5.42 (d, J = 10.15 Hz, 1H), 4.85 (d, J = 9.85 Hz, 1H), 4.68-
4.35 (m, 11H), 4.05 (m, 1H), 3.94 (m, 2H), 3.72 (m, 2H) 3.58 (m, 2H), 2.64 (m, 1H), 2.00 (m, 
1H), 1.91 (s, 3H), 1.86 (m, 1H), 1.78 (m, 1H), 1.29 (s, 3H), 1.26 (s, 3H). 13CNMR (125 MHz, 
CDCl3) δ 171.1, 138.7, 138.5, 138.4, 131.1, 128.6, 128.4, 128.0, 127.9, 127.8, 127.7, 126.1, 
110.1, 74.6, 74.2, 74.0, 73.9, 73.5, 73.3, 73.2, 67.9, 35.7, 26.5, 26.3, 21.3. 
 
α-C-mannosyl allyl alcohol 3.31 
 
Treatment of 3.30 (1.2 g, 2.12 mmol) under the same reaction conditions applied to 3.50 
provided E-3.31 (463 mg, 37.0 %) and Z-3.31 (198 mg, 33%).  
For E-3.32: Rf = 0.1 (20% EtOAc/PE); 1HNMR; (500Mz, CDCl3) δ 7.23-7.11 (m, 20H), 5.53 (m, 
2H), 4.64-4.43 (m, 8H), 3.94 (m, 3H), 3.75-3.61 (m, 5H), 3.51 (dd, J = 4.6, 3.1 Hz, 1H), 2.24 (m, 
2H); 13CNMR (125 MHz, CDCl3) δ 138.5, 138.4, 138.3, 132.0, 128.7, 128.6, 128.5, 128.3, 
128.2, 128.1, 127.9, 127.8, 77.1, 75.2, 74.1, 73.8, 73.5, 72.5, 72.4, 71.7, 69.4, 63.8, 33.2.  
For Z-3.32: Rf = 0.13 (20% EtOAc/PE); 1HNMR: (500Mz, CDCl3) δ 7.26-7.11 (m, 20H), 5.72 
(m, 1H), 5.47 (dd, J = 18.1, 8.3 Hz, 1H), 4.55-4.42 (m, 8H), 4.10 (dd, J = 12.5, 8.4 Hz, 1H), 
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3.53 (dd, J = 6.0, 3.0 Hz, 1H), 2.37 (m, 1H), 2.22 (m, 1H). 13CNMR (125 MHz, CDCl3) δ 138.2, 
131.5, 128.6, 128.5, 128.2, 128.1, 128.0, 127.9, 127.8, 76.2, 75.9, 74.9, 74.3, 73.5, 72.4, 71.7, 
71.5, 68.9, 58.1, 29.9.   
 
α-C-mannosyl crotylstannane 3.32 
 
          Treatment of E-3.31 (450 mg, mmol) under the same reaction conditions applied to 3.52 
provided 3.32 (472 mg, 72%): Rf = 0.60 (10% EtOAc/PE); 1HNMR for the major isomer; 
(600Mz, CDCl3) δ 7.33-7.21 (m, 20H), 5.53 (m, 1H), 5.11 (m, 1H), 4.78 (d, J = 9.3 Hz, 1H), 
4.68-4.53 (m, 8H), 4.01 (ddd, J = 9.1, 6.0, 3.1 Hz, 1H), 3.93 (t, J = 6.3 Hz, 1H), 3.84-3.75 (m, 
6H), 3.71 (t, J = 8.5 Hz, 1H), 2.29 (m, 2H), 1.65 (m, 2H), 1.52-1.48 (m, 7H), 1.34-1.28 (m, 9H), 
0.95-0.85 (m, 12H). 13CNMR (125 MHz, CDCl3) δ 138.7, 138.6, 138.5, 132.5, 130.9, 129.7, 
128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 120.6, 77.9, 75.3, 
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Bis alkene 3.34 
 
        To a solution of aldehyde 3.33  (235 mg. 1.5 mmol) in DCM (15.0 mL) was added 
BF3.OEt2 (190 uL, 1.5 mmol) at -78 o, reaction was stirred for 15 min, and then compound 3.32 
(680 mg, 1.0 mmol) in 5.0 mL DCM was added dropwise (during 30 min). The reaction mixture 
was stirred at this temperature for 2 h. reaction was quenched by addition of 5.0 mL of saturated 
solution of NaHCO3 at -78 oC and left to warm up at rt. Aqueous layer was extracted with EtOAc 
(3 x 10.0 mL). Organic layer was washed with brine, dried (Na2SO4), filtered and concentrated in 
vacuo. FCC of the residue afforded 3.34 as major compound (418 mg, 57%): Rf = 0.29 (20 % 
EtOAc/Hexane); 3.35 (104 mg, 14%): Rf = 0.30 (20 % EtOAc/Hexane); 
1HNMR for the major isomer 3.34; (400Mz, CDCl3) δ 7.25-7.11 (m, 20H), 5.66 (m, 2H), 5.28 
(m, 1H), 5.07 (m, 2H), 4.91 (m, 1H), 4.66-4.37 (m, 9H), 4.12 (m, 1H), 3.77-3.57 (m, 7H), 3.49 
(dd, J = 4.8, 3.7 Hz, 1H), 2.87 (m, 1H), 2.23 (m, 1H), 1.75 (m, 2H), 1.32 (s, 3H), 1.30 (s, 3H). 
13CNMR (100 MHz, CDCl3) δ 138.5, 138.4, 138.3, 138.1, 137.1, 128.5, 128.1, 128.0, 127.9, 
127.8, 118.4, 118.0, 108.9, 81.3, 78.5, 78.1, 77.4, 76.2, 75.4, 74.3, 73.6, 73.5, 73.0, 72.4, 71.7, 
71.4, 69.5, 43.5, 30.6, 27.3, 27.2.   
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(d, J = 17.2 Hz, 1H), 5.04 (m, 3H), 4.63-4.35 (m, 8H), 4.19 (t, J = 6.2 Hz, 1H), 4.01 (d, J = 8.6 
Hz, 1H), 3.83 (m, 2H), 3.67-3.48 (m, 6H), 2.99 (m, 1H), 2.50 (m, 1H), 1.87 (m, 1H), 1.33 (s, 
3H), 1.29 (m, 4H). 13CNMR (125 MHz, CDCl3) δ 138.4, 138.3, 138.2, 137.7, 137.5, 137.4, 
128.7, 128.6, 128.2, 128.1, 128.0, 127.9, 117.6, 116.4, 109.1, 81.7, 81.2, 78.0, 75.6, 74.1, 73.6, 
73.5, 73.3, 73.1, 72.4, 71.1, 69.8, 45.4, 29.9, 27.5, 27.1.   
Cyclohexene 3.37 
 
To a solution of triol 3.36 (5 mg, 0.0008 mmol) in 2,2 dimethoxypropane (0.1 mL) was added 
one crystal CSA. Reaction moxture was stirred at rt for 20 minm then was treated with NaHCO3 
solution 0.5 mL. The reaction mixture was extracted with EtOAc (3 x 0.5 mL) and the organic 
layer was washed with brine (0.5 mL), dried (Na2SO4), filtered, and evaporated in vacuo. The 
residue was dissoled in EtOAc (0.5 mL) and treated with Ac2O (50 uL) and one crystal of 
DMAP.Excess solvent was evaporated in vacuo. FCC of the residue afforded 3.37 as the only 
product (5 mg, 85%): Rf = 0.50 (50 % EtOAc/Hexane); 1HNMR (500 Mz, C6D6) δ 7.46-7.20 (m, 
20H), 5.90 (dt, J = 2.6, 9.8 Hz, 1H), 5.81 (dt, J = 2.6, 9.8 Hz, 1H), 5.77 (ddd, J = 2.2, 4.6, 8.0 Hz, 
1H), 4.74 (d, J = 11.7 Hz, 1H), 4.64-4.53 (m, 7H), 4.56 (m, 1H), 4.36 (dd, J = 5.7, 7.6 Hz, 1H), 
4.25 (dd, J = 5.6, 10.9 Hz, 1H), 4.18 (t, J = 6.2 Hz, 1H), 4.07-3.95 (m, 4H), 3.76 (dd, J = 2.9, 5.6 
Hz, 1H), 2.66 (m, 1H), 1.97-1.85 (m, 2H), 1.82 (s, 3H). 13CNMR (125 MHz, C6D6) δ 170.1, 
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              A solution of 3.34 (288 mg, 0.39 mmol) in dry DCM (100 mL) was degassed by 
ethylene gas for 30 min and GII catalyst (17.0 mg, 0.019 mmol) was added. The resulting 
mixture was heated at 40 oC for 30 min, after disappearance of the starting material (reaction 
progress was judged by TLC). Excess solvent was evaporated in vacuo. The residue was then 
dissolved in MeOH and treated with AcCl (50 uL), after stirring at rt for 20 min the excess 
solvent was evaporated and the residue was purified using CC to give 3.36 (74 % over 2 steps): 
Rf = 0.15  (70% EtOAc/hexane); Compound 3.36 (15 mg, 0.034 mmol) was dissolved in EtOAc 
and treated with 50 uL of Ac2O and DMAP (2 crystals). After stirring at rt for 10 min, organic 
solvent was evaporated under vacuo and the residue was purified on silica gel and 30% 
EtOAc/PE to give 3.38 (17 mg, 95 %): Rf = 0.56 (30% EtOAc/PE); 1HNMR for the major 
isomer; (400Mz, CDCl3) δ 7.32-7.16 (m, 20H), 5.96 (dd, J = 10.2, 2.5 Hz, 1H), 5.53 (ddd, J = 
10.2, 3.1, 1.8 Hz, 1H), 5.39 (ddd, J = 4.7, 3.1, 1.4 Hz, 1H), 5.16 (dd, J = 6.3, 2.4 Hz, 1H), 5.12 
(dd, J = 5.0, 2.3 Hz, 1H), 4.63-4.47 (m, 8H), 4.11 (ddd, J = 9.3, 5.5, 3.0 Hz, 1H), 3.84-3.68 (m, 
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(m, 2H); 13CNMR (100 MHz, CDCl3) δ 170.6, 170.5, 170.4, 138.6, 138.3, 133.5, 128.6, 128.5, 
128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 123.0, 77.4, 76.5, 74.9, 73.8, 73.7, 73.5, 72.4, 72.2, 




Treatment of 3.36 (10 mg, 0.015 mmol) under the same reaction conditions applied to 3.58 
provided 3.39 (9 mg, 66 %); 1HNMR (500Mz, C6D6) δ 7.47-7.20 (m, 20H), 6.15 (bt, J = 9.7 Hz, 
H4), 5.82 (m, 2H, H1 and H6), 5.70 (dd, J = 3.5, 8.9 Hz), 5.62 (m, J = 3.5, 8.5 Hz), 4.67-4.43 (m, 
9H), 4.38 (m, 1H), 4.21-4.14 (m, 3H), 3.95 (dd, J = 3.3, 5.8 Hz, 1H), 3.77 (dd, J = 2.9, 7.1 Hz, 
1H), 2.88 (m, 1H, 1.93 (m, 1H), 1.84 (m, 7H), 1.80 (s, 3H), 1.78 (s, 3H), 1.75 (s, 3H). 13CNMR 
(100 MHz, C6D6) δ 170.0, 169.9, 169.8, 169.7, 169.5, 139.8, 139.5, 139.3, 129.0, 128.9, 128.8, 
128.5, 128.1, 127.8, 77.2, 76.1, 75.5, 74.5, 73.1, 72.9, 72.4, 71.9, 70.3, 70.1, 70.0, 69.6, 69.0, 
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β-C-allyl galactose amine 3.50 
 
          To a solution of 3.49 (580 mg, 1.15 mmol) in a mixture of THF (70 mL) and H2O (30 mL) 
was added concentrated HCl (3.0 mL), acetic acid (16.0 mL), and Zn dust (1800 mg, 24 eq). The 
reaction mixture was stirred at 0 oC for 2 h, and unreacted Zn was filtered and the filtrate was 
extracted with DCM (5 x 30 mL). The organic layer was washed with saturated aqueous 
NaHCO3, brine, dried (Na2SO4), filtered, and evaporated in vacuo. The resulting amine 
derivative (474 mg, 87%) was used in the next step without further purification. 1HNMR 
(500Mz, C6D6) δ 7.76 (m, 1H), 7.60 (m, 3H), 7.30-6.93 (m, 19H), 6.24 (m, 1H), 5.64 (d, J = 17.2 
Hz, 1H), 5.24 (d, J = 10.5 Hz, 1H), 5.06 (d, J = 4.4 Hz, 1H), 4.83 (d, J = 11.4 Hz, 1H), 4.52 (m, 
2H), 4.41-4.21 (m, 4H), 4.00 (s, 1H), 3.79-3.63 (m, 4H), 3.14 (d, J = 11.3 Hz, 1H), 2.79 (m, 1H), 
13CNMR (125 MHz, C6D6) δ 177.4, 139.5, 139.0, 138.5, 134.0, 128.9, 128.7, 128.5, 128.3, 
128.1, 128.0, 119.2, 80.4, 77.3, 76.6, 75.2, 73.8, 72.5, 72.2, 69.2, 53.4, 36.9, 21.0.  
           To a solution of material from the previous step (475 mg, 1.0 mmol) in pyridine (1 mL) 
and Et3N (0.2 mL) was added phthalic anhydride (296 mg, 2.0 mmol). The reaction mixture was 
stirred at rt for 16 h, at which time pyridine (1.0 mL) and Ac2O (1.0 mL) were added. The 
mixture was stirred at rt for an additional 16 h. Excess organic solvents were evaporated in 
vacuo, and the residue purified by FCC to give 3.50 (425 mg, 61% over two steps): Rf = 0.37  
(20% EtOA/PE); 1HNMR (500Mz, CDCl3) δ 7.46-6.85 (m, 19 H), 5.90 (m, 1H), 5.15 (t, J = 10.5 
Hz, 1H), 4.88 (dd, J = 43.1, 17.1 Hz, 2H), 4.77 (ABq, J = 11.5 Hz, Δδ = 0.38 ppm, 2H), 4.49 (m, 
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2.38 (m, 2H); 13CNMR (125 MHz, CDCl3) δ169.2, 168.4, 139.9, 139.3, 139.0, 134.8, 134.0, 
133.9, 133.8, 132.7, 132.6, 129.0, 128.9, 128.8, 128.7, 128.5, 128.3, 128.0, 127.9, 123.7, 123.3, 
117.2, 78.8, 77.8, 76.1, 75.3, 73.9, 73.7, 71.7, 69.7, 53.8, 38.2. 
 
E/Z β-C-galactose amine 3.52 
  
         To a solution of 3.50 (400 mg, 0.66 mmol) in dry DCM (20 mL) was added di-tert-
butyldimethylsilyl ether of Z-2-butene-1,4-diol (630 mg, 2.0 mmol), and GI catalyst (27 mg, 
0.033). The reaction mixture was heated at 40 oC for 16 h. Excess solvent was removed in vacuo, 
and the residue was purified by FCC to give 3.52: Rf = 0.43 (15% EtOAc/PE). This material (500 
mg, 0.67 mmol) was dissolved in THF (5 mL) and then treated with 1M TBAF in THF (3.3 mL, 
3.3 mmol). The reaction mixture was stirred at rt for 2 h then diluted with water and extracted 
with EtOAc (3 X 20 mL). The organic material was washed with brine, dried (Na2SO4), filtered, 
and evaporated in vacuo. The residue was purified by FCC to give 3.52 as an inseparable mixture 
of E and Z isomers (280 mg, 45%): Rf = 0.1 (30% EtOAc/PE). 
 For E-isomer: 1HNMR (500Mz, CDCl3) δ 7.77 (m, 1H), 7.64 (m, 3H), 7.30 (m, 8H), 6.93 (m, 
4H), 5.56 (m, 1H), 5.42 (m, 1H), 4.89 (d, J = 11.7 Hz, 1H), 4.57-4.38 (m, 5H), 4.26 (m, 2H), 
4.13 (dd, J = 10.6, 5.4 Hz, 1H), 4.02 (m, 2H), 3.53 (m, 2H), 2.21 (m, 3H); 13CNMR (125 MHz, 
CDCl3) δ 168.8, 168.4, 138.8, 138.2, 138.0, 134.2, 134.1, 131.9, 131.8, 128.6, 128.4, 128.2, 
128.1, 128.0, 127.8, 127.7, 123.6, 123.3, 83.1, 77.7, 75.2, 74.6, 73.7, 72.6, 71.5, 69.2, 63.7, 62.7, 
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For Z-isomer: 1HNMR (500Mz, CDCl3) δ 7.77 (m, 1H), 7.65 (m, 3H), 7.30 (m, 8H), 6.95 (m, 
4H), 5.59 (m, 1H), 5.40 (m, 1H), 4.87 (d, J = 11.7 Hz, 1H), 4.57-4.19 (m, 7H), 4.11-3.88 (m, 
5H), 3.56 (dd, J = 9.4, 6.3 Hz, 1H), 3.44 (dd, J = 9.4, 6.5 Hz, 1H), 2.19 (m, 3H); 13CNMR (125 
MHz, CDCl3) δ 167.5, 137.5, 136.8, 136.6, 133.1, 132.9, 130.6, 130.5, 127.4, 127.3, 127.2, 
127.0, 126.9, 126.7, 126.6, 126.5, 126.3, 122.5, 122.2,81.8, 76.3, 76.1, 73.7, 73.4, 72.4, 71.3, 
70.3, 68.1, 61.5, 56.8, 51.6, 29.3.  
 
β-C-galactoseamine Crotylstannane 3.46 
 
 Treatment of 3.52 (250 mg, 0.40 mmol) under the conditions applied to 3.24 provided stannane 
3.46 (13%): Rf = 0.66 (20% EtOAc/PE); 
NMR Data for the xanthate intermediate: 1HNMR (500Mz, CDCl3) δ 7.76 (d, J = 6.3 Hz, 1H), 
7.63 (m, 3H), 7.27 (m, 7H), 6.92 (m, 5H), 5.69 (m, 1H), 5.50 (m, 1H), 4.88 (d, J = 11.7 Hz, 1H), 
4.65 (t, J = 5.5 Hz, 2H), 4.54 (m, 3H), 4.42 (ABq, J = 11.8 Hz, Δδ = 0.03 ppm, 2H), 4.28 (dd, J = 
10.8, 2.7 Hz, 1H), 4.23 (d, J = 12.1 Hz, 1H), 4.10 (m, 1H), 4.03 (m, 1H), 3.67 (t, J = 6.2 Hz, 1H), 
3.53 (m, 2H), 2.42 (s, 3H), 2.28 (m, 1H), 2.20 (m, 1H). 13CNMR (125 MHz, CDCl3) δ 215.5, 
168.8, 168.3, 138.8, 138.2, 138.0, 134.2, 134.1, 132.7, 131.9, 131.8, 128.7, 128.5, 128.4, 128.1, 
128.0, 127.8, 127.7, 125.1, 123.6, 123.3, 77.6, 77.3, 77.1, 75.1, 74.7, 74.0, 73.7, 72.7, 72.6, 71.5, 
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NMR data for E-Stannane:  1HNMR (500Mz, CDCl3) δ 7.76 (m, 1H), 7.60 (m, 3H), 7.30-6.93 
(m, 19H), 5.29 (m, 1H), 5.03 (m, 1H), 4.88 (m, 1H), 4.60-4.21 (m, 7H), 4.1-3.9 (m, 2H), 3.65 
(m, 1H), 3.53 (m, 2H), 2.01 (m, 2H), 1.57 (m, 4H), 1.33-1.08 (m, 11H), 0.86-0.61 (m, 12H). 
13CNMR (125 MHz, CDCl3) δ 168.8, 168.5, 138.9, 138.3, 138.1, 134.0, 133.9, 133.8, 132.1, 
131.6, 130.2, 128.7, 128.6, 128.5, 128.4, 128.3, 128.1, 127.9, 127.7, 127.6, 123.5, 123.2, 120.8, 
77.9, 77.8, 77.7, 77.3, 77.1, 76.2, 74.6, 73.7, 72.8, 72.6, 71.5, 69.2, 53.5, 36.7, 32.1, 30.9, 29.9, 




            To a solution of alcohol 3.53 (800 mg, 23 mmol) in toluene (15 mL) was added imidazole 
(316 mg, 4.6 mmol), triphenylphosphine (1.200 g, 4.6 mmol), and iodine (1.180 mg, 4.6 mmol). 
The reaction mixture was stirred at rt for 4 h. After tlc showed complete disappearance of the 
starting material, the reaction mixture was quenched with saturated solution of Na2S2O3 (20 mL) 
and extracted into EtOAc (3 x 25 mL). The organic layer was washed with brine, dried 
(Na2SO4), filtered, and evaporated under vacuo. Residue was purified over silica and (20% 
EtOAc/PE) (Rf = 0.63) to give the 6-iodo-lyxose derivative (720 mg, 69%); 1HNMR (500Mz, 
CDCl3) δ 7.26 (m, 10H), 4.98 (d, J = 2.9 Hz, 1H), 4.61 (ABq, J = 11.3 Hz, Δδ = 0.2 ppm, 2H), 
4.57 (ABq, J = 12.0 Hz, Δδ = 0.06 ppm, 2H), 4.30 (dd, J = 12.0, 7.1 Hz, 1H), 4.14 (t, J = 4.7 Hz, 
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MHz, CDCl3) δ 138.0, 137.8, 134.9, 129.8, 128.6, 128.5, 128.1, 127.9, 127.8, 107.0, 83.2, 80.1, 
78.3, 77.4, 77.1, 76.9, 73.9, 72.8, 55.9, 3.8.  
     To a solution of the product from the previous step (200 mg, 0.44 mmol) in EtOH (5 mL) was 
added Zn dust (143mg, 2.2 mmol). The reaction mixture was refluxed for 1 h; after diappearance 
of the starting material, reaction mixture was cool down to rt and unreacted Zn was filtered over 
celite pad. The organic solvent was concentrated in vacuo, and the residue was purified by CC to 
give aldehyde 3.47; 1HNMR (500Mz, CDCl3) δ 9.56 (s, 1H), 7.24 (m, 10 H), 5.80 (m, 1H), 5.30 
(m, 2H), 4.60 (ABq, J = 11.9 Hz, Δδ = 0.03 ppm, 2H), 4.45 (ABq, J = 12.0 Hz, Δδ = 0.2 ppm, 
2H), 4.09 (dd, J = 7.6, 4.8 Hz, 1H), 3.82 (dd, J = 4.8, 2.0 Hz, 1H), 13CNMR (125 MHz, CDCl3) δ 
201.9, 138.0, 137.4, 135.4, 135.0, 134.2, 129.9, 128.7, 128.6, 128.5, 128.4, 128.3, 128.1, 128.0, 
127.9, 120.3, 85.1, 80.4, 73.2, 70.7. 
 
Bis alkenes 3.54 and 3.55 
 
               To a solution of aldehyde 3.47  (25 mg. 0.083 mmol) in DCM (2.0 mL) was added 
BF3.OEt2 (21 µL, 0.165 mmol) at -78 oC. The reaction mixture was stirred for 15 min, and then 
stannane 3.46 (50 mg, 0.055 mmol) in DCM (1.0 mL) was added dropwise over 30 min. The 
reaction mixture was stirred at this temperature for 2 h. The reaction was then quenched by 
addition of 5.0 mL of saturated aqueous NaHCO3 (5 mL) at -78 oC and warmed up to rt. The 
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filtered (Na2SO4), and concentrated in vacuo. FCC of the residue afforded an inseparable mixture 
of two alcohols (42 mg, 99 %): Rf = 0.21 (20 % EtOAc/PE). 
               To this mixture (42 mg, 0.054 mmol) in EtOAc (1.0 mL) was added DMAP (ca 1 mg) 
and Ac2O (50 µL). The reaction mixture was stirred at rt for 5 min, the volatiles removed in 
vacuo, and the residue was purified over silica gel using 20% EtOAc/PE.  The major isomer 3.54 
was collected in 61%; NMR Data for 3.54 1HNMR (500Mz, CDCl3) δ 7.73 (d, J = 7.2 Hz, 1H), 
7.51 (m, 3H), 7.30-6.95 (m, 25H), 5.64 (m, 1H), 5.55 (m, 1H), 5.18 (d, J = 10.4 Hz, 1H), 5.04 (d, 
J = 17.3 Hz, 1H), 4.91 (m, 4H), 4.53 (m, 3H), 4.43 (m, 4H), 4.30 (m, 2H), 4.22 (m, 2H), 4.11 (m, 
2H), 3.60 (m, 5H), 2.51 (m, 1H), 1.78 (s, 3H), 1.68 (m, 2H). 13CNMR (125 MHz, CDCl3) δ 
170.1, 168.6, 168.5, 138.9, 138.8, 138.6, 138.4, 138.1, 134.9, 134.0, 131.9, 131.8, 128.6, 128.5, 
128.4, 128.3, 128.1, 127.9, 127.8, 127.7, 127.6, 127.5, 123.2, 119.5, 116.6, 80.9, 80.7, 77.7, 74.9, 
74.5, 73.6, 73.1, 72.6, 71.4, 70.1, 68.9, 53.9, 42.4, 29.9, 21.1.  
The minor Compound 3.55 (polar) was collected in 31%; NMR Data for 3.55 1HNMR (500Mz, 
CDCl3) δ 7.76 (d, J = 7.2 Hz, 1H), 7.63 (m, 3H), 7.30-6.90 (m, 25H), 5.80 (m, 1H), 5.22 (m, 
3H), 4.95 (m, 2H), 4.87 (m, 2H), 4.62-4.33 (m, 8H), 4.19 (m, 3H), 4.00 (m, 2H), 3.68 (t, J = 6.3 
Hz, 1H), 3.58 (m, 3H), 3.47 (m, 1H), 2.90 (m, 1H), 1.86 (s, 3H), 1.63 (m, 2H). 13CNMR (125 
MHz, CDCl3) δ 171.1, 168.6, 168.4, 138.9, 138.8, 138.4, 138.2, 138.0, 137.9, 137.6, 135.8, 
134.1, 134.0, 132.0, 128.6, 128.5, 128.4, 128.2, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 123.7, 
123.3, 119.6, 119.1, 80.9, 80.5, 77.8, 77.3, 77.1, 74.8, 74.7, 74.2, 73.7, 73.4, 72.8, 71.4, 70.4, 
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β-C-galactosyl Cyclohexene 3.56 
  
 A solution of 3.54 (25 mg, 0.06 mmol) in DCM (10 mL) was degassed with ethylene gas 
for 30 min, then GII catalyst (2.2 mg, 0.0026 mmol) was added in one portion and the reaction 
was left stirring at 40 oC for 6 h. because the reaction didn’t go to completion, another portion of 
GII catalyst (2.5 mg, 0.0030 mmol) was added and the reaction left stirring at the same 
temperature for an additional 12 h. excess solvent was evaporated in vacuo, and the residue was 
purified by CC to give 3.56 (18 mg, 88%): Rf = 0.21 (20% EtOAc/PE); 1HNMR (500Mz, C6D6) 
δ 7.24-6.97 (m, 29H), 5.72 (d, J = 9.9 Hz, 1H), 5.59 (d, J = 10.1 Hz, 1H), 5.19 (t, J = 10.4 Hz, 
1H), 5.07 (t, J = 11.6 Hz, 1H), 4.86 (ABq, J = 12.4 Hz, 2H), 4.67 (m, 2H), 4.60 (m, 1H), 4.53 
(m, 1H), 4.42-4.32 (m, 5H), 5.15 (m, 2H), 4.09 (bs, 1H), 3.92 (m, 1H), 3.83 (m, 2H), 3.30 (bs, 
1H), 2.03 (m, 1H), 1.92 (s, 3H), 1.76 (m, 1H); 13CNMR (125 MHz, C6D6) δ 170.5, 169.0, 168.5, 
140.2, 139.8, 139.6, 139.4, 138.9, 134.1, 133.5, 131.3, 129.0,127.9, 127.7, 127.0, 123.7, 123.3, 
78.6, 77.7, 76.2, 75.8, 75.6, 75.3, 74.3, 73.9, 73.6, 71.6, 71.2, 69.7, 54.4, 37.0, 30.5, 21.2.   
Neo-inositol 3.57 
 
          To a solution of 3.56 (18 mg, 0.021 mmol) in aceton/H2O 6:1 (1.0 mL) was added NMO 
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mixture was stirred at rt for 20 h. After disappearance of the starting material, Na2SO3 (50 mg) 
was added in one portion, reaction mixture was stirred at rt for 30 min, then it was extracted into 
EtOAc (4 x 2 mL). The organic layer was washed with brine, dried (Na2SO4), filtered, and 
evaporated in vacuo. Residue was dissolved in 0.5 mL of EtOAc and treated with Ac2O (25 uL) 
and DMAP (one crystal), reaction mixture was stirred at rt for 15 min, excess solvent was 
evaporated in vacuo. Residue was purified by CC to gave 3.57 (9 mg, 65%): Rf = 0.25 (30% 
EtOAc/PE); 1HNMR (500Mz, C6D6) δ 7.55-6.92 (m, 29H), 6.09 (t, J = 2.8 Hz, 1H), 5.92 (dd, J = 
10.6, 3.2 Hz, 1H), 5.19 (dd, J = 11.8, 2.1 Hz, 1H), 5.13 (t, J = 10.4 Hz, 1H), 5.01 (d, J = 11.6 Hz, 
1H), 4.79 (d, J = 12.3 Hz, 1H), 4.64 (m, 2H), 4.56 (m, 4H), 4.43-4.36 (m, 6H), 4.18 (d, J = 2.3 
Hz, 1H), 4.12 (d, J = 12.2 Hz, 1H), 3.94 (t, J = 8.8 Hz, 1H), 3.90 (m, 2H), 3.72 (dd, J = 8.2, 5.5 
Hz, 1H), 2.90 (m, 1H), 1.88 (m, 2H), 1.85 (s, 3H), 1.77 (s, 3H), 1.74 (s, 3H). 13CNMR (125 
MHz, C6D6) δ 170.4, 170.1, 169.8, 169.0, 168.7, 139.9, 139.6, 139.5, 139.3, 139.0, 134.0, 134.0, 
132.6, 132.4, 129.0, 128.9, 128.8, 128.1, 128.0, 127.9, 127.8, 127.7, 123.6, 123.4, 78.4, 77.7, 





Treatment of 3.55 (14 mg, mmol) under the same reaction conditions applied to 3.54 provided 
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6.00 (dd, J = 10.1, 2.4 Hz, 1H), 5.73 (dd, J = 9.3, 8.1 Hz, 1H), 5.64 (ddd, J = 10.0, 4.8, 2.6 Hz, 
1H), 5.16 (t, J = 10.5 Hz, 1H), 4.94 (d, J = 11.5 Hz, 1H), 4.67 (ddd, J = 11.6, 9.9, 1.9 Hz, 1H), 
4.59-4.28 (m, 910H), 4.04 (m, 2H), 3.90 (m, 1H), 3.79 (t, J = 5.8 Hz, 1H), 3.71 (m, 2H), 3.51 
(dd, J = 9.5, 3.6 Hz, 1H), 2.83 (m, 1H), 2.14 (m, 1H), 1.81 (m, 1H), 1.47 (s, 3H); 13CNMR (125 
MHz, C6D6) δ 170.0, 169.2, 168.5, 140.1, 139.8, 139.7, 139.4, 138.6, 133.8, 133.7, 132.5, 132.4, 
129.0, 127.9, 127.8, 127.7, 125.4, 123.7, 123.4, 80.1, 78.9, 77.9, 75.3, 74.4, 73.8, 73.7, 72.5, 




Treatment of 3.58 (10 mg, mmol) under the same reaction conditions applied to 3.56 provided 
3.59 (9 mg, 63%): Rf = 0.29 (30%EtOAc/PE); 1HNMR (500Mz, C6D6) δ 7.55-6.96 (m, 29H), 
6.05 (t, J = 3.5 Hz, 1H), 5.95 (t, J = 10.1 Hz, 1H), 5.80 (dd, J = 11.7, 3.0 Hz, 1H), 5.11 (t, J = 
10.4 Hz, 1H), 5.02 (d, J = 11.6 Hz, 1H), 4.79-4.63 (m, 5H), 4.50 (d, J = 11.7 Hz, 1H), 4.42 (d, J 
= 11.8 Hz, 2H), 4.33 (m, 2H), 4.16 (d, J = 2.4 Hz, 1H), 4.10 (d, J = 12.1 Hz, 1H), 3.95-3.86 (m, 
5H), 2.72 (m, 1H), 2.24 (m, 1H), 2.04 (s, 3H), 1.84 (m, 1H). 13CNMR (125 MHz, C6D6) δ 170.1, 
169.6, 169.5, 168.8, 168.7, 140.0, 139.5, 139.2, 139.0, 138.7, 133.9, 132.9, 132.5, 129.0, 128.9, 
128.8, 128.7, 128.1, 128.0, 127.9, 127.8, 127.7, 123.6, 123.3, 79.6, 78.3, 77.3, 75.1, 74.6, 73.9, 
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PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300250 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.1 K
DE                 6.00 usec
DW               62.400 usec
RG                 50.8
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              18.02
Date_          20131030
PROCNO                1
EXPNO                 6




























































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577638 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.1 K
DE                20.00 usec
DW               16.650 usec
RG               1724.1
AQ            1.0885438 sec
FIDRES         0.459357 Hz
SWH           30030.029 Hz
DS                    4
NS                   74
SOLVENT           CDCl3
TD                65374
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              18.15
Date_          20131030
PROCNO                1
EXPNO                 8














GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300200 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300188 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.1 K
DE                 6.00 usec
DW               75.000 usec
RG                 25.4
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    2
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              18.03
Date_          20131030
PROCNO                1
EXPNO                 7













































































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300234 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   64
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.11
Date_          20121004
PROCNO                1
EXPNO                 8












































































































































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577642 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG               1724.1
AQ            1.0912410 sec
FIDRES         0.458222 Hz
SWH           30030.029 Hz
DS                    4
NS                  128
SOLVENT           CDCl3
TD                65536
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.19
Date_          20121004
PROCNO                1
EXPNO                 9










































































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300237 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.15 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   64
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT            C6D6
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              17.49
Date_          20120825
PROCNO                1
EXPNO                 1








































































































































































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577631 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              20.00 dB
PL12              17.00 dB
PL2              120.00 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG               1724.1
AQ            1.0885438 sec
FIDRES         0.459357 Hz
SWH           30030.029 Hz
DS                    4
NS                  128
SOLVENT           CDCl3
TD                65374
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              18.01
Date_          20120825
PROCNO                1
EXPNO                 3



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300228 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   64
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              13.54
Date_          20130327
PROCNO                1
EXPNO                 1





































































































































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577654 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG               1724.1
AQ            1.0912410 sec
FIDRES         0.458222 Hz
SWH           30030.029 Hz
DS                    4
NS                  128
SOLVENT           CDCl3
TD                65536
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              14.05
Date_          20130327
PROCNO                1
EXPNO                 3




















































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300232 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                 35.9
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                   32
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              17.08
Date_          20130123
PROCNO                1
EXPNO                 1

















































































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577644 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG                46341
AQ            1.0885438 sec
FIDRES         0.459357 Hz
SWH           30030.029 Hz
DS                    4
NS                  300
SOLVENT           CDCl3
TD                65374
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              17.32
Date_          20130123
PROCNO                1
EXPNO                 3



















































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300246 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300240 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 28.5
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    2
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              17.08
Date_          20130123
PROCNO                1
EXPNO                 2











GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7578096 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300170 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       392.587952 Hz
SFO1           125.7678 MHz
TD                   64
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.26 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                22.80 usec
P3                11.40 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                18.24 usec
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122424 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG              20642.5
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                    9
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              17.33
Date_          20130123
PROCNO                1
EXPNO                 4


























































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300229 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   32
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.41
Date_          20130501
PROCNO                1
EXPNO                 1








































































































































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577681 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG               1724.1
AQ            1.0885438 sec
FIDRES         0.459357 Hz
SWH           30030.029 Hz
DS                    4
NS                  600
SOLVENT           CDCl3
TD                65374
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.35
Date_          20130501
PROCNO                1
EXPNO                 4



















































































































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300226 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                 35.9
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              17.29
Date_          20130502
PROCNO                1
EXPNO                 1























































































































































































































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577650 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG               1724.1
AQ            1.0912410 sec
FIDRES         0.458222 Hz
SWH           30030.029 Hz
DS                    4
NS                  150
SOLVENT           CDCl3
TD                65536
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              17.49
Date_          20130502
PROCNO                1
EXPNO                 3






























































































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300228 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                 35.9
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              15.42
Date_          20130329
PROCNO                1
EXPNO                 1


























































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577647 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG               1724.1
AQ            1.0885438 sec
FIDRES         0.459357 Hz
SWH           30030.029 Hz
DS                    4
NS                  128
SOLVENT           CDCl3
TD                65374
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              15.53
Date_          20130329
PROCNO                1
EXPNO                 3































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300176 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300181 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 28.5
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    1
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              15.42
Date_          20130329
PROCNO                1
EXPNO                 2
















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577668 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300190 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.26 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                22.80 usec
P3                11.40 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                18.24 usec
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122424 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                297.9 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   19
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              15.57
Date_          20130329
PROCNO                1
EXPNO                 4



















































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300235 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   32
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                   65
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.16
Date_          20130306
PROCNO                1
EXPNO                 8


























































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577633 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG                46341
AQ            1.0912410 sec
FIDRES         0.458222 Hz
SWH           30030.029 Hz
DS                    4
NS                  500
SOLVENT           CDCl3
TD                65536
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.54
Date_          20130306
PROCNO                1
EXPNO                10



















































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1299839 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   64
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                  467
SOLVENT             Pyr
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              13.06
Date_          20140121
PROCNO                1
EXPNO                 2






























































































































































































































































































PC                 0.20
GB                    0
LB                 1.00 Hz
SSB                   0
WDW                  EM
SF          125.7577046 MHz
SI                32768
SFO2        500.1320005 MHz
PL13              18.36 dB
PL12              18.36 dB
PL2               −0.50 dB
PCPD2             80.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        125.7703643 MHz
PL1                3.50 dB
P1                11.40 usec
NUC1                13C
======== CHANNEL f1 ========
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                20.00 usec
DW               16.650 usec
RG               1724.1
AQ            1.0885438 sec
FIDRES         0.459357 Hz
SWH           30030.029 Hz
DS                    4
NS                 1000
SOLVENT             Pyr
TD                65374
PULPROG            zgpg
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              18.44
Date_          20140115
PROCNO                1
EXPNO                 7

































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299833 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299820 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 35.9
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    4
SOLVENT             Pyr
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              13.07
Date_          20140121
PROCNO                1
EXPNO                 3
NAME           20140121









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300467 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300457 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 50.8
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    5
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               3.39
Date_          20130710
PROCNO                1
EXPNO                 6
















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577612 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300452 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.26 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                22.80 usec
P3                11.40 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                18.24 usec
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122424 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   25
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               5.43
Date_          20130710
PROCNO                1
EXPNO                 8













































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300173 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300180 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 35.9
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    3
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.53
Date_          20130731
PROCNO                1
EXPNO                 2
























































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300431 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300435 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 35.9
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    4
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              19.37
Date_          20140301
PROCNO                1
EXPNO                 9














GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577910 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300427 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                46341
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                    9
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.14
Date_          20140301
PROCNO                1
EXPNO                11
























































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300438 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300398 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 35.9
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    4
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              19.12
Date_          20140302
PROCNO                1
EXPNO                 7













GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577700 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300431 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   25
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.15
Date_          20140302
PROCNO                1
EXPNO                 9
































































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300437 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300438 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.1 K
DE                 6.00 usec
DW               75.000 usec
RG                 22.6
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    1
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.59
Date_          20131104
PROCNO                1
EXPNO                10

















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7578330 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300459 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       375.009369 Hz
SFO1           125.7678 MHz
TD                   67
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.26 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                22.80 usec
P3                11.40 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                18.24 usec
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122424 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.1 K
DE                 6.00 usec
DW               75.000 usec
RG                46341
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   30
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              23.22
Date_          20131104
PROCNO                1
EXPNO                17












GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          600.1300560 MHz
MC2         States−TPPI
SI                 1024
PC                 1.00
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          600.1300585 MHz
SI                 1024
FnMODE      States−TPPI
SW                8.502 ppm
FIDRES        39.859695 Hz
SFO1           600.1323 MHz
TD                  128
ND0                   1
P17             2500.00 usec
P1                 7.75 usec
NUC1                 1H
SFO1        600.1322805 MHz
======== CHANNEL f1 ========
IN0          0.00019600 sec
D12          0.00002000 sec
D11          0.03000000 sec
D8           0.30000001 sec
D1           2.00000000 sec
D0           0.00008813 sec
TE                303.0 K
DE                10.00 usec
DW               98.000 usec
RG                  114
AQ            0.2007540 sec
FIDRES         2.491231 Hz
SWH            5102.041 Hz
DS                   16
NS                  190
SOLVENT           CDCl3
TD                 2048
PULPROG       noesyphpp
PROBHD   5 mm CPTCI 1H−
INSTRUM           spect
Time              18.30
Date_          20131106
PROCNO                1
EXPNO                 8





















































































































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300438 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300456 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.1 K
DE                 6.00 usec
DW               75.000 usec
RG                 22.6
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    1
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               4.18
Date_          20131027
PROCNO                1
EXPNO                 2

















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577626 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300446 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.26 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                22.80 usec
P3                11.40 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                18.24 usec
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122424 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.1 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   20
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               7.03
Date_          20131027
PROCNO                1
EXPNO                15










GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300503 MHz
MC2         States−TPPI
SI                 2048
PC                 1.00
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300486 MHz
SI                 2048
FnMODE      States−TPPI
SW               10.243 ppm
FIDRES        40.023052 Hz
SFO1           500.1323 MHz
TD                  128
ND0                   1
SFO1        500.1323022 MHz
PL1               −0.50 dB
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
ST1CNT                0
IN0          0.00019520 sec
D8           0.50000000 sec
D1           2.00000000 sec
d0           0.00008599 sec
TE                298.1 K
DE                 6.00 usec
DW               97.600 usec
RG                203.2
AQ            0.2000324 sec
FIDRES         2.501441 Hz
SWH            5122.951 Hz
DS                    4
NS                  120
SOLVENT           CDCl3
TD                 2048
PULPROG         noesyph
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               8.04
Date_          20131027
PROCNO                1
EXPNO                16























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW               QSINE
SF          600.1299951 MHz
MC2                  QF
SI                 1024
PC                 1.00
GB                    0
LB                 0.00 Hz
SSB                   0
WDW               QSINE
SF          600.1299863 MHz
SI                 1024
FnMODE               QF
SW               13.352 ppm
FIDRES        62.600159 Hz
SFO1           600.1336 MHz
TD                  128
ND0                   1
P17             2500.00 usec
P1                 8.00 usec
P0                 8.00 usec
NUC1                 1H
SFO1        600.1336081 MHz
======== CHANNEL f1 ========
IN0          0.00012480 sec
D16          0.00020000 sec
D13          0.00000400 sec
D12          0.00002000 sec
D11          0.03000000 sec
D1           2.00000000 sec
D0           0.00000300 sec
TE                303.0 K
DE                10.00 usec
DW               62.400 usec
RG                   64
AQ            0.1278452 sec
FIDRES         3.912510 Hz
SWH            8012.820 Hz
DS                    8
NS                    1
SOLVENT            C6D6
TD                 2048
PULPROG      cosygpppqf
PROBHD   5 mm CPTCI 1H−
INSTRUM           spect
Time              14.00
Date_          20131111
PROCNO                1
EXPNO                 4











GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          150.9028360 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.00
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          600.1299924 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              165.657 ppm
FIDRES        97.656250 Hz
SFO1           150.9141 MHz
TD                  256
ND0                   2
P28             1000.00 usec
P2                16.00 usec
P1                 8.00 usec
NUC1                 1H
SFO1        600.1336081 MHz
======== CHANNEL f1 ========
ZGOPTNS
IN0          0.00002000 sec
D16          0.00020000 sec
D11          0.03000000 sec
D4           0.00172414 sec
D1           1.50000000 sec
D0           0.00000300 sec
CNST2       145.0000000
TE                303.0 K
DE                10.00 usec
DW               64.000 usec
RG                 2050
AQ            0.0655860 sec
FIDRES         7.629395 Hz
SWH            7812.500 Hz
DS                   16
NS                    2
SOLVENT            C6D6
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPTCI 1H−
INSTRUM           spect
Time              13.45
Date_          20131111
PROCNO                1
EXPNO                 3

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300545 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300538 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   32
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    3
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              23.53
Date_          20130805
PROCNO                1
EXPNO                14











GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577299 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300518 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       644.246887 Hz
SFO1           125.7678 MHz
TD                   39
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.26 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                22.80 usec
P3                11.40 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                18.24 usec
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122424 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   50
SOLVENT            C6D6
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               0.34
Date_          20130806
PROCNO                1
EXPNO                16
















































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299795 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299812 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.12 usec
P0                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.1 K
DE                 6.00 usec
DW               75.000 usec
RG                   18
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    2
SOLVENT             Pyr
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               0.22
Date_          20131120
PROCNO                1
EXPNO                 2
NAME           20131120

















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7580035 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1299816 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.26 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                22.80 usec
P3                11.40 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                18.24 usec
P1                 9.12 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122424 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.1 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   60
SOLVENT             Pyr
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               2.24
Date_          20131120
PROCNO                1
EXPNO                 5
NAME           20131120


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300786 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300524 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   64
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    5
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.14
Date_          20140310
PROCNO                1
EXPNO                 9
NAME           20140310















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577520 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300534 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                  100
SOLVENT            C6D6
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              22.47
Date_          20140310
PROCNO                1
EXPNO                12
NAME           20140310







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300544 MHz
MC2                  QF
SI                 1024
PC                 1.00
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300537 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1                1.50 dB
P1                12.50 usec
P0                12.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   64
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    1
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDUL 13C
INSTRUM           spect
Time               4.21
Date_          20120303
PROCNO                1
EXPNO                19














GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300647 MHz
MC2         States−TPPI
SI                 2048
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300600 MHz
SI                 2048
FnMODE      States−TPPI
SW               10.243 ppm
FIDRES        20.011526 Hz
SFO1           500.1323 MHz
TD                  256
ND0                   1
SFO1        500.1323022 MHz
PL1                1.50 dB
P1                12.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ST1CNT                0
IN0          0.00019520 sec
D8           0.50000000 sec
D1           2.00000000 sec
d0           0.00008168 sec
TE                298.0 K
DE                 6.00 usec
DW               97.600 usec
RG                   64
AQ            0.2000324 sec
FIDRES         2.501441 Hz
SWH            5122.951 Hz
DS                    4
NS                   40
SOLVENT           CDCl3
TD                 2048
PULPROG         noesyph
PROBHD   5 mm CPDUL 13C
INSTRUM           spect
Time               4.32
Date_          20120303
PROCNO                1
EXPNO                20
































































































































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          600.1300000 MHz
SI                65536
P1                 8.95 usec
NUC1                 1H
SFO1        600.1337060 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               41.600 usec
RG                  114
AQ            2.7263477 sec
FIDRES         0.183399 Hz
SWH           12019.230 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm QXI 1H Z−
INSTRUM           spect
Time              21.49
Date_          20140107
PROCNO                1
EXPNO                 5





















































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300485 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                 40.3
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                  128
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               1.14
Date_          20140811
PROCNO                1
EXPNO                 4

































































































































































































































































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300481 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                  114
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                  128
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               2.34
Date_          20140812
PROCNO                1
EXPNO                 6

































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300436 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300448 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   64
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    5
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               2.35
Date_          20140812
PROCNO                1
EXPNO                 7
NAME           20140812















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577326 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300412 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   65
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               5.33
Date_          20140812
PROCNO                1
EXPNO                 9
NAME           20140812









































































































































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300000 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   64
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              23.32
Date_          20140814
PROCNO                1
EXPNO                23







































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299998 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299994 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   57
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    1
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              23.34
Date_          20140814
PROCNO                1
EXPNO                25
NAME           20140814
















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7578704 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300010 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   25
SOLVENT            C6D6
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              23.46
Date_          20140814
PROCNO                1
EXPNO                27
NAME           20140814












































































































































































































































































































PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300000 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                 45.3
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT            C6D6
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               2.09
Date_          20140820
PROCNO                1
EXPNO                 5







































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300010 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299998 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   32
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    1
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               2.09
Date_          20140820
PROCNO                1
EXPNO                 6
NAME           20140820

































































































































































































































































AAACRYOPROTON C6D6 /opt/topspin aaltiti 6
PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300000 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   64
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT            C6D6
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               0.46
Date_          20140817
PROCNO                1
EXPNO                 1










































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300010 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299998 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   57
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    1
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               0.47
Date_          20140817
PROCNO                1
EXPNO                 2
NAME           20140817























































































































































































































































































































AAACRYOPROTON C6D6 /opt/topspin aaltiti 9
PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300000 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                 40.3
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT            C6D6
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               1.12
Date_          20140820
PROCNO                1
EXPNO                 1










































































































































































































































































































































































































































































































































































































AAACRYOPROTON C6D6 /opt/topspin aaltiti 9
PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300000 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   64
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                   24
SOLVENT            C6D6
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               2.45
Date_          20140820
PROCNO                1
EXPNO                17












































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300010 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299998 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 45.3
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    2
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               2.45
Date_          20140820
PROCNO                1
EXPNO                18
NAME           20140820



















































































































































































































































































































AAACRYOPROTON CDCl3 /opt/topspin aaltiti 12
PC                 1.00
GB                    0
LB                 0.30 Hz
SSB                   0
WDW                  EM
SF          500.1300486 MHz
SI                32768
SFO1        500.1330885 MHz
PL1               −0.50 dB
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.00 usec
DW               62.400 usec
RG                   64
AQ            2.0448356 sec
FIDRES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                   32
SOLVENT           CDCl3
TD                32768
PULPROG            zg30
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.49
Date_          20140821
PROCNO                1
EXPNO                16




























































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300446 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300450 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 40.3
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    1
SOLVENT           CDCl3
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.49
Date_          20140821
PROCNO                1
EXPNO                17
NAME           20140821













GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577386 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300431 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                46341
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   60
SOLVENT           CDCl3
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time               9.24
Date_          20140822
PROCNO                1
EXPNO                23
NAME           20140821

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300009 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299998 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                 35.9
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    2
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              18.33
Date_          20140319
PROCNO                1
EXPNO                15
NAME           20140319
















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7578704 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300010 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                    9
SOLVENT            C6D6
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              18.49
Date_          20140319
PROCNO                1
EXPNO                17
NAME           20140319











GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300046 MHz
MC2         States−TPPI
SI                 2048
PC                 1.00
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300000 MHz
SI                 2048
FnMODE      States−TPPI
SW               10.243 ppm
FIDRES        40.023052 Hz
SFO1           500.1323 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ2             −40.00 %
GPZ1              40.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1323022 MHz
PL1               −0.50 dB
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TAU          0.24879999 sec
ST1CNT                0
IN0          0.00019520 sec
D16          0.00020000 sec
D8           0.50000000 sec
D1           2.00000000 sec
d0           0.00008550 sec
TE                298.0 K
DE                 6.00 usec
DW               97.600 usec
RG                   32
AQ            0.2000324 sec
FIDRES         2.501441 Hz
SWH            5122.951 Hz
DS                   16
NS                   60
SOLVENT            C6D6
TD                 2048
PULPROG       noesygpph
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              19.54
Date_          20140319
PROCNO                1
EXPNO                18
NAME           20140319














































































































































































































































































































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300010 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299998 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   32
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    2
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.57
Date_          20140321
PROCNO                1
EXPNO                 2
NAME           20140321













GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7578704 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300010 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                    2
SOLVENT            C6D6
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.13
Date_          20140321
PROCNO                1
EXPNO                 4
NAME           20140321



































































































































































































































































































































































































































































































































































































































































































6.0 GB                    0LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300575 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300578 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        52.083332 Hz
SFO1            500.133 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   32
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    2
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.11
Date_          20140405
PROCNO                1
EXPNO                 2
NAME           20140405















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577351 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300538 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       256.383972 Hz
SFO1           125.7678 MHz
TD                   98
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                29193
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   12
SOLVENT            C6D6
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              20.38
Date_          20140405
PROCNO                1
EXPNO                 4
NAME           20140405














GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300589 MHz
MC2         States−TPPI
SI                 2048
PC                 1.00
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300584 MHz
SI                 2048
FnMODE      States−TPPI
SW               10.243 ppm
FIDRES        40.023052 Hz
SFO1           500.1323 MHz
TD                  128
ND0                   1
P16             1000.00 usec
GPZ2             −40.00 %
GPZ1              40.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1323022 MHz
PL1               −0.50 dB
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
TAU          0.24879999 sec
ST1CNT                0
IN0          0.00019520 sec
D16          0.00020000 sec
D8           0.50000000 sec
D1           2.00000000 sec
d0           0.00008550 sec
TE                298.0 K
DE                 6.00 usec
DW               97.600 usec
RG                203.2
AQ            0.2000324 sec
FIDRES         2.501441 Hz
SWH            5122.951 Hz
DS                   16
NS                   90
SOLVENT            C6D6
TD                 2048
PULPROG       noesygpph
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              21.09
Date_          20140405
PROCNO                1
EXPNO                 5
NAME           20140405




























































































































































































































































































































































































GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1300010 MHz
MC2                  QF
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   0
WDW                SINE
SF          500.1299998 MHz
SI                 1024
FnMODE               QF
SW               13.330 ppm
FIDRES        53.333332 Hz
SFO1            500.133 MHz
TD                  125
ND0                   1
P16             1000.00 usec
GPZ1              10.00 %
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO1        500.1330069 MHz
PL1               −0.50 dB
P1                 9.50 usec
P0                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
IN0          0.00015000 sec
D16          0.00020000 sec
d13          0.00000400 sec
D1           1.48689198 sec
d0           0.00000300 sec
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                   32
AQ            0.1537250 sec
FIDRES         3.255208 Hz
SWH            6666.667 Hz
DS                    8
NS                    3
SOLVENT            C6D6
TD                 2048
PULPROG        cosygpqf
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              15.00
Date_          20140409
PROCNO                1
EXPNO                 2
NAME           20140409
















GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          125.7577490 MHz
MC2       echo−antiecho
SI                 1024
PC                 1.40
GB                    0
LB                 0.00 Hz
SSB                   2
WDW               QSINE
SF          500.1300011 MHz
SI                 1024
FnMODE    Echo−Antiecho
SW              199.778 ppm
FIDRES       196.293976 Hz
SFO1           125.7678 MHz
TD                  128
ND0                   2
P16             1000.00 usec
GPZ2              20.10 %
GPZ1              80.00 %
GPNAM2         SINE.100
GPNAM1         SINE.100
====== GRADIENT CHANNEL =====
SFO2        125.7678496 MHz
PL12              19.98 dB
PL2                3.50 dB
PCPD2             70.00 usec
p4                21.00 usec
P3                10.50 usec
NUC2                13C
CPDPRG2            garp
======== CHANNEL f2 ========
SFO1        500.1330069 MHz
PL1               −0.50 dB
P28             2000.00 usec
p2                19.00 usec
P1                 9.50 usec
NUC1                 1H
======== CHANNEL f1 ========
ZGOPTNS
ST1CNT                0
IN0          0.00001990 sec
DELTA1       0.00071614 sec
DELTA        0.00122500 sec
D16          0.00020000 sec
d13          0.00000400 sec
d11          0.03000000 sec
d4           0.00172414 sec
D1           1.20000005 sec
d0           0.00000300 sec
CNST2       145.0000000
TE                298.0 K
DE                 6.00 usec
DW               75.000 usec
RG                46341
AQ            0.0769250 sec
FIDRES         6.510417 Hz
SWH            6666.667 Hz
DS                   16
NS                   29
SOLVENT            C6D6
TD                 1024
PULPROG        hsqcetgp
PROBHD   5 mm CPDCH 13C
INSTRUM           spect
Time              15.33
Date_          20140409
PROCNO                1
EXPNO                 4
NAME           20140409
AAACRYOHSQC C6D6 /opt/topspin aaltiti 13
405
